BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335-1343. [PMID: 19564476 DOI: 10.2337/dc09-9032] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 727] [Article Influence: 77.1] [Reference Citation Analysis]
Number Citing Articles
1 Tao Z, Shi A, Zhao J. Epidemiological Perspectives of Diabetes. Cell Biochem Biophys. 2015;73:181-185. [PMID: 25711186 DOI: 10.1007/s12013-015-0598-4] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 20.0] [Reference Citation Analysis]
2 Osataphan S, Chalermchai T, Ngaosuwan K. Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study: 临床惰性可导致2型糖尿病患者新发视网膜病变或视网膜病变进展:一项回顾性队列研究. J Diabetes 2017;9:267-74. [DOI: 10.1111/1753-0407.12410] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
3 Losko M, Kotlinowski J, Jura J. Long Noncoding RNAs in Metabolic Syndrome Related Disorders. Mediators Inflamm 2016;2016:5365209. [PMID: 27881904 DOI: 10.1155/2016/5365209] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
4 Yoshida K, Sato H, Kimura S, Tanaka T, Kasai K. A case of sudden cardiac death due to mitochondrial disease. Legal Medicine 2022. [DOI: 10.1016/j.legalmed.2022.102026] [Reference Citation Analysis]
5 Hritani AW, Jan MF, Schleis G, Zehrer T, Olet S, Ammar KA, Allaqaband S. Clinical Features and Prognosis of Type 2 Myocardial Infarction in Acutely Decompensated Diabetic Patients. Am J Med 2018;131:820-8. [PMID: 29518369 DOI: 10.1016/j.amjmed.2018.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sheng Y, Zheng S, Ma T, Zhang C, Ou X, He X, Xu W, Huang K. Mulberry leaf alleviates streptozotocin-induced diabetic rats by attenuating NEFA signaling and modulating intestinal microflora. Sci Rep 2017;7:12041. [PMID: 28935866 DOI: 10.1038/s41598-017-12245-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
7 Lu C, Chang H, Chen H, Ku LE, Chang Y, Shen H, Li C. Inverse relationship between ambient temperature and admissions for diabetic ketoacidosis and hyperglycemic hyperosmolar state: A 14-year time-series analysis. Environment International 2016;94:642-8. [DOI: 10.1016/j.envint.2016.06.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Zhu B, Lin Z, Chen X, Gusdon AM, Shen W, Chen J, Zheng L, Sun H, Li Y, Zhu C, Li J, Qu S. Circulating osteocalcin: A potential predictor of ketosis in type 2 diabetes. Diabetes Metab Res Rev 2020;36:e3265. [PMID: 31850672 DOI: 10.1002/dmrr.3265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ahmed S, Sulaiman SA, Baig AA, Ibrahim M, Liaqat S, Fatima S, Jabeen S, Shamim N, Othman NH. Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action. Oxid Med Cell Longev 2018;2018:8367846. [PMID: 29492183 DOI: 10.1155/2018/8367846] [Cited by in Crossref: 65] [Cited by in F6Publishing: 42] [Article Influence: 16.3] [Reference Citation Analysis]
10 Ciechanowska A, Ladyzynski P, Wojcicki JM, Sabalinska S, Krzymien J, Pulawska E, Karnafel W, Foltynski P, Kawiak J. Microdialysis monitoring of glucose, lactate, glycerol, and pyruvate in patients with diabetic ketoacidosis. Int J Artif Organs 2013;36:869-77. [PMID: 24362895 DOI: 10.5301/ijao.5000265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Singh H, Singh JV, Bhagat K, Gulati HK, Sanduja M, Kumar N, Kinarivala N, Sharma S. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. Bioorg Med Chem 2019;27:3477-510. [PMID: 31255497 DOI: 10.1016/j.bmc.2019.06.033] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 12.3] [Reference Citation Analysis]
12 Saravani R, Esmaeeli E, Kordi Tamendani M, Nejad MN. Oxytocin Receptor Gene Polymorphisms in Patients With Diabetes. Gene Cell Tissue 2015;2. [DOI: 10.17795/gct-27904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Diaz-Ramos A, Eilbert W, Marquez D. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Int J Emerg Med 2019;12:27. [PMID: 31488052 DOI: 10.1186/s12245-019-0240-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
14 Seddik AA, Bashier A, Alhadari AK, Alalawi F, Alnour HH, Bin Hussain AA, Frankel A, Railey MJ. Challenges in management of diabetic ketoacidosis in hemodialysis patients, case presentation and review of literature. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:2481-7. [DOI: 10.1016/j.dsx.2019.06.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Mahler SA, Conrad SA, Wang H, Arnold TC. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med. 2011;29:670-674. [PMID: 20825879 DOI: 10.1016/j.ajem.2010.02.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
16 Wang R, Kave B, McIlroy E, Kyi M, Colman PG, Fourlanos S. Metabolic outcomes in patients with diabetes mellitus administered SGLT2 inhibitors immediately before emergency or elective surgery: single centre experience and recommendations. Br J Anaesth 2021;127:e5-7. [PMID: 33934891 DOI: 10.1016/j.bja.2021.03.023] [Reference Citation Analysis]
17 Pilotto A, Noale M, Maggi S, Addante F, Tiengo A, Perin PC, Rengo G, Crepaldi G. Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients. Biomed Res Int 2014;2014:906103. [PMID: 24689062 DOI: 10.1155/2014/906103] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
18 Rohrscheib M, Argyropoulos C, Rondon-berrios H, Glew RH, Murata GH, Tzamaloukas AH. Indices of Serum Tonicity in Clinical Practice. The American Journal of the Medical Sciences 2015;349:537-44. [DOI: 10.1097/maj.0000000000000470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Zhang Y, Wu M, Dai W, Li Y, Wang X, Tan D, Yang Z, Liu S, Xue L, Lei Y. Gold nanoclusters for controlled insulin release and glucose regulation in diabetes. Nanoscale 2019;11:6471-9. [DOI: 10.1039/c9nr00668k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
20 Shen X, Li J, Zou S, Wu H, Zhang Y. The relationship between oxidative stress and the levels of serum circulating adhesion molecules in patients with hyperglycemia crises. Journal of Diabetes and its Complications 2012;26:291-5. [DOI: 10.1016/j.jdiacomp.2012.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Eskandarani RM, Sawan S. Diabetic Ketoacidosis on Hospitalization with COVID-19 in a Previously Nondiabetic Patient: A Review of Pathophysiology. Clin Med Insights Endocrinol Diabetes 2020;13:1179551420984125. [PMID: 33488135 DOI: 10.1177/1179551420984125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Khan M, Nagal V, Nakate UT, Khan MR, Khosla A, Ahmad R. Engineered CuO Nanofibers with Boosted Non-Enzymatic Glucose Sensing Performance. J Electrochem Soc 2021;168:067507. [DOI: 10.1149/1945-7111/ac030d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
23 Nguyen AD, Luong CQ, Chu HC, Nguyen VKD, Nguyen CV, Nguyen TA, Nguyen QH, Mai TD, Nguyen DV, Nguyen BQ, Tran TH, Dao PV, Nguyen DT, Nguyen NN, Do SN. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report. BMC Endocr Disord 2019;19:121. [PMID: 31711488 DOI: 10.1186/s12902-019-0451-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Li Y, Yi M, Deng X, Li W, Chen Y, Zhang X. Evaluation of the Thyroid Characteristics and Correlated Factors in Hospitalized Patients with Newly Diagnosed Type 2 Diabetes. Diabetes Metab Syndr Obes 2022;15:873-84. [PMID: 35340987 DOI: 10.2147/DMSO.S355727] [Reference Citation Analysis]
25 Kim SK, Baek JH, Lee KJ, Hahm JR, Jung JH, Kim HJ, Kim H, Kim S, Chung SI, Jung TS. Clinical Characteristics of Patients with Hyperglycemic Emergency State Accompanying Rhabdomyolysis. Endocrinol Metab 2011;26:317. [DOI: 10.3803/enm.2011.26.4.317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Siregar NN, Soewondo P, Subekti I, Muhadi M. Seventy-Two Hour Mortality Prediction Model in Patients with Diabetic Ketoacidosis: A Retrospective Cohort Study. J ASEAN Fed Endocr Soc 2018;33:124-9. [PMID: 33442117 DOI: 10.15605/jafes.033.02.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kreider KE. Updates in the Management of Diabetic Ketoacidosis. The Journal for Nurse Practitioners 2018;14:591-7. [DOI: 10.1016/j.nurpra.2018.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
28 Nuwagaba J, Srikant S, Darshit D. Case Series: Management of Hypernatremia in DKA in a Tertiary Healthcare Setting in a Developing Country. Int Med Case Rep J 2021;14:567-71. [PMID: 34475785 DOI: 10.2147/IMCRJ.S326350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Macarthur C, Phillips A. Ketoacidosis in diabetes: Recognition and avoidance. Practice Nursing 2015;26:393-9. [DOI: 10.12968/pnur.2015.26.8.393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Papadokostaki E, Liberopoulos E. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy. Case Rep Endocrinol 2019;2019:3901741. [PMID: 31198610 DOI: 10.1155/2019/3901741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Pałasz A, Cież D, Trzewik B, Miszczak K, Tynor G, Bazan B. In the Search of Glycoside-Based Molecules as Antidiabetic Agents. Top Curr Chem (Cham) 2019;377:19. [PMID: 31165274 DOI: 10.1007/s41061-019-0243-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
32 O’neill S, Drobatz K, Satyaraj E, Hess R. Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus. Veterinary Immunology and Immunopathology 2012;148:276-83. [DOI: 10.1016/j.vetimm.2012.06.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
33 Levine JA, Karam SL, Aleppo G. SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns. Curr Diab Rep 2017;17:54. [PMID: 28597228 DOI: 10.1007/s11892-017-0874-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lipatov K, Kurian KK, Shaver C, White HD, Ghamande S, Arroliga AC, Surani S. Early vs late oral nutrition in patients with diabetic ketoacidosis admitted to a medical intensive care unit. World J Diabetes 2019; 10(1): 57-62 [PMID: 30697371 DOI: 10.4239/wjd.v10.i1.57] [Reference Citation Analysis]
35 Kjærulff MLBG, Astrup BS. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data. J Forensic Leg Med 2019;63:34-9. [PMID: 30856551 DOI: 10.1016/j.jflm.2019.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Al Hazmi A, Manning S. Limb Ischemia in a Patient with Hyperosmolar Hyperglycemic State. Clin Pract Cases Emerg Med 2018;2:348-52. [PMID: 30443624 DOI: 10.5811/cpcem.2018.9.39920] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Zee-Cheng JE, Webber EC, Abu-Sultaneh S. Adherence to pediatric diabetic ketoacidosis guidelines by community emergency departments' providers. Int J Emerg Med 2017;10:11. [PMID: 28321786 DOI: 10.1186/s12245-017-0137-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
38 Villani M, Nanayakkara N, Ranasinha S, Earnest A, Smith K, Soldatos G, Teede H, Zoungas S. Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study. PLoS One 2017;12:e0182413. [PMID: 28771639 DOI: 10.1371/journal.pone.0182413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
39 Espes D, Engström J, Reinius H, Carlsson PO. Severe diabetic ketoacidosis in combination with starvation and anorexia nervosa at onset of type 1 diabetes: a case report. Ups J Med Sci 2013;118:130-3. [PMID: 23544963 DOI: 10.3109/03009734.2013.786000] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, Davis G, Vellanki P, Migdal A, Gujral U, Narayan KMV, Umpierrez GE. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care 2020;43:349-57. [PMID: 31704689 DOI: 10.2337/dc19-1168] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
41 Song R, Cao S. Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating a "Chicken and Egg" Paradigm in Ketosis-Prone Diabetes. Diabetes Ther 2018;9:1377-83. [PMID: 29600506 DOI: 10.1007/s13300-018-0417-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Claret P, Douay B, Chaiba D, Catoire P. Actualités en médecine d’urgence. Ann Fr Med Urgence 2021;11:344-50. [DOI: 10.3166/afmu-2021-0354] [Reference Citation Analysis]
43 Yaman A. Severe Rhabdomyolysis and Acute Renal Failure Treated by Continuous Venovenous Hemodiafiltration in a Child with Diabetic Ketoacidosis. Indian Journal of Critical Care Medicine 2022;26:136-8. [DOI: 10.5005/jp-journals-10071-24093] [Reference Citation Analysis]
44 Fukuyama Y, Numata K, Yoshino K, Santanda T, Funakoshi H. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors. Acute Med Surg. 2020;7:e480. [PMID: 31988792 DOI: 10.1002/ams2.480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
45 Azevedo LC, Choi H, Simmonds K, Davidow J, Bagshaw SM. Incidence and long-term outcomes of critically ill adult patients with moderate-to-severe diabetic ketoacidosis: retrospective matched cohort study. J Crit Care. 2014;29:971-977. [PMID: 25220529 DOI: 10.1016/j.jcrc.2014.07.034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
46 Melidonis A, Kamaratos A, Angelidi A, Thomakos P, Vrakas S, Bakalis J, Fousteris E, Iraklianou S. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study. Diabetes Technol Ther 2016;18:159-63. [PMID: 26862678 DOI: 10.1089/dia.2015.0309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Rafiee Z, Mosahebfard A, Sheikhi MH. High-performance ZnO nanowires-based glucose biosensor modified by graphene nanoplates. Materials Science in Semiconductor Processing 2020;115:105116. [DOI: 10.1016/j.mssp.2020.105116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
48 Alghamdi MA, Alzahrani AM, Alshams HA, Al-saif MH, Moafa AM, Alenzi MM, Seadawi LE, Ali AKA, Al-hufayyan NS, Mujallid MF. Hyperosmolar hyperglycemic state management in the emergency department. Arch Pharma Pract 2021;12:37-40. [DOI: 10.51847/8gxto9c75t] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Nakajima K, Mita T, Osonoi Y, Azuma K, Takasu T, Fujitani Y, Watada H. Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. Int J Endocrinol 2015;2015:406394. [PMID: 26366172 DOI: 10.1155/2015/406394] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
50 Waldenmaier D, Zschornack E, Kalt L, Buhr A, Pleus S, Haug C, Freckmann G. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy. J Diabetes Sci Technol 2019;13:96-102. [PMID: 29998760 DOI: 10.1177/1932296818785386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Bhave G, Neilson EG. Volume depletion versus dehydration: how understanding the difference can guide therapy. Am J Kidney Dis 2011;58:302-9. [PMID: 21705120 DOI: 10.1053/j.ajkd.2011.02.395] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
52 Eubanks A, Raza F, Alkhouli M, Glenn AN, Homko C, Kashem A, Bove A. Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome. Cardiovasc Diabetol 2012;11:154. [PMID: 23270513 DOI: 10.1186/1475-2840-11-154] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
53 Quintanilla-Flores DL, Rendón-Ramírez EJ, Colunga-Pedraza PR, Gallardo-Escamilla J, Corral-Benavides SA, González-González JG, Tamez-Pérez HE. Clinical course of diabetic ketoacidosis in hypertriglyceridemic pancreatitis. Pancreas 2015;44:615-8. [PMID: 25785723 DOI: 10.1097/MPA.0000000000000300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Frank LA, Solomon A. Hyperglycaemic hyperosmolar state. Br J Hosp Med (Lond) 2016;77:C130-3. [PMID: 27640667 DOI: 10.12968/hmed.2016.77.9.C130] [Reference Citation Analysis]
55 American Diabetes Association. (6) Glycemic targets. Diabetes Care 2015;38 Suppl:S33-40. [PMID: 25537705 DOI: 10.2337/dc15-S009] [Cited by in Crossref: 152] [Cited by in F6Publishing: 69] [Article Influence: 21.7] [Reference Citation Analysis]
56 Morla L, Shore O, Lynch IJ, Merritt ME, Wingo CS. A noninvasive method to study the evolution of extracellular fluid volume in mice using time-domain nuclear magnetic resonance. Am J Physiol Renal Physiol 2020;319:F115-24. [PMID: 32475134 DOI: 10.1152/ajprenal.00377.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Sanusi I, Sarnowski A, Russell-Jones D, Forni LG. A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition. J Crit Care 2020;57:19-22. [PMID: 32007835 DOI: 10.1016/j.jcrc.2019.12.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Van Ness-Otunnu R, Hack JB. Hyperglycemic crisis. J Emerg Med 2013;45:797-805. [PMID: 23786780 DOI: 10.1016/j.jemermed.2013.03.040] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
59 Kaur G, Invally M, Chintamaneni M. Influence of piperine and quercetin on antidiabetic potential of curcumin. J Complement Integr Med 2016;13:247-55. [PMID: 27343476 DOI: 10.1515/jcim-2016-0016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
60 Mohammed A, Koorbanally NA, Islam MS. Ethyl acetate fraction of Aframomum melegueta fruit ameliorates pancreatic β-cell dysfunction and major diabetes-related parameters in a type 2 diabetes model of rats. Journal of Ethnopharmacology 2015;175:518-27. [DOI: 10.1016/j.jep.2015.10.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
61 Marzio A, Merigliano C, Gatti M, Vernì F. Sugar and chromosome stability: clastogenic effects of sugars in vitamin B6-deficient cells. PLoS Genet 2014;10:e1004199. [PMID: 24651653 DOI: 10.1371/journal.pgen.1004199] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
62 Huang CC, Chien TW, Su SB, Guo HR, Chen WL, Chen JH, Chang SH, Lin HJ, Wang YF. Infection, absent tachycardia, cancer history, and severe coma are independent mortality predictors in geriatric patients with hyperglycemic crises. Diabetes Care 2013;36:e151-2. [PMID: 23970727 DOI: 10.2337/dc12-2334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
63 Miller JD, Richman DC. Preoperative Evaluation of Patients with Diabetes Mellitus. Anesthesiology Clinics 2016;34:155-69. [DOI: 10.1016/j.anclin.2015.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
64 Valek R, Von der Mark J. Wenn der Patient sauer aber nicht süß ist: Die euglykämische diabetische Ketoacidose unter SGLT2-Inhibitoren. Med Klin Intensivmed Notfmed 2017;112:145-8. [DOI: 10.1007/s00063-016-0153-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JA, Courtney CH, Hilton L, Dyer PH, Hamersley MS; Joint British Diabetes Societies. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med 2011;28:508-15. [PMID: 21255074 DOI: 10.1111/j.1464-5491.2011.03246.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 15.3] [Reference Citation Analysis]
66 Tajima N, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Fujimoto K, Sakamoto M, Haneda M. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. Diabetol Int 2015;6:151-87. [DOI: 10.1007/s13340-015-0206-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 12] [Article Influence: 8.3] [Reference Citation Analysis]
67 Chaudhary A, Chaudhary A, Yadav RS, Shrestha Y, Shah R. Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5584] [Reference Citation Analysis]
68 Ado Moumouni AN, Robin P, Hillaire-buys D, Faillie J. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database. Fundam Clin Pharmacol 2018;32:216-26. [DOI: 10.1111/fcp.12334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
69 Pillay DK, Ross AJ, Campbell L. A review of hypoglycaemia in a South African family practice setting. Afr J Prim Health Care Fam Med 2016;8:e1-6. [PMID: 27380790 DOI: 10.4102/phcfm.v8i1.1095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Chang LH, Lin LY, Tsai MT, How CK, Chiang JH, Hsieh VC, Hu SY, Hsieh MS. Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study. BMJ Open 2016;6:e012233. [PMID: 27554106 DOI: 10.1136/bmjopen-2016-012233] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Cheng YC, Huang CH, Lin WR, Lu PL, Chang K, Tsai JJ, Bojang KS, Lin CY, Chen YH. Clinical outcomes of septic patients with diabetic ketoacidosis between 2004 and 2013 in a tertiary hospital in Taiwan. J Microbiol Immunol Infect 2016;49:663-71. [PMID: 25442866 DOI: 10.1016/j.jmii.2014.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
72 Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes 2021; 12(5): 514-523 [PMID: 33995841 DOI: 10.4239/wjd.v12.i5.514] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
73 Munir I, Fargo R, Garrison R, Yang A, Cheng A, Kang I, Motabar A, Xu K, Loo LK, Kim DI. Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis. BMJ Open Diabetes Res Care 2017;5:e000395. [PMID: 28878933 DOI: 10.1136/bmjdrc-2017-000395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Prater J, Chaiban JT. Euglycemic Diabetic Ketoacidosis with Acute Pancreatitis in a Patient Not Known to Have Diabetes. AACE Clinical Case Reports 2015;1:e88-91. [DOI: 10.4158/ep14182.cr] [Cited by in Crossref: 9] [Article Influence: 1.3] [Reference Citation Analysis]
75 Zhang Z, Meng Y, Wang Z, Mei Y, Gao S, Wu Y, Du S. Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin. ACS Omega 2022;7:3812-22. [PMID: 35128289 DOI: 10.1021/acsomega.1c06778] [Reference Citation Analysis]
76 Long B, Willis GC, Lentz S, Koyfman A, Gottlieb M. Diagnosis and Management of the Critically Ill Adult Patient with Hyperglycemic Hyperosmolar State. J Emerg Med 2021:S0736-4679(21)00465-0. [PMID: 34256953 DOI: 10.1016/j.jemermed.2021.05.008] [Reference Citation Analysis]
77 Liamis G, Filippatos TD, Elisaf MS. Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapy. Postgraduate Medicine 2015;127:405-12. [DOI: 10.1080/00325481.2015.1029421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
78 Michaelis M, Shochat T, Shimon I, Akirov A. Features and long-term outcomes of patients hospitalized for diabetic ketoacidosis. Diabetes Metab Res Rev 2021;37:e3408. [PMID: 32942337 DOI: 10.1002/dmrr.3408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Lopes AD, Maciel AT, Park M. Evolutive physicochemical characterization of diabetic ketoacidosis in adult patients admitted to the intensive care unit. Journal of Critical Care 2011;26:303-10. [DOI: 10.1016/j.jcrc.2010.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
80 Long B, Lentz S, Koyfman A, Gottlieb M. Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management. Am J Emerg Med 2021;44:157-60. [PMID: 33626481 DOI: 10.1016/j.ajem.2021.02.015] [Reference Citation Analysis]
81 Mernea M, Ionescu A, Vasile I, Nica C, Stoian G, Dascalu T, Mihailescu DF. In vitro human serum albumin glycation monitored by Terahertz spectroscopy. Opt Quant Electron 2015;47:961-73. [DOI: 10.1007/s11082-015-0129-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
82 Munir I, Fargo R, Garrison R, Yang A, Cheng A, Kang I, Motabar A, Xu K, Loo LK, Kim DI. Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis. BMJ Open Diabetes Res Care 2017;5:e000395. [PMID: 28878933 DOI: 10.1136/bmjdrc-2017-000395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
83 Garg SK, Garg P. Is There Any Lower Limit of Serum Bicarbonate in Diabetic Ketoacidosis? Indian J Crit Care Med 2019;23:542. [PMID: 31911750 DOI: 10.5005/jp-journals-10071-23287] [Reference Citation Analysis]
84 Chou W, Chung MH, Wang HY, Chen JH, Chen WL, Guo HR, Lin HJ, Su SB, Huang CC, Hsu CC. Clinical characteristics of hyperglycemic crises in patients without a history of diabetes. J Diabetes Investig 2014;5:657-62. [PMID: 25422765 DOI: 10.1111/jdi.12209] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
85 Shelton C, Demidowich AP, Motevalli M, Sokolinsky S, MacKay P, Tucker C, Abundo C, Peters E, Gooding R, Hackett M, Wedler J, Alexander LA, Barry L, Flynn M, Rios P, Fulda CL, Young MF, Kahl B, Pummer E, Mathioudakis NN, Sidhaye A, Howell EE, Rotello L, Zilbermint M. Retrospective Quality Improvement Study of Insulin-Induced Hypoglycemia and Implementation of Hospital-Wide Initiatives. J Diabetes Sci Technol 2021;15:733-40. [PMID: 33880952 DOI: 10.1177/19322968211008513] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Martucci G, Bonicolini E, Parekh D, Thein OS, Scherkl M, Amrein K. Metabolic and Endocrine Challenges. Semin Respir Crit Care Med 2021;42:78-97. [PMID: 32882734 DOI: 10.1055/s-0040-1713084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Infante M, Fabbri A, Padilla N, Pacifici F, Di Perna P, Vitiello L, Feraco A, Giuliano M, Passeri M, Caprio M, Ricordi C, Della-Morte D, Uccioli L. BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines (Basel) 2022;10:1096. [PMID: 35891261 DOI: 10.3390/vaccines10071096] [Reference Citation Analysis]
88 Mays L. Diabetes Mellitus Standards of Care. Nurs Clin North Am 2015;50:703-11. [PMID: 26596658 DOI: 10.1016/j.cnur.2015.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
89 Hussain F, Khan Z, Jan MS, Ahmad S, Ahmad A, Rashid U, Ullah F, Ayaz M, Sadiq A. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives. Bioorganic Chemistry 2019;91:103128. [DOI: 10.1016/j.bioorg.2019.103128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
90 Chiang JL, Kirkman MS, Laffel LM, Peters AL;  Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37:2034-2054. [PMID: 24935775 DOI: 10.2337/dc14-1140] [Cited by in Crossref: 546] [Cited by in F6Publishing: 460] [Article Influence: 68.3] [Reference Citation Analysis]
91 Mahobia S, Bajpai J, Bajpai A. Glutaraldehyde crosslinked and alkaline denaturation induced self association of haemoglobin to design nanocarriers for In vitro release of insulin in simulated gastrointestinal fluids (SGFs). Journal of Drug Delivery Science and Technology 2018;44:71-81. [DOI: 10.1016/j.jddst.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015;38:1687-1693. [PMID: 26078479 DOI: 10.2337/dc15-0843] [Cited by in Crossref: 485] [Cited by in F6Publishing: 393] [Article Influence: 69.3] [Reference Citation Analysis]
93 Kim B, Kim YY, Jung H, Nam H, Suh JG. Delayed onset of obesity and glucose tolerance in interleukin 18 deficient mice by single housed condition. Appl Biol Chem 2019;62. [DOI: 10.1186/s13765-019-0414-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Katayama Y, Hifumi T, Inoue J, Koido Y. A case of Takotsubo cardiomyopathy induced by accidental hypothermia and diabetic ketoacidosis. BMJ Case Rep 2013;2013:bcr2012008143. [PMID: 23559645 DOI: 10.1136/bcr-2012-008143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
95 Tang X, Olatunji OJ, Zhou Y, Hou X. Allium tuberosum: Antidiabetic and hepatoprotective activities. Food Res Int 2017;102:681-9. [PMID: 29196001 DOI: 10.1016/j.foodres.2017.08.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
96 Lee K, Park IB, Yu SH, Kim SK, Kim SH, Seo DH, Hong S, Jeon JY, Kim DJ, Kim SW, Choi CS, Lee DH. Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis. Diabetes Metab Syndr Obes 2019;12:1161-71. [PMID: 31410042 DOI: 10.2147/DMSO.S209938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 Steiger C, Phan NV, Huang HW, Sun H, Chu JN, Reker D, Gwynne D, Collins J, Tamang S, McManus R, Lopes A, Hayward A, Baron RM, Kim EY, Traverso G. Dynamic Monitoring of Systemic Biomarkers with Gastric Sensors. Adv Sci (Weinh) 2021;8:e2102861. [PMID: 34713599 DOI: 10.1002/advs.202102861] [Reference Citation Analysis]
98 Kilic O, Gultekin Y, Yazici S. The Impact of Intravenous Fluid Therapy on Acid-Base Status of Critically Ill Adults: A Stewart Approach-Based Perspective. Int J Nephrol Renovasc Dis 2020;13:219-30. [PMID: 33061531 DOI: 10.2147/IJNRD.S266864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
99 Kao Y, Hsu C, Weng S, Lin H, Wang J, Su S, Huang C, Guo H. Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study. Endocrine 2016;51:72-82. [DOI: 10.1007/s12020-015-0669-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
100 Doyle K. Commentary on Extreme Hyperglycemia in an Elderly Patient. Clin Chem 2021;67:729. [PMID: 33928367 DOI: 10.1093/clinchem/hvaa329] [Reference Citation Analysis]
101 Kumar D, Nasim MZ, Shoukat BA, Shah SSA. Presentation of mixed diabetic ketoacidosis and metabolic acidosis due to ileal neobladder reconstruction. BMJ Case Rep 2021;14:e223668. [PMID: 33622736 DOI: 10.1136/bcr-2017-223668] [Reference Citation Analysis]
102 Amjad S, Jafri A, Sharma A, Serajuddin M. A novel strategy of nanotized herbal drugs and their delivery in the treatment of diabetes: Present status and future prospects. Journal of Herbal Medicine 2019;17-18:100279. [DOI: 10.1016/j.hermed.2019.100279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
103 Flower O, Wainwright MS, Caulfield AF. Emergency Neurological Life Support: Acute Non-traumatic Weakness. Neurocrit Care 2015;23:23-47. [DOI: 10.1007/s12028-015-0160-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
104 Araki E, Watada H, Uchigata Y, Tomonaga O, Fujii H, Ohashi H, Okabe T, Asano M, Thoren F, Kim H, Yajima T, Langkilde AM. Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial. Diabetes Obes Metab 2020;22:540-8. [PMID: 31742898 DOI: 10.1111/dom.13922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
105 Clark A, Mohammed AS, Raut A, Moore S, Houlden R, Awad S. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital. Can J Diabetes 2021;45:214-9. [PMID: 33046401 DOI: 10.1016/j.jcjd.2020.08.100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Vincent M, Nobécourt E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab 2013;39:299-305. [PMID: 23642642 DOI: 10.1016/j.diabet.2012.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
107 Rawla P, Vellipuram AR, Bandaru SS, Pradeep Raj J. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017;2017. [PMID: 28924481 DOI: 10.1530/edm-17-0081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
108 Hu H, Wang C, Liang K, He Q, Song J, Guo X, Hou X, Chen L, Yan F. Relationship Between Muscle Cramps and Diabetic Retinopathy in Patients with Type 2 Diabetes. Diabetes Metab Syndr Obes 2022;15:827-37. [PMID: 35313678 DOI: 10.2147/DMSO.S352735] [Reference Citation Analysis]
109 Nadro MS, Elkanah G. Hypoglycaemic effect of fractions and crude methanolic leaf extract of Phyllanthus fraternus in streptozotocin - induced diabetic and normal rats. J Med Plants Res 2017;11:58-65. [DOI: 10.5897/jmpr2016.6300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
110 Dogan ADA, Jørgensen UL, Gjessing HJ. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion. J Diabetes Sci Technol 2017;11:631-2. [PMID: 27595713 DOI: 10.1177/1932296816668375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Jay CA, Solbrig MV. Neurologic infections in diabetes mellitus. Handb Clin Neurol 2014;126:175-94. [PMID: 25410222 DOI: 10.1016/B978-0-444-53480-4.00014-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Kreider KE, Lien LF. Transitioning safely from intravenous to subcutaneous insulin. Curr Diab Rep 2015;15:23. [PMID: 25772640 DOI: 10.1007/s11892-015-0595-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
113 Massonneau J, Ouellet C, Lucien F, Dubois CM, Tyler J, Boissonneault G. Suboptimal extracellular pH values alter DNA damage response to induced double-strand breaks. FEBS Open Bio 2018;8:416-25. [PMID: 29511618 DOI: 10.1002/2211-5463.12384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
114 Boye KS, Thieu VT, Lage MJ, Miller H, Paczkowski R. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Adv Ther 2022;39:2208-21. [PMID: 35316502 DOI: 10.1007/s12325-022-02106-4] [Reference Citation Analysis]
115 Yang J, Yin P, Zhou M, Ou CQ, Li M, Liu Y, Gao J, Chen B, Liu J, Bai L, Liu Q. The effect of ambient temperature on diabetes mortality in China: A multi-city time series study. Sci Total Environ 2016;543:75-82. [PMID: 26580729 DOI: 10.1016/j.scitotenv.2015.11.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
116 Lee IH, Ahn DJ. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report. Medicine (Baltimore) 2020;99:e20228. [PMID: 32481295 DOI: 10.1097/MD.0000000000020228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
117 Hernández-Ochoa EO, Banks Q, Schneider MF. Acute Elevated Glucose Promotes Abnormal Action Potential-Induced Ca2+ Transients in Cultured Skeletal Muscle Fibers. J Diabetes Res 2017;2017:1509048. [PMID: 28835899 DOI: 10.1155/2017/1509048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
118 Kong W, Wu D, Hu N, Li N, Dai C, Chen X, Suo Y, Li G, Wu Y. Robust hybrid enzyme nanoreactor mediated plasmonic sensing strategy for ultrasensitive screening of anti-diabetic drug. Biosens Bioelectron 2018;99:653-9. [PMID: 28843936 DOI: 10.1016/j.bios.2017.08.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
119 Hernández-Ochoa EO, Vanegas C. Diabetic Myopathy and Mechanisms of Disease. Biochem Pharmacol (Los Angel) 2015;4:e179. [PMID: 26693099 DOI: 10.4172/2167-0501.1000e179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
120 Gosmanov AR, Smiley D, Robalino G, Siqueira JM, Peng L, Kitabchi AE, Umpierrez GE. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Diabetes Care 2010;33:854-60. [PMID: 20067967 DOI: 10.2337/dc09-1687] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
121 Liu J, Chen C, Wu F, Tang J. Study on the synthesis and biological activities of α-substituted arylacetates derivatives. Bioorganic & Medicinal Chemistry Letters 2016;26:1715-9. [DOI: 10.1016/j.bmcl.2016.02.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
122 Gibb J, Xu Z, Rohrscheib M, Tzamaloukas AH. Hyperglycemic Crisis in an Anuric Peritoneal Dialysis Patient with Profound and Symptomatic Hypertonicity. Cureus 2018;10:e2566. [PMID: 29974021 DOI: 10.7759/cureus.2566] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
123 Kumar V, Nanavati SM, Melki G, Upadhyaya M, Dhillon R, Gibiezaite S, Michael P, Singhal M. A Case of Diabetic Ketoacidosis Presenting with Hypernatremia, Hyperosmolarity, and Altered Sensorium. Case Rep Endocrinol 2018;2018:4806598. [PMID: 30112226 DOI: 10.1155/2018/4806598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Lv J, Sharma A, Zhang T, Wu Y, Ding X. Pharmacological Review on Asiatic Acid and Its Derivatives: A Potential Compound. SLAS Technol 2018;23:111-27. [PMID: 29361877 DOI: 10.1177/2472630317751840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
125 Weinert LS, Scheffel RS, Severo MD, Cioffi AP, Teló GH, Boschi A, Schaan BD. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96:29-34. [PMID: 22153415 DOI: 10.1016/j.diabres.2011.11.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
126 Ausländer D, Ausländer S, Charpin-el hamri G, Sedlmayer F, Müller M, Frey O, Hierlemann A, Stelling J, Fussenegger M. A Synthetic Multifunctional Mammalian pH Sensor and CO2 Transgene-Control Device. Molecular Cell 2014;55:397-408. [DOI: 10.1016/j.molcel.2014.06.007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
127 Voss TS, Vendelbo MH, Kampmann U, Pedersen SB, Nielsen TS, Johannsen M, Svart MV, Jessen N, Møller N. Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis. Diabetologia 2019;62:494-503. [DOI: 10.1007/s00125-018-4785-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
128 Song R, Cao S. Post-bariatric surgery starvation ketoacidosis and lipase elevation in the absence of DKA or pancreatitis. The American Journal of Emergency Medicine 2018;36:525.e3-5. [DOI: 10.1016/j.ajem.2017.10.068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
129 Driver BE, Olives TD, Bischof JE, Salmen MR, Miner JR. Discharge Glucose Is Not Associated With Short-Term Adverse Outcomes in Emergency Department Patients With Moderate to Severe Hyperglycemia. Ann Emerg Med 2016;68:697-705.e3. [PMID: 27353284 DOI: 10.1016/j.annemergmed.2016.04.057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
130 Lee HM, Yang YC, Chen SF, Hsu CY, Shen YC. Risk of hyperglycemic crisis episode in diabetic patients with depression: A nationwide population-based cohort study. J Diabetes Complications 2020;34:107509. [PMID: 31864898 DOI: 10.1016/j.jdiacomp.2019.107509] [Reference Citation Analysis]
131 Wang G, Wang J, He D, Li X, Li J, Peng Z. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. Bioorganic & Medicinal Chemistry Letters 2016;26:2806-9. [DOI: 10.1016/j.bmcl.2016.04.071] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
132 Kaefer K, Botta I, Mugisha A, Berdaoui B, De Bels D, Attou R, Honoré PM, Redant S. Acute coronary syndrome and diabetic keto acidosis: the chicken or the egg? Ann Transl Med 2019;7:397. [PMID: 31555711 DOI: 10.21037/atm.2019.07.38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Curry TB, Brown DR. Perioperative Management of the Patient with Diabetes. Advances in Anesthesia 2014;32:171-90. [DOI: 10.1016/j.aan.2014.08.001] [Reference Citation Analysis]
134 Malerba E, Alessandrini F, Grossi G, Giunti M, Fracassi F. Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis. Front Vet Sci 2020;7:559008. [PMID: 33195532 DOI: 10.3389/fvets.2020.559008] [Reference Citation Analysis]
135 Yan JW, Gushulak KM, Columbus MP, Hamelin AL, Wells GA, Stiell IG. Sentinel visits in emergency department patients with diabetes mellitus as a warning sign for hyperglycemic emergencies. CJEM 2018;20:230-7. [DOI: 10.1017/cem.2017.338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Voulgari C, Tentolouris N. The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room. Diabetes Technol Ther 2010;12:529-35. [PMID: 20597827 DOI: 10.1089/dia.2010.0011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
137 Ahmad S, Yousaf A, Muhammad S, Ghaffar F. Coexistence of diabetic ketoacidosis and thyrotoxicosis: a jeopardy of two endocrine emergencies. BMJ Case Rep 2021;14:e243534. [PMID: 34130982 DOI: 10.1136/bcr-2021-243534] [Reference Citation Analysis]
138 Gonçalves P, Araújo JR, Martel F. Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms. European Neuropsychopharmacology 2015;25:1-16. [DOI: 10.1016/j.euroneuro.2014.11.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
139 Hsieh HC, Wu SH, Chiu CC, Ko KC. Response to 'Comment on "Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report" by Hsieh et al.'. Diabetes Ther 2019;10:1551-2. [PMID: 31264096 DOI: 10.1007/s13300-019-0660-0] [Reference Citation Analysis]
140 Tang C, Kouides R. How well do we need to control blood glucose before discharging DKA patients? A retrospective cohort study. J Community Hosp Intern Med Perspect 2014;4:25755. [PMID: 25432654 DOI: 10.3402/jchimp.v4.25755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
141 Cai L, Dong X, Wu G, Sun J, Chen N, Wei H, Zhu S, Tian Q, Wang X, Jing Q, Li P, Liu B. Ultrasensitive acetone gas sensor can distinguish the diabetic state of people and its high performance analysis by first-principles calculation. Sensors and Actuators B: Chemical 2022;351:130863. [DOI: 10.1016/j.snb.2021.130863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
142 Jang WB, Park JH, Ji ST, Lee NK, Kim DY, Kim YJ, Jung SY, Kang S, Lamichane S, Lamichane BD, Ha J, Yun J, Moon HR, Baek SH, Chung HY, Kwon SM. Cytoprotective Roles of a Novel Compound, MHY-1684, against Hyperglycemia-Induced Oxidative Stress and Mitochondrial Dysfunction in Human Cardiac Progenitor Cells. Oxid Med Cell Longev 2018;2018:4528184. [PMID: 30002788 DOI: 10.1155/2018/4528184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
143 Egan AM, Cunningham A, Jafar-Mohammadi B, Dunne FP. Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young. BMJ Case Rep 2015;2015:bcr2014209163. [PMID: 25837654 DOI: 10.1136/bcr-2014-209163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
144 Bader N, Mirza L. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin. Pak J Med Sci 2016;32:786-8. [PMID: 27375734 DOI: 10.12669/pjms.323.9201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
145 Seth P, Kaur H, Kaur M. Clinical Profile of Diabetic Ketoacidosis: A Prospective Study in a Tertiary Care Hospital. J Clin Diagn Res. 2015;9:OC01-OC04. [PMID: 26266145 DOI: 10.7860/jcdr/2015/8586.5995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
146 Hiremath SB, Gautam AA, George PJ, Thomas A, Thomas R, Benjamin G. Hyperglycemia-induced seizures - Understanding the clinico- radiological association. Indian J Radiol Imaging 2019;29:343-9. [PMID: 31949334 DOI: 10.4103/ijri.IJRI_344_19] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med 2016;33:252-60. [DOI: 10.1111/dme.12875] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
148 Baul PB, Deepak AD, Kakkar M, Modi S. Effect of Atorvastatin on blood ketone levels and glycemic control in patients with type 2 diabetes mellitus: A single arm pilot study. Diabetes Metab Syndr 2020;14:1333-7. [PMID: 32755832 DOI: 10.1016/j.dsx.2020.07.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Liu M, Sun B, Zhou X, Chen L. Disturbed glucose metabolism by perfluorobutanesulfonate pollutant and benefit of young fecal transplantation in aged zebrafish. Ecotoxicol Environ Saf 2022;241:113721. [PMID: 35660380 DOI: 10.1016/j.ecoenv.2022.113721] [Reference Citation Analysis]
150 Ohara N, Koda R, Watanabe H, Iino N, Ohashi K, Terajima K, Ozawa T, Ikeda Y, Sekiguchi H, Ohashi H, Yamaguchi S. Generalized Status Epilepticus in a Patient with Acute-onset Type 1 Diabetes Mellitus Associated with Severe Kidney Dysfunction: A Case Report and Literature Review. Intern Med 2017;56:1993-9. [PMID: 28768970 DOI: 10.2169/internalmedicine.56.8304] [Reference Citation Analysis]
151 Xu AC, Broome DT, Bena JF, Lansang MC. PREDICTORS FOR ADVERSE OUTCOMES IN DIABETIC KETOACIDOSIS IN A MULTIHOSPITAL HEALTH SYSTEM. Endocr Pract 2020;26:259-66. [PMID: 31652103 DOI: 10.4158/EP-2018-0551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Ward CT, Fiza B, Prabhakar A, Budhrani G, Moll V. A Case of Multifactorial Diabetic Ketoacidosis Acquired in the Intensive Care Unit: A Case Report. Cureus 2019;11:e5128. [PMID: 31523559 DOI: 10.7759/cureus.5128] [Reference Citation Analysis]
153 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int 2020;11:165-223. [PMID: 32802702 DOI: 10.1007/s13340-020-00439-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 19.5] [Reference Citation Analysis]
154 Pourmand A, Mazer-amirshahi M, Caggiula A, Nawab A, Payette C, Johnson S. Targeted Glycemic Control for Adult Patients With Type 2 Diabetes Mellitus in the Acute Care Setting. Canadian Journal of Diabetes 2018;42:671-7. [DOI: 10.1016/j.jcjd.2018.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
155 Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 2016;12:222-32. [PMID: 26893262 DOI: 10.1038/nrendo.2016.15] [Cited by in Crossref: 210] [Cited by in F6Publishing: 147] [Article Influence: 35.0] [Reference Citation Analysis]
156 Gibb FW, Teoh WL, Graham J, Lockman KA. Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia 2016;59:2082-7. [PMID: 27397023 DOI: 10.1007/s00125-016-4034-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
157 Hirobata T, Inaba H, Kaido Y, Kosugi D, Itoh S, Matsuoka T, Inoue G. Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetol Int. [DOI: 10.1007/s13340-022-00581-2] [Reference Citation Analysis]
158 Cartier JL, Look DC, Dunn JP. Pseudohypobicarbonatemia in a Patient Presenting with Suspected Diabetic Ketoacidosis. AACE Clinical Case Reports 2018;4:108-11. [DOI: 10.4158/ep171855.cr] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
159 Bozkurt B, Hershberger RE, Butler J, Grady KL, Heidenreich PA, Isler ML, Kirklin JK, Weintraub WS. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). Circ Cardiovasc Qual Outcomes 2021;14:e000102. [PMID: 33755495 DOI: 10.1161/HCQ.0000000000000102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Shaikh S, Mohamed MM, Mujeeb A, Shaikh F, Harris B. Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis. Cureus. 2020;12:e10199. [PMID: 33033677 DOI: 10.7759/cureus.10199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Sheung N, Beechar A, Belalcazar LM. Nonsevere Diabetic Ketoacidosis and Adrenal Insufficiency: Exploring the Impact of Glucocorticoid Replacement on Metabolic Outcomes and ICU Length of Stay. Crit Care Explor 2020;2:e0260. [PMID: 33196048 DOI: 10.1097/CCE.0000000000000260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Pannu AK, Sharma R, Sharma N, Kaur J, Walia R, Kumar S. Stewart (physicochemical) approach versus conventional anion gap approach for resolution of metabolic acidosis in diabetic ketoacidosis. Int J Diabetes Dev Ctries 2021;41:628-33. [DOI: 10.1007/s13410-021-00927-7] [Reference Citation Analysis]
163 von Oettingen J, Wolfsdorf J, Feldman HA, Rhodes ET. Use of Serum Bicarbonate to Substitute for Venous pH in New-Onset Diabetes. Pediatrics 2015;136:e371-7. [PMID: 26195535 DOI: 10.1542/peds.2015-0156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
164 Hatada M, Wilson E, Khanwalker M, Probst D, Okuda-shimazaki J, Sode K. Current and future prospective of biosensing molecules for point-of-care sensors for diabetes biomarker. Sensors and Actuators B: Chemical 2022;351:130914. [DOI: 10.1016/j.snb.2021.130914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
165 Yogi-Morren D, Lansang MC. Management of patients with type 1 diabetes in the hospital. Curr Diab Rep 2014;14:458. [PMID: 24398661 DOI: 10.1007/s11892-013-0458-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
166 Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, Ferrannini E, Fonseca VA, Garber AJ, Grunberger G, LeRoith D, Umpierrez GE, Weir MR. American association of clinical endocrinologists and american college of endocrinology position statement on the association of sglt-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22:753-762. [PMID: 27082665 DOI: 10.4158/ep161292.ps] [Cited by in Crossref: 159] [Cited by in F6Publishing: 70] [Article Influence: 26.5] [Reference Citation Analysis]
167 Hudak SK, Overkamp D, Wagner R, Häring HU, Heni M. Ketoacidosis in a non-diabetic woman who was fasting during lactation. Nutr J 2015;14:117. [PMID: 26537818 DOI: 10.1186/s12937-015-0076-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
168 Peterson C, Fox JA, Devallis P, Rizzo R, Mizuguchi KA. Starvation in the Midst of Cardiopulmonary Bypass: Diabetic Ketoacidosis During Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 2012;26:910-6. [DOI: 10.1053/j.jvca.2012.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
169 Davidow AL, Thomas P, Kim S, Passannante M, Tsai S, Tan C. Access to Care in the Wake of Hurricane Sandy, New Jersey, 2012. Disaster Med Public Health Prep 2016;10:485-91. [PMID: 27292171 DOI: 10.1017/dmp.2016.79] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
170 Hassan I. Models for enhancing competency-based training and contextual clinical decision making. Clin Teach 2012;9:392-7. [PMID: 23167883 DOI: 10.1111/j.1743-498X.2012.00584.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
171 Thewjitcharoen Y, Plianpan P, Chotjirat A, Nakasatien S, Chotwanvirat P, Wanothayaroj E, Krittiyawong S, Himathongkam T. Clinical characteristics and outcomes of care in adult patients with diabetic ketoacidosis: A retrospective study from a tertiary diabetes center in Thailand. J Clin Transl Endocrinol 2019;16:100188. [PMID: 31011538 DOI: 10.1016/j.jcte.2019.100188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Mertens M, Dauben L, Roden M, Müssig K. [Acute metabolic complications in diabetes]. Dtsch Med Wochenschr 2021;146:266-78. [PMID: 33592663 DOI: 10.1055/a-1270-8878] [Reference Citation Analysis]
173 Zhang H, Su Y, Wang X, Mi J, Huo Y, Wang Z, Liu Y, Gao Y. Antidiabetic activity and chemical constituents of the aerial parts of Heracleum dissectum Ledeb. Food Chemistry 2017;214:572-9. [DOI: 10.1016/j.foodchem.2016.07.065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
174 El Hussein MT, Kilfoil L. Using your "head backward" in the management of diabetic ketoacidosis. Nurse Pract 2020;45:7-11. [PMID: 31851138 DOI: 10.1097/01.NPR.0000615576.42292.68] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Gallo de Moraes A, Surani S. Effects of diabetic ketoacidosis in the respiratory system. World J Diabetes 2019; 10(1): 16-22 [PMID: 30697367 DOI: 10.4239/wjd.v10.i1.16] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
176 Jaber JF, Standley M, Reddy R. Euglycemic Diabetic Ketoacidosis in Pregnancy: A Case Report and Review of Current Literature. Case Rep Crit Care. 2019;2019:8769714. [PMID: 31531246 DOI: 10.1155/2019/8769714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
177 Ho Y, Chen YF, Wang LH, Hsu KY, Chin YT, Yang YSH, Wang SH, Chen YR, Shih YJ, Liu LF, Wang K, Whang-Peng J, Tang HY, Lin HY, Liu HL, Lin SJ. Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation. Front Pharmacol 2018;9:807. [PMID: 30116189 DOI: 10.3389/fphar.2018.00807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
178 Almalki MH, Buhary BM, Khan SA, Almaghamsi A, Alshahrani F. Clinical and Biochemical Characteristics of Diabetes Ketoacidosis in a Tertiary Hospital in Riyadh. Clin Med Insights Endocrinol Diabetes 2016;9:7-11. [PMID: 27226739 DOI: 10.4137/CMED.S39639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
179 Shen H, Zhu WK, Lu Z, Zhou HC. Hotspot Analysis of Traditional Drugs in Diabetes Treatment Literature. Chin J Integr Med 2021;27:304-12. [PMID: 33000416 DOI: 10.1007/s11655-020-3322-1] [Reference Citation Analysis]
180 Tran TTT, Pease A, Wood AJ, Zajac JD, Mårtensson J, Bellomo R, Ekinci EII. Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols. Front Endocrinol (Lausanne) 2017;8:106. [PMID: 28659865 DOI: 10.3389/fendo.2017.00106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
181 Hu P, McKenzie JA, Buettmann EG, Migotsky N, Gardner MJ, Silva MJ. Type 1 diabetic Akita mice have low bone mass and impaired fracture healing. Bone 2021;147:115906. [PMID: 33662611 DOI: 10.1016/j.bone.2021.115906] [Reference Citation Analysis]
182 Massonneau J, Lacombe-Burgoyne C, Boissonneault G. pH-induced variations in the TK1 gene model. Mutat Res Genet Toxicol Environ Mutagen 2020;849:503128. [PMID: 32087849 DOI: 10.1016/j.mrgentox.2019.503128] [Reference Citation Analysis]
183 Murunga AN, Owira PM. Diabetic ketoacidosis: an overlooked child killer in sub-Saharan Africa? Trop Med Int Health. 2013;18:1357-1364. [PMID: 24112393 DOI: 10.1111/tmi.12195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
184 Guisado-Vasco P, Cano-Megías M, Carrasco-de la Fuente M, Corres-González J, Matei AM, González-Albarrán O. Clinical features, mortality, hospital admission, and length of stay of a cohort of adult patients with diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain. Endocrinol Nutr 2015;62:277-84. [PMID: 25888157 DOI: 10.1016/j.endonu.2015.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
185 Lee MH, Calder GL, Santamaria JD, MacIsaac RJ. Diabetic ketoacidosis in adult patients: an audit of factors influencing time to normalisation of metabolic parameters. Intern Med J 2018;48:529-34. [PMID: 29316133 DOI: 10.1111/imj.13735] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
186 Er KC, Hsu CY, Lee YK, Huang MY, Su YC. Effect of glycemic control on the risk of pancreatic cancer: A nationwide cohort study. Medicine (Baltimore) 2016;95:e3921. [PMID: 27311001 DOI: 10.1097/MD.0000000000003921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
187 Ahmad B, Rehman MU, Amin I, Mir MUR, Ahmad SB, Farooq A, Muzamil S, Hussain I, Masoodi M, Fatima B. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation. Saudi Pharm J 2018;26:1137-45. [PMID: 30532634 DOI: 10.1016/j.jsps.2018.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
188 Wood T, Pang AJ, Hallet J, Greig P. Euglycaemic ketoacidosis in a postoperative Whipple patient using canaglifozin. BMJ Case Rep 2016;2016:bcr2016216607. [PMID: 27677576 DOI: 10.1136/bcr-2016-216607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
189 Chmiel-perzyńska I, Kloc R, Perzyński A, Rudzki S, Urbańska EM. Novel Aspect of Ketone Action: β-Hydroxybutyrate Increases Brain Synthesis of Kynurenic Acid In Vitro. Neurotox Res 2011;20:40-50. [DOI: 10.1007/s12640-010-9220-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
190 Demirci H, Coşar R, Çiftçi Ö, Sarı IK. Atypical diabetic ketoacidosis: case report. Balkan Med J 2015;32:124-6. [PMID: 25759786 DOI: 10.5152/balkanmedj.2015.15123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
191 Echouffo-Tcheugui JB, Garg R. Management of Hyperglycemia and Diabetes in the Emergency Department. Curr Diab Rep 2017;17:56. [PMID: 28646357 DOI: 10.1007/s11892-017-0883-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
192 Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 2014;37:3124-31. [PMID: 25342831 DOI: 10.2337/dc14-0984] [Cited by in Crossref: 148] [Cited by in F6Publishing: 90] [Article Influence: 21.1] [Reference Citation Analysis]
193 Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ. Atypical antipsychotics and diabetic ketoacidosis: a review. Psychopharmacology (Berl) 2013;226:1-12. [PMID: 23344556 DOI: 10.1007/s00213-013-2982-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
194 Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 2015;32:14-23. [DOI: 10.1111/dme.12604] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
195 Wolf RA, Haw JS, Paul S, Spezia Faulkner M, Cha E, Findley MK, Khan F, Markley Webster S, Alexopoulos AS, Mehta K, Alfa DA, Ali MK. Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital. Diabetes Res Clin Pract 2019;157:107869. [PMID: 31560962 DOI: 10.1016/j.diabres.2019.107869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
196 Kalscheuer H, Serfling G, Schmid S, Lehnert H. [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma]. Internist (Berl) 2017;58:1020-8. [PMID: 28849301 DOI: 10.1007/s00108-017-0317-x] [Cited by in Crossref: 8] [Article Influence: 1.6] [Reference Citation Analysis]
197 Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S; On behalf of RSSDI-ESI Consensus Group. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. Int J Diabetes Dev Ctries 2020;40:1-122. [DOI: 10.1007/s13410-020-00819-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
198 Sirichaiwetchakoon K, Lowe GM, Kupittayanant S, Churproong S, Eumkeb G. Pluchea indica (L.) Less. Tea Ameliorates Hyperglycemia, Dyslipidemia, and Obesity in High Fat Diet-Fed Mice. Evid Based Complement Alternat Med 2020;2020:8746137. [PMID: 32595747 DOI: 10.1155/2020/8746137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
199 Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017;7:e016587. [PMID: 28765134 DOI: 10.1136/bmjopen-2017-016587] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 12.4] [Reference Citation Analysis]
200 Hamelin AL, Yan JW, Stiell IG. Emergency Department Management of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in Adults: National Survey of Attitudes and Practice. Can J Diabetes 2018;42:229-36. [PMID: 28734951 DOI: 10.1016/j.jcjd.2017.05.005] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
201 Okada A, Yamana H, Morita K, Sato Y, Yamaguchi S, Kurakawa KI, Michihata N, Matsui H, Fushimi K, Nangaku M, Yamauchi T, Yasunaga H, Kadowaki T. Potassium Concentration in Initial Fluid Therapy and In-Hospital Mortality of Patients with Diabetic Ketoacidosis. J Clin Endocrinol Metab 2021;106:e2162-75. [PMID: 33493293 DOI: 10.1210/clinem/dgab029] [Reference Citation Analysis]
202 Kilpatrick ES, Butler AE, Ostlundh L, Atkin SL, Sacks DB. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care 2022;45:267-72. [PMID: 35050366 DOI: 10.2337/dc21-2279] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Yu CH. Cases: "safety" technology: a hidden cause of diabetic ketoacidosis. CMAJ 2012;184:557-8. [PMID: 22371509 DOI: 10.1503/cmaj.111624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
204 VanderWeele J, Pollack T, Oakes DJ, Smyrniotis C, Illuri V, Vellanki P, O'Leary K, Holl J, Aleppo G, Molitch ME, Wallia A. Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed. J Diabetes Complications 2018;32:650-4. [PMID: 29903409 DOI: 10.1016/j.jdiacomp.2018.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
205 Trotman TK, Drobatz KJ, Hess RS. Retrospective evaluation of hyperosmolar hyperglycemia in 66 dogs (1993-2008). J Vet Emerg Crit Care (San Antonio) 2013;23:557-64. [PMID: 24102960 DOI: 10.1111/vec.12100] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
206 Yeoh HL, Lee M, Pan WJ, Ong HY. Case of sodium-glucose cotransporter-2 inhibitor-associated euglycaemic diabetic ketoacidosis. BMJ Case Rep 2021;14:e235953. [PMID: 34404640 DOI: 10.1136/bcr-2020-235953] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Armeni E, Aziz U, Qamar S, Nasir S, Nethaji C, Negus R, Murch N, Beynon HC, Bouloux P, Rosenthal M, Khan S, Yousseif A, Menon R, Karra E. Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series. Lancet Diabetes Endocrinol. 2020;8:660-663. [PMID: 32621809 DOI: 10.1016/s2213-8587(20)30221-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
208 Hamblin PS, Wong R, Ekinci EI, Fourlanos S, Shah S, Jones AR, Hare MJL, Calder GL, Epa DS, George EM, Giri R, Kotowicz MA, Kyi M, Lafontaine N, MacIsaac RJ, Nolan BJ, O'Neal DN, Renouf D, Varadarajan S, Wong J, Xu S, Bach LA. SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission. J Clin Endocrinol Metab 2019;104:3077-87. [PMID: 30835263 DOI: 10.1210/jc.2019-00139] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
209 Haas NL, Whitmore SP, Cranford JA, Tsuchida RE, Nicholson A, Boyd C, Gunnerson KJ, Gianchandani RY, Bassin BS. An Emergency Department-Based Intensive Care Unit is Associated with Decreased Hospital and Intensive Care Unit Utilization for Diabetic Ketoacidosis. J Emerg Med 2020;58:620-6. [PMID: 31843318 DOI: 10.1016/j.jemermed.2019.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
210 Sun X, James TD. Glucose Sensing in Supramolecular Chemistry. Chem Rev 2015;115:8001-37. [DOI: 10.1021/cr500562m] [Cited by in Crossref: 238] [Cited by in F6Publishing: 182] [Article Influence: 34.0] [Reference Citation Analysis]
211 Steenkamp DW, Alexanian SM, McDonnell ME. Adult hyperglycemic crisis: a review and perspective. Curr Diab Rep 2013;13:130-7. [PMID: 23115048 DOI: 10.1007/s11892-012-0342-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
212 Tafesse TB, Moghadam ES, Bule MH, Abadian N, Abdollahi M, Faramarzi MA, Amini M. Synthesis and biological evaluation of 2-(2-methyl-1H-pyrrol-3-yl)-2-oxo-N-(pyridine-3-yl) acetamide derivatives: in vitro α-glucosidase inhibition, and kinetic and molecular docking study. Chem Pap 2020;74:1583-96. [DOI: 10.1007/s11696-019-00999-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Roumelioti ME, Sun Y, Ganta K, Gibb J, Tzamaloukas AH. Management of extracellular volume in patients with end-stage kidney disease and severe hyperglycemia. J Diabetes Complications 2020;34:107615. [PMID: 32402841 DOI: 10.1016/j.jdiacomp.2020.107615] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Alão S, Conceição J, Dores J, Santos L, Araújo F, Pape E, Reis M, Chipepo Á, Nascimento E, Baptista A, Pires V, Marques C, Lages AS, Pelicano-Romano J, de Jesus PM. Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study. Clin Diabetes Endocrinol 2021;7:2. [PMID: 33402217 DOI: 10.1186/s40842-020-00114-3] [Reference Citation Analysis]
215 Wu XY, She DM, Wang F, Guo G, Li R, Fang P, Li L, Zhou Y, Zhang KQ, Xue Y. Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period. BMC Endocr Disord 2020;20:182. [PMID: 33317485 DOI: 10.1186/s12902-020-00659-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Haak T. Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia. Adv Ther 2012;29:1005-15. [PMID: 23212658 DOI: 10.1007/s12325-012-0066-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
217 McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am 2012;41:175-201. [PMID: 22575413 DOI: 10.1016/j.ecl.2012.01.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 6.2] [Reference Citation Analysis]
218 Duhon B, Attridge RL, Franco-Martinez AC, Maxwell PR, Hughes DW. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Ann Pharmacother 2013;47:970-5. [PMID: 23737516 DOI: 10.1345/aph.1S014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
219 Krenz JR, Kaakeh Y. An Overview of Hyperinsulinemic-Euglycemic Therapy in Calcium Channel Blocker and β-blocker Overdose. Pharmacotherapy 2018;38:1130-42. [DOI: 10.1002/phar.2177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
220 American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33 Suppl 1:S11-S61. [PMID: 20042772 DOI: 10.2337/dc10-s011] [Cited by in Crossref: 2069] [Cited by in F6Publishing: 1103] [Article Influence: 172.4] [Reference Citation Analysis]
221 Puls HA, Haas NL, Franklin BJ, Theyyunni N, Harvey CE. Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series. Am J Emerg Med 2021;44:11-3. [PMID: 33571749 DOI: 10.1016/j.ajem.2021.01.033] [Reference Citation Analysis]
222 Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W. Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocrine Practice 2016;22:1008-21. [DOI: 10.4158/ep161392.cs] [Cited by in Crossref: 107] [Cited by in F6Publishing: 53] [Article Influence: 17.8] [Reference Citation Analysis]
223 Fu Y, Liu X, Cui B, Wang C, Liu Z, Zhao B. Clinical Characteristics of Concomitant Diabetic Ketoacidosis in Type 2 Diabetes Patients with Acute Pancreatitis. Diabetes Metab Syndr Obes 2022;15:111-9. [PMID: 35046682 DOI: 10.2147/DMSO.S336619] [Reference Citation Analysis]
224 Jeon SJ, Choi SS, Kim HY, Yu IK. Acute Acquired Metabolic Encephalopathy Based on Diffusion MRI. Korean J Radiol 2021;22:2034-51. [PMID: 34564957 DOI: 10.3348/kjr.2019.0303] [Reference Citation Analysis]
225 Negera GZ, Weldegebriel B, Fekadu G. Acute Complications of Diabetes and its Predictors among Adult Diabetic Patients at Jimma Medical Center, Southwest Ethiopia. Diabetes Metab Syndr Obes 2020;13:1237-42. [PMID: 32368116 DOI: 10.2147/DMSO.S249163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
226 Jin WL, Azuma K, Mita T, Goto H, Kanazawa A, Shimizu T, Ikeda F, Fujitani Y, Hirose T, Kawamori R, Watada H. Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia 2011;54:1921-9. [PMID: 21499675 DOI: 10.1007/s00125-011-2141-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
227 Jecht M. Bedeutung von Glukosewerten im Krankenhaus. Diabetologe. [DOI: 10.1007/s11428-022-00868-7] [Reference Citation Analysis]
228 Caduff A, Lutz HU, Heinemann L, Di Benedetto G, Talary MS, Theander S. Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes. Diabetologia 2011;54:2678-89. [DOI: 10.1007/s00125-011-2210-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
229 Vellanki P, Bean R, Oyedokun FA, Pasquel FJ, Smiley D, Farrokhi F, Newton C, Peng L, Umpierrez GE. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes. Diabetes Care 2015;38:568-74. [PMID: 25665812 DOI: 10.2337/dc14-1796] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
230 Njoku MJ. Patients with Chronic Endocrine Disease. Medical Clinics of North America 2013;97:1123-37. [DOI: 10.1016/j.mcna.2013.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
231 Guo X, Dai X, Ni J, Cao N, Yang G, Xue J, Wang X. High concentration of sugars is genotoxic to folate-deficient cells. Mutat Res 2019;814:15-22. [PMID: 30682723 DOI: 10.1016/j.mrfmmm.2019.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
232 Yakou F, Saburi M, Hirose A, Akaoka H, Hirota Y, Kobayashi T, Awane N, Asahi N, Amagawa T, Ozawa S, Ohno A, Matsushita T. A Case Series of Ketoacidosis After Coronavirus Disease 2019 Vaccination in Patients With Type 1 Diabetes. Front Endocrinol 2022;13:840580. [DOI: 10.3389/fendo.2022.840580] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
233 Kang DY, S.p. N, Darvin P, Joung YH, Byun HJ, Do CH, Park KD, Park MN, Cho KH, Yang YM. Momilactone B Inhibits Ketosis In Vitro by Regulating the ANGPTL3-LPL Pathway and Inhibiting HMGCS2. Animal Biotechnology 2017;28:189-97. [DOI: 10.1080/10495398.2016.1252769] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
234 Lee HJ, Sajan A, Tomer Y. Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion. J Endocr Soc 2021;5:bvab141. [PMID: 34604689 DOI: 10.1210/jendso/bvab141] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
235 Jasso-Avila MI, Castro-Argüelles AA, Centeno-Del Toro SM, Rivera-López E, Valadez-Castillo FJ. Base excess measured at hospital admission is useful for predicting diabetic ketoacidosis severity and resolution time in adult patients. Diabetes Metab Syndr 2022;16:102385. [PMID: 35026666 DOI: 10.1016/j.dsx.2021.102385] [Reference Citation Analysis]
236 Mikhael E, Al-rubaye M. Assessing the adherence to insulin therapy and the effect of injection pain on insulin adherence among type 2 diabetes mellitus patients. J Pharm Negative Results 2020;11:65. [DOI: 10.4103/jpnr.jpnr_8_19] [Reference Citation Analysis]
237 Rugo HS, Lacouture ME, Goncalves MD, Masharani U, Aapro MS, O'Shaughnessy JA. A multidisciplinary approach to optimizing care of patients treated with alpelisib. Breast 2022;61:156-67. [PMID: 35016012 DOI: 10.1016/j.breast.2021.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Menéndez Torre E, Lafita Tejedor J, Artola Menéndez S, Millán Núñez-cortés J, Alonso García Á, Puig Domingo M, García Solans J, Álvarez Guisasola F, García Alegría J, Mediavilla Bravo J, Miranda Fernández-santos C, Romero González R. Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2. Revista Clínica Española 2011;211:147-55. [DOI: 10.1016/j.rce.2010.11.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
239 Berger B, Jenetzky E, Köblös D, Stange R, Baumann A, Simstich J, Michalsen A, Schmelzer KM, Martin DD. Seven-day fasting as a multimodal complex intervention for adults with type 1 diabetes: Feasibility, benefit and safety in a controlled pilot study. Nutrition 2021;86:111169. [PMID: 33636417 DOI: 10.1016/j.nut.2021.111169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Getie A, Wondmieneh A, Bimerew M, Gedefaw G, Demis A. Determinants of diabetes ketoacidosis among diabetes mellitus patients at North Wollo and Waghimra zone public hospitals, Amhara region, Northern Ethiopia. BMC Endocr Disord 2021;21:26. [PMID: 33602195 DOI: 10.1186/s12902-021-00692-y] [Reference Citation Analysis]
241 Feldman HA. When Crisis Strikes. Physician Assistant Clinics 2020;5:191-211. [DOI: 10.1016/j.cpha.2019.12.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Liu J, Li X, Wu J, Chen Y, Li H, Tian Z. Non-diabetic ketoacidosis: A case of alcoholic ketoacidosis accompanied by hyperglycemia. Am J Emerg Med 2021:S0735-6757(21)00703-8. [PMID: 34474943 DOI: 10.1016/j.ajem.2021.08.063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Kiran R, Saroch A, Pannu AK, Sharma N, Dutta P, Kumar M. Clinical Profile and Outcomes of Diabetic Ketoacidosis During COVID-19 Pandemic in North India. Trop Doct 2022;:494755221076896. [PMID: 35300552 DOI: 10.1177/00494755221076896] [Reference Citation Analysis]
244 Macfarlane J, Dhatariya K. Incidence of Euglycemic Diabetic Ketoacidosis in Adults With Type 1 Diabetes in the United Kingdom Before the Widespread Use of Sodium Glucose Cotransporter 2 Inhibitors. Mayo Clin Proc 2019;94:1909-10. [PMID: 31486388 DOI: 10.1016/j.mayocp.2019.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
245 Park EY, Baik J, Kim H, Park SM, Kim C. Ultrasound-modulated optical glucose sensing using a 1645 nm laser. Sci Rep 2020;10:13361. [PMID: 32770091 DOI: 10.1038/s41598-020-70305-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Kacki S, Velemínský P, Lynnerup N, Kaupová S, Jeanson AL, Povýšil C, Horák M, Kučera J, Rasmussen KL, Podliska J, Dragoun Z, Smolík J, Vellev J, Brůžek J. Rich table but short life: Diffuse idiopathic skeletal hyperostosis in Danish astronomer Tycho Brahe (1546-1601) and its possible consequences. PLoS One 2018;13:e0195920. [PMID: 29672561 DOI: 10.1371/journal.pone.0195920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
247 Taye GM, Bacha AJ, Taye FA, Bule MH, Tefera GM. Diabetic Ketoacidosis Management and Treatment Outcome at Medical Ward of Shashemene Referral Hospital, Ethiopia: A Retrospective Study. Clin Med Insights Endocrinol Diabetes 2021;14:11795514211004957. [PMID: 33911912 DOI: 10.1177/11795514211004957] [Reference Citation Analysis]
248 Bteich F, Daher G, Kapoor A, Charbek E, Kamel G. Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit. Cureus 2019;11:e4496. [PMID: 31259114 DOI: 10.7759/cureus.4496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
249 Wu Z, Chen Q, Ke D, Li G, Deng W. Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model. Molecules 2014;19:14782-93. [PMID: 25232702 DOI: 10.3390/molecules190914782] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
250 Carrizales-Sepúlveda EF, Vera-Pineda R, Jiménez-Castillo RA, Violante-Cumpa JR, Flores-Ramírez R, Ordaz-Farías A. The Heart in Diabetic Ketoacidosis: A Narrative Review Focusing on the Acute Cardiac Effects and Electrocardiographic Abnormalities. Am J Med Sci 2021;361:690-701. [PMID: 33941367 DOI: 10.1016/j.amjms.2020.11.030] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 American Diabetes Association. 6. Glycemic Targets. Diabetes Care 2017;40:S48-56. [PMID: 27979893 DOI: 10.2337/dc17-S009] [Cited by in Crossref: 235] [Cited by in F6Publishing: 87] [Article Influence: 39.2] [Reference Citation Analysis]
252 Jang TB, Chauhan V, Morchi R, Najand H, Naunheim R, Kaji AH. Hypokalemia in diabetic ketoacidosis is less common than previously reported. Intern Emerg Med 2015;10:177-80. [PMID: 25403843 DOI: 10.1007/s11739-014-1146-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
253 Popovic D, Lalic K, Jotic A, Milicic T, Bogdanovic J, Đorđevic M, Stankovic S, Jeremic V, Lalic NM. The Inflammatory and Hemostatic Cardiovascular Risk Markers During Acute Hyperglycemic Crisis in Type 1 and Type 2 Diabetes. J Med Biochem 2019;38:126-33. [PMID: 30867640 DOI: 10.2478/jomb-2018-0024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
254 Seposo XT, Dang TN, Honda Y. How Does Ambient Air Temperature Affect Diabetes Mortality in Tropical Cities? Int J Environ Res Public Health 2017;14:E385. [PMID: 28379204 DOI: 10.3390/ijerph14040385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
255 Endo K, Itoh T, Tanno M, Ohno K, Hotta H, Kato N, Matsumoto T, Ooiwa H, Kubo H, Miki T. Characteristics of patients with emergency attendance for severe hypoglycemia and hyperglycemia in a general hospital in Japan. Medicine (Baltimore) 2021;100:e26505. [PMID: 34160469 DOI: 10.1097/MD.0000000000026505] [Reference Citation Analysis]
256 Arora S, Probst MA, Agy C, Menchine M. Point-of-care beta-hydroxybutyrate testing for assessing diabetic ketoacidosis severity prior to treatment in the emergency department. Diabetes Res Clin Pract 2011;94:e86-8. [PMID: 21955959 DOI: 10.1016/j.diabres.2011.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
257 Alotaibi R, Alsulami M, Hijji S, Alghamdi S, Alnahdi Y, Alnahdi H, Samargandy SA. Diabetic ketoacidosis in Saudi Arabia: factors precipitating initial admission and readmission. Ann Saudi Med 2022;42:119-26. [PMID: 35380064 DOI: 10.5144/0256-4947.2022.119] [Reference Citation Analysis]
258 Flores M, Amir M, Ahmed R, Alashi S, Li M, Wang X, Lansang MC, Al-Jaghbeer MJ. Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users. BMJ Open Diabetes Res Care 2020;8:e001329. [PMID: 33318067 DOI: 10.1136/bmjdrc-2020-001329] [Reference Citation Analysis]
259 [DOI: 10.1109/smartworld-uic-atc-scalcom-iop-sci.2019.00151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
260 Lee SH, Park JH, Hong M, Hyeon S, Kim MY, Lee SE, Ahn J, Kim J. True euglycemic diabetic ketoacidosis in a person with type 2 diabetes and Duchenne muscular dystrophy. Diabetes Research and Clinical Practice 2011;92:e7-8. [DOI: 10.1016/j.diabres.2010.12.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
261 Lucero P, Chapela S. Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Case Rep Crit Care. 2018;2018:1747850. [PMID: 30364093 DOI: 10.1155/2018/1747850] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
262 Rodríguez-Gutiérrez R, Cámara-Lemarroy CR, Quintanilla-Flores DL, González-Moreno EI, González-Chávez JM, Lavalle-González FJ, González-González JG, Caballero AE. Severe Ketoacidosis (pH ≤ 6.9) in Type 2 Diabetes: More Frequent and Less Ominous Than Previously Thought. Biomed Res Int 2015;2015:134780. [PMID: 26180779 DOI: 10.1155/2015/134780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
263 Rosenbloom AL. The management of diabetic ketoacidosis in children. Diabetes Ther. 2010;1:103-120. [PMID: 22127748 DOI: 10.1007/s13300-010-0008-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
264 Regmi A, Konstantinov NK, Agaba EI, Rohrscheib M, Dorin RI, Tzamaloukas AH. Respiratory failure in the course of treatment of diabetic ketoacidosis. Clinical Diabetes. 2014;32:28-31. [PMID: 26246676 DOI: 10.2337/diaclin.32.1.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
265 Masuda S, Ota K, Okazaki R, Ishii R, Cho K, Hiramatsu Y, Adachi Y, Koseki S, Ueda E, Minami I, Yamada T, Watanabe T. Clinical Characteristics Associated with the Development of Diabetic Ketoacidosis in Patients with Type 2 Diabetes. Intern Med 2022;61:1125-32. [DOI: 10.2169/internalmedicine.7266-21] [Reference Citation Analysis]
266 Wang G, Wang J, He D, Li X, Li J, Peng Z. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Chem Biol Drug Des 2017;89:456-63. [DOI: 10.1111/cbdd.12867] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
267 Roumelioti ME, Glew RH, Khitan ZJ, Rondon-Berrios H, Argyropoulos CP, Malhotra D, Raj DS, Agaba EI, Rohrscheib M, Murata GH, Shapiro JI, Tzamaloukas AH. Fluid balance concepts in medicine: Principles and practice. World J Nephrol 2018; 7(1): 1-28 [PMID: 29359117 DOI: 10.5527/wjn.v7.i1.1] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
268 Natarajan S, Kulkarni R, Tangri A. Fatal Cerebral Edema in a Young Adult with Diabetic Ketoacidosis: Blame the Bicarbonate? Case Rep Crit Care 2020;2020:5917459. [PMID: 32411486 DOI: 10.1155/2020/5917459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
269 Yu HE, Agus M, Kellogg MD. Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patients. Pediatric Diabetes 2011;12:649-55. [DOI: 10.1111/j.1399-5448.2011.00768.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
270 Galindo RJ, Pasquel FJ, Fayfman M, Tsegka K, Dhruv N, Cardona S, Wang H, Vellanki P, Umpierrez GE. Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis. BMJ Open Diabetes Res Care 2020;8:e000763. [PMID: 32111715 DOI: 10.1136/bmjdrc-2019-000763] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
271 de Alencar JCG, da Silva GW, Ribeiro SCDC, Marchini JFM, Neto RAB, de Souza HP. Euglycemic Diabetic Ketoacidosis in Pregnancy. Clin Pract Cases Emerg Med 2020;4:26-8. [PMID: 32064418 DOI: 10.5811/cpcem.2019.9.43624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
272 Oliver WD, Willis GC, Hines MC, Hayes BD. Comparison of Plasma-Lyte A and Sodium Chloride 0.9% for Fluid Resuscitation of Patients With Diabetic Ketoacidosis. Hosp Pharm 2018;53:326-30. [PMID: 30210151 DOI: 10.1177/0018578718757517] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
273 Crilly CJ, Allen AJ, Amato TM, Tiberio A, Schulman RC, Silverman RA. Evaluating the Emergency Department Observation Unit for the management of hyperglycemia in adults. The American Journal of Emergency Medicine 2018;36:1975-9. [DOI: 10.1016/j.ajem.2018.02.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
274 Adachi J, Inaba Y, Maki C. Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin. Intern Med 2017;56:187-90. [PMID: 28090050 DOI: 10.2169/internalmedicine.56.7501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
275 Malekian A, Esmaeeli Djavid G, Akbarzadeh K, Soltandallal M, Rassi Y, Rafinejad J, Rahimi Foroushani A, Farhoud AR, Bakhtiary R, Totonchi M. Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial. Journal of Wound, Ostomy & Continence Nursing 2019;46:25-9. [DOI: 10.1097/won.0000000000000496] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 5.7] [Reference Citation Analysis]
276 Diker N, Aytac D, Helvacioglu F, Dagdelen C, Oguz Y. Evaluation of the Effects of Low-Level Laser Therapy on Diabetic Bone Healing. J Craniofac Surg 2019;30:1994-8. [PMID: 31232987 DOI: 10.1097/SCS.0000000000005654] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
277 Roostalu U, Lercke Skytte J, Gravesen Salinas C, Klein T, Vrang N, Jelsing J, Hecksher-Sørensen J. 3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II. Dis Model Mech 2020;13:dmm045351. [PMID: 33158929 DOI: 10.1242/dmm.045351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
278 Horiya M, Anno T, Shigemoto R, Koyama K, Kawasaki F, Tomoda K, Kaku K, Kaneto H. Acute respiratory distress syndrome triggered by marked cytokine storm in a subject with diabetic ketoacidosis: A case report. Medicine (Baltimore) 2022;101:e29119. [PMID: 35357353 DOI: 10.1097/MD.0000000000029119] [Reference Citation Analysis]
279 Dandona P, Mathieu C, Phillip M, Hansen L, Griffen SC, Tschöpe D, Thorén F, Xu J, Langkilde AM; DEPICT-1 Investigators. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial. Lancet Diabetes Endocrinol 2017;5:864-76. [PMID: 28919061 DOI: 10.1016/S2213-8587(17)30308-X] [Cited by in Crossref: 183] [Cited by in F6Publishing: 98] [Article Influence: 36.6] [Reference Citation Analysis]
280 Liu H, Yan S, Chen G, Li B, Zhao L, Wang Y, Hu X, Jia X, Dou J, Mu Y, Wen J, Lyu Z. Association of the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol Levels with the Risk of Type 2 Diabetes: A Retrospective Cohort Study in Beijing. J Diabetes Res 2021;2021:5524728. [PMID: 33969127 DOI: 10.1155/2021/5524728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Orban JC, Maizière EM, Ghaddab A, Van Obberghen E, Ichai C. Incidence and characteristics of acute kidney injury in severe diabetic ketoacidosis. PLoS One 2014;9:e110925. [PMID: 25338064 DOI: 10.1371/journal.pone.0110925] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
282 Li W, Gong C, Wu D, Liu M. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure. J Pediatr Endocrinol Metab 2014;27:1227-31. [PMID: 25051275 DOI: 10.1515/jpem-2014-0131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
283 Phillips C, Sinha A. Successful management of diabetic ketoacidosis: an innovative protocol: Successful management of diabetic ketoacidosis: an innovative protocol. Pract Diab 2018;35:51-4. [DOI: 10.1002/pdi.2161] [Reference Citation Analysis]
284 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S244-53. [PMID: 34964884 DOI: 10.2337/dc22-S016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
285 Benetos A, Novella J, Guerci B, Blickle J, Boivin J, Cuny P, Delemer B, Gabreau T, Jan P, Louis J, Passadori Y, Petit J, Weryha G. Pragmatic Diabetes Management in Nursing Homes: Individual Care Plan. Journal of the American Medical Directors Association 2013;14:791-800. [DOI: 10.1016/j.jamda.2013.08.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
286 Huang W, Su L, Zhang X, Xu X, Li R. Endocrinological characterization of pancreatic ducts in HFD and HGD fed mice. J Cell Biochem 2019;120:16153-9. [DOI: 10.1002/jcb.28896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
287 Howe CJ, Lewis KR. Social Determinants for Recurrent Diabetic Ketoacidosis in Children With Diabetes. Journal of Pediatric Nursing 2012;27:773-4. [DOI: 10.1016/j.pedn.2012.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
288 Anis TR, Boudreau M, Thornton T. Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment Protocol. Clin Pharmacol 2021;13:197-202. [PMID: 34675693 DOI: 10.2147/CPAA.S334119] [Reference Citation Analysis]
289 Alsadhan I, Alruwashid S, Alhamad M, Alajmi S, Alshehri S, Alfadhli E, Ekhzaimy A. Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series. Curr Ther Res Clin Exp 2020;93:100609. [PMID: 33132404 DOI: 10.1016/j.curtheres.2020.100609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
290 Pereira TM, Pimenta FS, Porto ML, Baldo MP, Campagnaro BP, Gava AL, Meyrelles SS, Vasquez EC. Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects. Int J Mol Sci 2016;17:E1273. [PMID: 27527163 DOI: 10.3390/ijms17081273] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
291 Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M. Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. J Diabetes Complications 2017;31:468-72. [PMID: 27499457 DOI: 10.1016/j.jdiacomp.2016.06.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
292 Komiyama S, Numata K, Ogushi K, Chuma M, Tanaka R, Chiba S, Otani M, Inayama Y, Nakano M, Maeda S. Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report. Diagnostics (Basel) 2021;11:1394. [PMID: 34441328 DOI: 10.3390/diagnostics11081394] [Reference Citation Analysis]
293 Blank SP, Blank RM, Ziegenfuss MD; Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes & Resource Evaluation (CORE) for the ANZICS CORE Committee. The importance of hyperosmolarity in diabetic ketoacidosis. Diabet Med 2020;37:2001-8. [PMID: 32096281 DOI: 10.1111/dme.14277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Rappaport SH, Endicott JA, Gilbert MP, Farkas JD, Clouser RD, McMillian WD. A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis. J Endocr Soc 2019;3:1079-86. [PMID: 31069278 DOI: 10.1210/js.2018-00400] [Reference Citation Analysis]
295 Zádori N, Gede N, Antal J, Szentesi A, Alizadeh H, Vincze Á, Izbéki F, Papp M, Czakó L, Varga M, de-Madaria E, Petersen OH, Singh VP, Mayerle J, Faluhelyi N, Miseta A, Reiber I, Hegyi P. EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized clinical trial. Pancreatology 2020;20:369-76. [DOI: 10.1016/j.pan.2019.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
296 Karakaya Z, Topal FE, Topal F, Payza U, Akyol PY. Euglisemic diabetic ketoacidotic coma caused by dapagliflozin. The American Journal of Emergency Medicine 2018;36:2136.e1-2. [DOI: 10.1016/j.ajem.2018.08.054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
297 Barski L, Brandstaetter E, Sagy I, Jotkowitz A. Basal insulin for the management of diabetic ketoacidosis. European Journal of Internal Medicine 2018;47:14-6. [DOI: 10.1016/j.ejim.2017.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
298 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. J Diabetes Investig 2018. [PMID: 29582574 DOI: 10.1111/jdi.12810] [Cited by in Crossref: 118] [Cited by in F6Publishing: 95] [Article Influence: 29.5] [Reference Citation Analysis]
299 Qari F. Clinical characteristics of patients with diabetic ketoacidosis at the Intensive Care Unit of a University Hospital. Pak J Med Sci. 2015;31:1463-1466. [PMID: 26870116 DOI: 10.12669/pjms.316.7550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
300 Wang CY, Li XD, Hao ZH, Xu D. Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats. Korean J Physiol Pharmacol 2016;20:613-9. [PMID: 27847438 DOI: 10.4196/kjpp.2016.20.6.613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
301 Schlienger J. Complications du diabète de type 2. La Presse Médicale 2013;42:839-48. [DOI: 10.1016/j.lpm.2013.02.313] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
302 Donihi AC, Moorman JM, Abla A, Hanania R, Carneal D, Macmaster HW. Pharmacists' role in glycemic management in the inpatient setting: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm 2019;2:167-76. [DOI: 10.1002/jac5.1041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
303 Wang M, Wang M, Zhang F, Su X. A ratiometric fluorescent biosensor for the sensitive determination of α-glucosidase activity and acarbose based on N-doped carbon dots. Analyst 2020;145:5808-15. [PMID: 32672281 DOI: 10.1039/d0an01065k] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
304 Wu M, Zhang Y, Liu Q, Huang H, Wang X, Shi Z, Li Y, Liu S, Xue L, Lei Y. A smart hydrogel system for visual detection of glucose. Biosensors and Bioelectronics 2019;142:111547. [DOI: 10.1016/j.bios.2019.111547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
305 Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018;67:362-365. [PMID: 29596400 DOI: 10.15585/mmwr.mm6712a3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 19.8] [Reference Citation Analysis]
306 Cho N, Bushell T, Choi M, Moussavi K. Evaluation of the Two-Bag System in Adult Diabetic Ketoacidosis Patients. J Pharm Pract 2021;34:17-22. [PMID: 31216923 DOI: 10.1177/0897190019855163] [Reference Citation Analysis]
307 Vellanki P, Smiley DD, Stefanovski D, Anzola I, Duan W, Hudson M, Peng L, Pasquel FJ, Umpierrez GE. Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises. Diabetes Care 2016;39:1948-55. [PMID: 27573938 DOI: 10.2337/dc16-0406] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
308 von Oettingen JE, Rhodes ET, Wolfsdorf JI. Resolution of ketoacidosis in children with new onset diabetes: Evaluation of various definitions. Diabetes Res Clin Pract 2018;135:76-84. [PMID: 29111277 DOI: 10.1016/j.diabres.2017.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
309 Jesus AR, Vila-viçosa D, Machuqueiro M, Marques AP, Dore TM, Rauter AP. Targeting Type 2 Diabetes with C -Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation. J Med Chem 2017;60:568-79. [DOI: 10.1021/acs.jmedchem.6b01134] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 6.4] [Reference Citation Analysis]
310 Muppidi V, Meegada S, Challa T, Siddamreddy S, Samal S. Euglycemic Diabetic Ketoacidosis in a Young Pregnant Woman Precipitated by Urinary Tract Infection. Cureus 2020;12:e7331. [PMID: 32313772 DOI: 10.7759/cureus.7331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
311 Singh H, Krishna RHS, Jain A, Sharma N. Peritoneal dialysis for the rescue in critical refractory metabolic acidosis in diabetic ketoacidosis. J Family Med Prim Care 2019;8:1792-3. [PMID: 31198761 DOI: 10.4103/jfmpc.jfmpc_138_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
312 Américo P, Rocha R. Subsidizing access to prescription drugs and health outcomes: The case of diabetes. J Health Econ 2020;72:102347. [PMID: 32622153 DOI: 10.1016/j.jhealeco.2020.102347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Carlson CJ, Santamarina ML. Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus. Expert Opinion on Drug Safety 2016;15:1401-12. [DOI: 10.1080/14740338.2016.1216100] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
314 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Auflage). Diabetologie und Stoffwechsel 2020;15:S40-50. [DOI: 10.1055/a-1193-3724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
315 Feldman-Billard S, Altman JJ. [Insulin therapy among inpatients]. Presse Med 2013;42:871-9. [PMID: 23588189 DOI: 10.1016/j.lpm.2013.02.319] [Reference Citation Analysis]
316 Pandit K, Khanal S, Adhikari S, Acharya SP. Acute mountain sickness induced diabetic ketoacidosis managed with hemodialysis: A case report. Ann Med Surg (Lond) 2020;56:165-8. [PMID: 32637094 DOI: 10.1016/j.amsu.2020.06.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Biester T, Kordonouri O, Danne T. Beyond type 2 diabetes: sodium glucose co‐transporter‐inhibition in type 1 diabetes. Diabetes Obes Metab 2019;21:53-61. [DOI: 10.1111/dom.13659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
318 Chen JX, Li HY, Li TT, Fu WC, Du X, Liu CH, Zhang W. Alisol A-24-acetate promotes glucose uptake via activation of AMPK in C2C12 myotubes. BMC Complement Med Ther 2020;20:22. [PMID: 32020870 DOI: 10.1186/s12906-019-2802-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
319 Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus. Int J Clin Pharm 2012;34:863-70. [PMID: 22869200 DOI: 10.1007/s11096-012-9682-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
320 Gupta D, Prasad A, Siddiqui F, Sitaula S, Albert SG. Insulin infusion responses in diabetic ketoacidosis alone and with a mixed hypochloremic alkalosis. Diabetes Metab Syndr 2019;13:216-21. [PMID: 30641700 DOI: 10.1016/j.dsx.2018.08.015] [Reference Citation Analysis]
321 Zaghlol LY, Beirat AF, Amarin JZ, Hassoun Al Najar AM, Hasan YY, Qtaishat A, Tierney ME, Zaghlol RY, Zayed AA. Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial. Front Endocrinol (Lausanne) 2021;12:613826. [PMID: 34305809 DOI: 10.3389/fendo.2021.613826] [Reference Citation Analysis]
322 Li A, Jiang X, Zhong M, Li N, Tao Y, Wu W, Yang C, Wang H, Min L, Ma Y, Deng W. Intractable hiccups as a rare gastrointestinal manifestation in severe endocrine and metabolic crisis: case report and review of the literature. Therapeutic Advances in Endocrinology 2020;11:204201882093430. [DOI: 10.1177/2042018820934307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
323 Tilinca MC, Gliga MC, Varga A. The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0024] [Reference Citation Analysis]
324 Griffey RT, Schneider RM, Malone N, Peterson C, McCammon C. Diabetic Ketoacidosis Management in the Emergency Department: Implementation of a Protocol to Reduce Variability and Improve Safety. J Healthc Qual 2019;41:e61-9. [PMID: 31211740 DOI: 10.1097/JHQ.0000000000000211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
325 Ford W, Self WH, Slovis C, McNaughton CD. Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients. Curr Emerg Hosp Med Rep 2013;1:1-9. [PMID: 23997994 DOI: 10.1007/s40138-012-0007-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
326 Karajgikar ND, Manroa P, Acharya R, Codario RA, Reider JA, Donihi AC, Salata RA, Korytkowski MT. ADDRESSING PITFALLS IN MANAGEMENT OF DIABETIC KETOACIDOSIS WITH A STANDARDIZED PROTOCOL. Endocr Pract 2019;25:407-12. [PMID: 30657360 DOI: 10.4158/EP-2018-0398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
327 Wang G, He D, Li X, Li J, Peng Z. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors. Bioorganic Chemistry 2016;65:167-74. [DOI: 10.1016/j.bioorg.2016.03.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
328 Rao P, Jiang SF, Kipnis P, Patel DM, Katsnelson S, Madani S, Liu VX. Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis. JAMA Netw Open 2022;5:e226417. [PMID: 35389497 DOI: 10.1001/jamanetworkopen.2022.6417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Builes-Montaño CE, Chavarriaga A, Ballesteros L, Muñoz M, Medina S, Donado-Gomez JH, Ramirez-Rincón A. Characteristics of hyperglycemic crises in an adult population in a teaching hospital in Colombia. J Diabetes Metab Disord 2018;17:143-8. [PMID: 30918848 DOI: 10.1007/s40200-018-0353-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
330 Ou H, Wu H, Lin C, Du Y, Hu C, Hung H, Wu P, Li H, Wang S, Chang C. The Hepatic Protection Effects of Hepassocin in Hyperglycemic Crisis. The Journal of Clinical Endocrinology & Metabolism 2017;102:2407-15. [DOI: 10.1210/jc.2016-3287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
331 Eledrisi MS, Elzouki AN. Management of Diabetic Ketoacidosis in Adults: A Narrative Review. Saudi J Med Med Sci 2020;8:165-73. [PMID: 32952507 DOI: 10.4103/sjmms.sjmms_478_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
332 Adeva-Andany MM, Fernández-Fernández C, Mouriño-Bayolo D, Castro-Quintela E, Domínguez-Montero A. Sodium bicarbonate therapy in patients with metabolic acidosis. ScientificWorldJournal 2014;2014:627673. [PMID: 25405229 DOI: 10.1155/2014/627673] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
333 Seki H, Kuratani N, Shiga T, Iwasaki Y, Karita K, Yasuda K, Yorozu T. Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol. BMJ Open 2021;11:e049592. [PMID: 34815277 DOI: 10.1136/bmjopen-2021-049592] [Reference Citation Analysis]
334 Baker L, Juneja R, Bruno A. Management of Hyperglycemia in Acute Ischemic Stroke. Curr Treat Options Neurol 2011;13:616-28. [DOI: 10.1007/s11940-011-0143-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
335 Barranco RJ, Gomez-Peralta F, Abreu C, Delgado-Rodriguez M, Moreno-Carazo A, Romero F, de la Cal MA, Barranco JM, Pasquel FJ, Umpierrez GE. Incidence, recurrence and cost of hyperglycaemic crises requiring emergency treatment in Andalusia, Spain. Diabet Med 2017;34:966-72. [PMID: 28326628 DOI: 10.1111/dme.13355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
336 Goundan PN, Willard DL, Sahin-Efe A, Fan SL, Alexanian SM. Comparison of bicarbonate values from venous blood gas and chemistry panels measured at the time of diagnosis and resolution of diabetes ketoacidosis. J Clin Transl Endocrinol 2019;18:100205. [PMID: 31508318 DOI: 10.1016/j.jcte.2019.100205] [Reference Citation Analysis]
337 Deeks ED. Sotagliflozin: A Review in Type 1 Diabetes. Drugs 2019;79:1977-87. [PMID: 31761990 DOI: 10.1007/s40265-019-01230-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
338 Rosival V. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014;7:571-573. [PMID: 25489249 DOI: 10.2147/dmso.s73896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
339 Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am 2017;101:587-606. [PMID: 28372715 DOI: 10.1016/j.mcna.2016.12.011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
340 Muneer M, Akbar I. Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA. Adv Exp Med Biol 2021;1307:85-114. [PMID: 32488607 DOI: 10.1007/5584_2020_545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
341 Le Neveu F, Hywel B, Harvey JN. Euglycaemic ketoacidosis in patients with and without diabetes. Practical Diabetes 2013;30:167-71. [DOI: 10.1002/pdi.1769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
342 Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T; consultation of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetol Int 2019;10:58-66. [PMID: 30800564 DOI: 10.1007/s13340-018-0362-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
343 Schellhaas B, Haak T. Diabetische Ketoazidose – erkennen, behandeln, vermeiden. Diabetologe. [DOI: 10.1007/s11428-022-00870-z] [Reference Citation Analysis]
344 Laliberte B, Yeung SYA, Gonzales JP. Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation. Int J Pharm Pract 2017;25:238-43. [PMID: 28338247 DOI: 10.1111/ijpp.12346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
345 Bode BW, Garg SK. The Emerging Role Of Adjunctive Noninsulin Antihyperglycemic Therapy In The Management Of Type 1 Diabetes. Endocrine Practice 2016;22:220-30. [DOI: 10.4158/ep15869.ra] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 6.2] [Reference Citation Analysis]
346 Ibrahim A, Bayramoglu B, Hokenek NM, Tekyol D. Lactate clearance during the first 2 hours after hospital admission: A useful biomarker for predicting 30-day mortality in patients with diabetic ketoacidosis. Int J Clin Pract 2021;75:e14204. [PMID: 33811737 DOI: 10.1111/ijcp.14204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
347 Satomura A, Oikawa Y, Sato H, Takagi S, Yamashita T, Shimada A. A patient with ketosis-prone type 2 diabetes showing nearly normalized glucose tolerance after recovery from severe diabetic ketoacidosis. Diabetol Int. [DOI: 10.1007/s13340-022-00599-6] [Reference Citation Analysis]
348 Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, Kowalski AJ, Madden P, McAuliffe-Fogarty AH, McElwee-Malloy M, Peters A, Raman S, Reifschneider K, Rubin K, Weinzimer SA. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40:1622-1630. [PMID: 29162582 DOI: 10.2337/dc17-1624] [Cited by in Crossref: 205] [Cited by in F6Publishing: 159] [Article Influence: 51.3] [Reference Citation Analysis]
349 Khajehali N, Khajehali Z, Tarokh MJ. The prediction of mortality influential variables in an intensive care unit: a case study. Pers Ubiquitous Comput 2021;:1-17. [PMID: 33654479 DOI: 10.1007/s00779-021-01540-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
350 Tsai CL, Yang YC, Chen SF, Hsu CY, Shen YC. Risk of hyperglycemic crisis episode in diabetic patients with bipolar disorder: A nationwide population-based cohort study. J Affect Disord 2019;257:281-6. [PMID: 31302516 DOI: 10.1016/j.jad.2019.07.025] [Reference Citation Analysis]
351 Rathish D, Karalliyadda S. Concurrent presentation of thyroid storm and diabetic ketoacidosis: a systematic review of previously reported cases. BMC Endocr Disord 2019;19:49. [PMID: 31101104 DOI: 10.1186/s12902-019-0374-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
352 Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, Leroith D, Levy P, Mcgill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015. Endocrine Practice 2015;21:1-87. [DOI: 10.4158/ep15672.glsuppl] [Cited by in Crossref: 364] [Article Influence: 52.0] [Reference Citation Analysis]
353 Li J, Huang M, Shen X. The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. Journal of Diabetes and its Complications 2014;28:662-6. [DOI: 10.1016/j.jdiacomp.2014.06.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
354 Alharbi OM, Basheer AA, Khattab RA, Ali I. Health and environmental effects of persistent organic pollutants. Journal of Molecular Liquids 2018;263:442-53. [DOI: 10.1016/j.molliq.2018.05.029] [Cited by in Crossref: 209] [Cited by in F6Publishing: 98] [Article Influence: 52.3] [Reference Citation Analysis]
355 Scherbaum WA, Scherbaum CR. [Diabetes emergencies]. Med Klin Intensivmed Notfmed 2014;109:279-92; quiz 293-4. [PMID: 24820043 DOI: 10.1007/s00063-013-0334-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
356 Patel K, Carbone A. Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data. Ann Pharmacother 2019;53:1227-37. [DOI: 10.1177/1060028019859323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
357 Everett E, Mathioudakis NN. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diabetes Res Care 2019;7:e000621. [PMID: 31114699 DOI: 10.1136/bmjdrc-2018-000621] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
358 Luethi N, Cioccari L, Crisman M, Bellomo R, Eastwood GM, Mårtensson J. Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study. Crit Care 2016;20:297. [PMID: 27633987 DOI: 10.1186/s13054-016-1462-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
359 Chen MB, Wang H, Zheng QH, Xu HL, Cui WY. Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24101. [PMID: 33429775 DOI: 10.1097/MD.0000000000024101] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
360 Wu Y, Hu Y, Yuan Y, Luo Y, lai D, Zhou H, Tong Z, Liu D. Gymnemic acid I triggers mechanistic target of rapamycin‐mediated β cells cytoprotection through the promotion of autophagy under high glucose stress. J Cell Physiol 2019;234:9370-7. [DOI: 10.1002/jcp.27621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
361 Tzamaloukas AH, Khitan ZJ, Glew RH, Roumelioti ME, Rondon-Berrios H, Elisaf MS, Raj DS, Owen J, Sun Y, Siamopoulos KC, Rohrscheib M, Ing TS, Murata GH, Shapiro JI, Malhotra D. Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications. J Am Heart Assoc 2019;8:e011786. [PMID: 31549572 DOI: 10.1161/JAHA.118.011786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
362 Jivan D. Management of diabetic ketoacidosis. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2014;16:10-4. [DOI: 10.1080/22201009.2011.10872247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
363 Auchterlonie A, Okosieme OE. Preventing diabetic ketoacidosis: do patients adhere to sick-day rules? Clin Med (Lond) 2013;13:120. [PMID: 23472520 DOI: 10.7861/clinmedicine.13-1-120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
364 Vellanki P, Umpierrez GE. Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care 2018;41:1839-41. [PMID: 30135197 DOI: 10.2337/dci18-0004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
365 Dhatariya KK. Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract 2019;155:107797. [PMID: 31344382 DOI: 10.1016/j.diabres.2019.107797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
366 Sato Y, Morita K, Okada A, Matsui H, Fushimi K, Yasunaga H. Factors affecting in-hospital mortality of diabetic ketoacidosis patients: A retrospective cohort study. Diabetes Res Clin Pract 2021;171:108588. [PMID: 33310121 DOI: 10.1016/j.diabres.2020.108588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
367 Pinto ME, Villena JE. Diabetic ketoacidosis during gestational diabetes. A case report. Diabetes Research and Clinical Practice 2011;93:e92-4. [DOI: 10.1016/j.diabres.2011.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
368 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig 2020;11:1020-76. [PMID: 33021749 DOI: 10.1111/jdi.13306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
369 Goad NT, Bakhru RN, Pirkle JL, Kenes MT. Association of Hyperchloremia With Unfavorable Clinical Outcomes in Adults With Diabetic Ketoacidosis. J Intensive Care Med 2020;35:1307-13. [PMID: 31342846 DOI: 10.1177/0885066619865469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
370 Flower O, Bowles C, Wijdicks E, Weingart SD, Smith WS. Emergency Neurological Life Support: Acute Non-Traumatic Weakness. Neurocrit Care 2012;17:79-95. [DOI: 10.1007/s12028-012-9752-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
371 Carrillo AR, Elwood K, Werth C, Mitchell J, Sarangarm P. Balanced Crystalloid Versus Normal Saline as Resuscitative Fluid in Diabetic Ketoacidosis. Ann Pharmacother. [DOI: 10.1177/10600280211063651] [Reference Citation Analysis]
372 Kankala RK, Lin XF, Song HF, Wang SB, Yang DY, Zhang YS, Chen AZ. Supercritical Fluid-Assisted Decoration of Nanoparticles on Porous Microcontainers for Codelivery of Therapeutics and Inhalation Therapy of Diabetes. ACS Biomater Sci Eng 2018;4:4225-35. [PMID: 33418821 DOI: 10.1021/acsbiomaterials.8b00992] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
373 Palmiere C, Bardy D, Mangin P, Werner D. Postmortem diagnosis of unsuspected diabetes mellitus. Forensic Science International 2013;226:160-7. [DOI: 10.1016/j.forsciint.2013.01.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
374 Chen Z, Wang J, Sun W, Archibong E, Kahkoska AR, Zhang X, Lu Y, Ligler FS, Buse JB, Gu Z. Synthetic beta cells for fusion-mediated dynamic insulin secretion. Nat Chem Biol 2018;14:86-93. [PMID: 29083418 DOI: 10.1038/nchembio.2511] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 15.4] [Reference Citation Analysis]
375 Eledrisi MS, Beshyah SA, Malik RA. Management of diabetic ketoacidosis in special populations. Diabetes Res Clin Pract 2021;174:108744. [PMID: 33713717 DOI: 10.1016/j.diabres.2021.108744] [Reference Citation Analysis]
376 Wei W, Lin S, Hsu J, Wu Y, Loh C, Huang H, Liu PP. Association between Hyperosmolar Hyperglycemic State and Venous Thromboembolism in Diabetes Patients: A Nationwide Analysis in Taiwan. JPM 2022;12:302. [DOI: 10.3390/jpm12020302] [Reference Citation Analysis]
377 Roussel R, Riveline JP, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B. Important Drop Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study. Diabetes Care 2021:dc201690. [PMID: 33879536 DOI: 10.2337/dc20-1690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 20.0] [Reference Citation Analysis]
378 Caulfield AF, Flower O, Pineda JA, Uddin S. Emergency Neurological Life Support: Acute Non-traumatic Weakness. Neurocrit Care 2017;27:29-50. [PMID: 28916943 DOI: 10.1007/s12028-017-0450-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
379 Anzola I, Gomez PC, Umpierrez GE. Management of diabetic ketoacidosis and hyperglycemic hyperosmolar state in adults. Expert Review of Endocrinology & Metabolism 2016;11:177-85. [DOI: 10.1586/17446651.2016.1145049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
380 Arora S, Menchine M. The Role of Point-of-Care β-Hydroxybutyrate Testing in the Diagnosis of Diabetic Ketoacidosis: A Review. Hospital Practice 2015;40:73-8. [DOI: 10.3810/hp.2012.04.972] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
381 Mendes R, Sousa N, Reis VM, Themudo-barata JL. Prevention of exercise-related injuries and adverse events in patients with type 2 diabetes. Postgrad Med J 2013;89:715-21. [DOI: 10.1136/postgradmedj-2013-132222] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
382 Depczynski B, Lee ATK, Varndell W, Chiew AL. The Significance of an Increased Beta-Hydroxybutyrate at Presentation to the Emergency Department in Patients with Diabetes in the Absence of a Hyperglycemic Emergency. J Diabetes Res 2019;2019:7387128. [PMID: 31687409 DOI: 10.1155/2019/7387128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
383 Moore MM, Bailey AM, Flannery AH, Baum RA. Treatment of Diabetic Ketoacidosis With Intravenous U-500 Insulin in a Patient With Rabson-Mendenhall Syndrome: A Case Report. J Pharm Pract 2017;30:468-75. [PMID: 27112737 DOI: 10.1177/0897190016645036] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
384 Freckmann G, Kamecke U, Waldenmaier D, Haug C, Ziegler R. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates. J Diabetes Sci Technol 2018;12:608-13. [PMID: 29284290 DOI: 10.1177/1932296817750404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
385 Gao L, Li Y, Fei D, Ma L, Chen S, Feng B, Su Q, Ji L. Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L: Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) study: 随机血糖> 13.9 mmol/L 的中国糖尿病患者糖尿病酮症患病率及危险因素分析:来自中国糖尿病酮症(CHECK)研究的结果. Journal of Diabetes 2018;10:249-55. [DOI: 10.1111/1753-0407.12582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
386 Akturk HK, Kahramangil D, Sarwal A, Hoffecker L, Murad MH, Michels AW. Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis. Diabet Med 2019;36:1075-81. [PMID: 31199005 DOI: 10.1111/dme.14050] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 19.3] [Reference Citation Analysis]
387 Batista DV, Vieira CAFA, Costa TA, Lima EG. COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. Diabetol Int 2020;:1-4. [PMID: 33133998 DOI: 10.1007/s13340-020-00473-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
388 Gassiep I, Bachmeier C, Hendry S, Emeto TI, Armstrong M, Sangla K, Heather CS. Antimicrobial stewardship in diabetic ketoacidosis: a single-centre experience. Intern Med J 2020;50:173-7. [PMID: 31059195 DOI: 10.1111/imj.14335] [Reference Citation Analysis]
389 Nyenwe EA, Wan JY, Kitabchi AE. Venous serum bicarbonate concentration predicts arterial pH in adults with diabetic ketoacidosis. Endocr Pract 2014;20:201-6. [PMID: 24014006 DOI: 10.4158/EP13250.OR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Phillip M, Mathieu C, Lind M, Araki E, di Bartolo P, Bergenstal R, Heller S, Hansen L, Scheerer MF, Thoren F, Arya N, Xu J, Iqbal N, Dandona P; DEPICT-1 and DEPICT-2 Investigators. Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. Diabetes Obes Metab 2021;23:549-60. [PMID: 33145944 DOI: 10.1111/dom.14248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
391 del Nogal M, Troyano N, Calleros L, Griera M, Rodriguez-puyol M, Rodriguez-puyol D, Ruiz-torres MP. Hyperosmolarity induced by high glucose promotes senescence in human glomerular mesangial cells. The International Journal of Biochemistry & Cell Biology 2014;54:98-110. [DOI: 10.1016/j.biocel.2014.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
392 Lin YH. Sodium-glucose cotransporter-2 inhibitors induced eu-glycemic diabetic ketoacidosis: The first report in a type 2 diabetic (T2D) Taiwanese and literature review of possible pathophysiology and contributing factors. J Formos Med Assoc 2018;117:849-54. [PMID: 29477576 DOI: 10.1016/j.jfma.2018.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
393 Boyanova L, Mitov I. Antibiotic resistance rates in causative agents of infections in diabetic patients: rising concerns. Expert Review of Anti-infective Therapy 2014;11:411-20. [DOI: 10.1586/eri.13.19] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
394 Ahad A, Ganai AA, Mujeeb M, Siddiqui WA. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chemico-Biological Interactions 2014;219:64-75. [DOI: 10.1016/j.cbi.2014.05.011] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 11.6] [Reference Citation Analysis]
395 Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol 2021;9:174-88. [PMID: 33515493 DOI: 10.1016/S2213-8587(20)30381-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 36.0] [Reference Citation Analysis]
396 Small C, Egan AM, Elhadi EM, O'Reilly MW, Cunningham A, Finucane FM. Diabetic ketoacidosis: a challenging diabetes phenotype. Endocrinol Diabetes Metab Case Rep 2017;2017:16-0109. [PMID: 28458888 DOI: 10.1530/EDM-16-0109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
397 Ciechanowska A, Gora IM, Sabalinska S, Ladyzynski P. The Effect of High and Variable Glucose on the Viability of Endothelial Cells Co-Cultured with Smooth Muscle Cells. Int J Mol Sci 2022;23:6704. [PMID: 35743147 DOI: 10.3390/ijms23126704] [Reference Citation Analysis]
398 Yamada H, Funazaki S, Kakei M, Hara K, Ishikawa SE. Diabetic ketoacidosis producing extreme hyperkalemia in a patient with type 1 diabetes on hemodialysis. Endocrinol Diabetes Metab Case Rep 2017;2017:17-0068. [PMID: 28924484 DOI: 10.1530/EDM-17-0068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
399 Pipeleers L, Wissing KM, Hilbrands R. Acid-base and electrolyte disturbances in patients with diabetes mellitus. Acta Clin Belg 2019;74:28-33. [PMID: 30470164 DOI: 10.1080/17843286.2018.1546983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
400 van der Vaart A, Waanders F, van Beek AP, Vriesendorp TM, Wolffenbutel BHR, van Dijk PR. Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study. BMJ Open Diabetes Res Care 2021;9:e002018. [PMID: 33597187 DOI: 10.1136/bmjdrc-2020-002018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
401 Garg SK, Rewers AH, Akturk HK. Ever-Increasing Insulin-Requiring Patients Globally. Diabetes Technology & Therapeutics 2018;20:S2-1-4. [DOI: 10.1089/dia.2018.0101] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
402 Braithwaite DT, Umpierrez GE, Braithwaite SS. A quadruply-asymmetric sigmoid to describe the insulin-glucose relationship during intravenous insulin infusion. J Healthc Eng 2014;5:23-53. [PMID: 24691385 DOI: 10.1260/2040-2295.5.1.23] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
403 Zhang N, Gu ZQ, Ding YL, Yang L, Chen MB, Zheng QH. A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis. Medicine (Baltimore) 2019;98:e17976. [PMID: 31764805 DOI: 10.1097/MD.0000000000017976] [Reference Citation Analysis]
404 Hsu C, Su F, Peng P, Young H, Liao S, Wang G. Highly sensitive non-enzymatic electrochemical glucose biosensor using a photolithography fabricated micro/nano hybrid structured electrode. Sensors and Actuators B: Chemical 2016;230:559-65. [DOI: 10.1016/j.snb.2016.02.109] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
405 Chuang C, Guo YW, Chen HS. Corrected sodium levels for hyperglycemia is a better predictor than measured sodium levels for clinical outcomes among patients with extreme hyperglycemia. J Chin Med Assoc 2020;83:845-51. [PMID: 32773588 DOI: 10.1097/JCMA.0000000000000407] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
406 Lee WC, Chiu CH, Chen JB, Chen CH, Chang HW. Mitochondrial Fission Increases Apoptosis and Decreases Autophagy in Renal Proximal Tubular Epithelial Cells Treated with High Glucose. DNA Cell Biol 2016;35:657-65. [PMID: 27420408 DOI: 10.1089/dna.2016.3261] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
407 Giessmann LC, Kann PH. Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes. Exp Clin Endocrinol Diabetes 2020;128:745-51. [PMID: 30049002 DOI: 10.1055/a-0654-5134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
408 Mourad AAE, Khodir AE, Saber S, Mourad MAE. Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids. Pharmaceuticals (Basel) 2021;14:144. [PMID: 33670273 DOI: 10.3390/ph14020144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Menéndez Torre E, Lafita Tejedor J, Artola Menéndez S, Millán Núñez-cortés J, Alonso García Á, Puig Domingo M, García Solans J, Álvarez Guisasola F, García Alegría J, Mediavilla Bravo J, Miranda Fernández-santos C, Romero González R. Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2. SEMERGEN - Medicina de Familia 2011;37:74-82. [DOI: 10.1016/j.semerg.2010.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
410 Iino T, Akatsuka M, Yamamoto S. Case Report: Occurrence of Thyroid Storm in a Young Patient With Recurrent Diabetic Ketoacidosis. Front Endocrinol 2022;13:834505. [DOI: 10.3389/fendo.2022.834505] [Reference Citation Analysis]
411 Deng J, Sitou K, Zhang Y, Yan R, Hu Y. Analyzing the Chinese landscape in anti-diabetic drug research: leading knowledge production institutions and thematic communities. Chin Med 2016;11:13. [PMID: 27030797 DOI: 10.1186/s13020-016-0084-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
412 Palermo NE, Sadhu AR, McDonnell ME. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations. J Clin Endocrinol Metab 2020;105:dgaa360. [PMID: 32556147 DOI: 10.1210/clinem/dgaa360] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 22.0] [Reference Citation Analysis]
413 McHugh MD, Shang J, Sloane DM, Aiken LH. Risk factors for hospital-acquired 'poor glycemic control': a case-control study. Int J Qual Health Care 2011;23:44-51. [PMID: 21084321 DOI: 10.1093/intqhc/mzq067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
414 Marren SM, Beale A, Yiin GS. Hyperosmolar hyperglycaemic state as a stroke cause or stroke mimic: an illustrative case and review of literature. Clin Med 2022;22:83-6. [DOI: 10.7861/clinmed.2021-0734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
415 Han Y, Nie L, Ye X, Zhou Z, Huang S, Zeng C, Guo C, Ou M, Xiao D, Zhang B, Huang C, Ye X, Jing C, Yang G. The association between Toxoplasma gondii infection and hypertensive disorders in T2DM patients: a case-control study in the Han Chinese population. Parasitol Res 2018;117:689-95. [PMID: 29349623 DOI: 10.1007/s00436-017-5737-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
416 Liu Y, Chen S, Liu Z, Lu Y, Xia G, Liu H, He L, She Z. Bioactive Metabolites from Mangrove Endophytic Fungus Aspergillus sp. 16-5B. Mar Drugs 2015;13:3091-102. [PMID: 25996099 DOI: 10.3390/md13053091] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
417 Ciechanowska A, Gora I, Sabalinska S, Foltynski P, Ladyzynski P. Effect of glucose concentration and culture substrate on HUVECs viability in in vitro cultures: A literature review and own results. Biocybernetics and Biomedical Engineering 2021;41:1390-405. [DOI: 10.1016/j.bbe.2021.04.010] [Reference Citation Analysis]
418 Saperstein Y, Park J, McFarlane SI. Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App. Int J Clin Endocrinol Metab 2018;4:8-11. [PMID: 31058273 DOI: 10.17352/ijcem.000031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
419 Oridupa OA, Folasire OF, Owolabi AJ. Evaluation of the sub-chronic toxicity profile of the corm of Xanthosoma sagittifolium on hematology and biochemistry of alloxan-induced diabetic Wistar rats. J Complement Integr Med 2017;14:/j/jcim. [PMID: 28306532 DOI: 10.1515/jcim-2016-0072] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
420 Elangovan A, Cattamanchi S, Farook AR, Trichur RV. Validation of Predicting Hyperglycemic Crisis Death Score: A Risk Stratification Tool for Appropriate Disposition of Hyperglycemic Crisis Patients from the Emergency Department. J Emerg Trauma Shock 2018;11:104-10. [PMID: 29937639 DOI: 10.4103/JETS.JETS_2_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
421 Papanastasiou L, Glycofridi S, Gravvanis C, Skarakis N, Papadimitriou I, Kanti G, Kapsali C, Kounadi T. Diabetic ketoacidosis in patients treated with SGLT2 inhibitors: experience at a tertiary hospital. Hormones (Athens) 2021;20:369-76. [PMID: 33151508 DOI: 10.1007/s42000-020-00256-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Self WH, Evans CS, Jenkins CA, Brown RM, Casey JD, Collins SP, Coston TD, Felbinger M, Flemmons LN, Hellervik SM, Lindsell CJ, Liu D, McCoin NS, Niswender KD, Slovis CM, Stollings JL, Wang L, Rice TW, Semler MW; Pragmatic Critical Care Research Group. Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of Cluster Randomized Clinical Trials. JAMA Netw Open 2020;3:e2024596. [PMID: 33196806 DOI: 10.1001/jamanetworkopen.2020.24596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
423 Fatourechi A, Ardakani HM, Sayarifard F, Sheikh M. Hypothyroidism among pediatric patients with type 1 diabetes mellitus, from patients' characteristics to disease severity. Clin Pediatr Endocrinol 2017;26:73-80. [PMID: 28458459 DOI: 10.1297/cpe.26.73] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
424 Schneider S. [Hyperglycemic crisis in patients with diabetes mellitus]. Med Klin Intensivmed Notfmed 2012;107:435-9. [PMID: 22907518 DOI: 10.1007/s00063-012-0114-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
425 Muniz TP, Araujo DV, Savage KJ, Cheng T, Saha M, Song X, Gill S, Monzon JG, Grenier D, Genta S, Allen MJ, Arteaga DP, Saibil SD, Butler MO, Spreafico A, Hogg D. CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus. Cancers (Basel) 2021;14:89. [PMID: 35008256 DOI: 10.3390/cancers14010089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Agarwal MA, Jain N, Podila PSB, Varadarajan V, Patel B, Shah M, Garg L, Khouzam RN, Ibebuogu U, Reed GL, Dagogo-Jack S. Association of history of heart failure with hospital outcomes of hyperglycemic crises: Analysis from a University hospital and national cohort. J Diabetes Complications 2020;34:107466. [PMID: 31735638 DOI: 10.1016/j.jdiacomp.2019.107466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
427 Sichaem J, Aree T, Lugsanangarm K, Tip-Pyang S. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites. Pharm Biol 2017;55:1436-41. [PMID: 28320255 DOI: 10.1080/13880209.2017.1304426] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
428 Eichenlaub M, Pleus S, Shaginian R, Richardson J, Pardo S, Stuhr A, Freckmann G. Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management. J Diabetes Sci Technol. [DOI: 10.1177/19322968221080916] [Reference Citation Analysis]
429 Alabdaljabar MS, Abdullah KM, Almasood A, Ali SS, Ashmeg A. Euglycemic Diabetic Ketoacidosis in a Sedated Patient after Coronary Artery Bypass Grafting: A Case Report and Literature Review. Case Rep Med 2021;2021:2086520. [PMID: 34840578 DOI: 10.1155/2021/2086520] [Reference Citation Analysis]
430 Shah A, Deak A, Allen S, Silfani E, Koppin C, Zisman-Ilani Y, Sirisena I, Rose C, Rubin D. Some characteristics of hyperglycaemic crisis differ between patients with and without COVID-19 at a safety-net hospital in a cross-sectional study. Ann Med 2021;53:1642-5. [PMID: 34511013 DOI: 10.1080/07853890.2021.1975042] [Reference Citation Analysis]
431 Ince C, Groeneveld AB. The case for 0.9% NaCl: is the undefendable, defensible? Kidney Int. 2014;86:1087-1095. [PMID: 25007167 DOI: 10.1038/ki.2014.193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
432 Cui HX, Hu YN, Li JW, Yuan K. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Oxid Med Cell Longev. 2018;2018:8930374. [PMID: 30662584 DOI: 10.1155/2018/8930374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
433 Tentolouris N, Katsilambros N. Diabetic Ketoacidosis in Adults. Diabetic Emergencies. Oxford: Wiley-Blackwell; 2011. pp. 1-32. [DOI: 10.1002/9781119971825.ch1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
434 Donnan K, Segar L. SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. Eur J Pharmacol. 2019;846:23-29. [PMID: 30639796 DOI: 10.1016/j.ejphar.2019.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
435 Morey-vargas OL, Aminian A, Steckner K, Zhou K, Kashyap S, Cetin D, Pantalone KM, Daigle C, Griebeler ML, Butsch WS, Zimmerman R, Kroh M, Saadi HF, Diemer Cnp D, Burguera B, Rosenthal RJ, Lansang MC. Perioperative Management of Diabetes in Patients Undergoing Bariatric and Metabolic Surgery: A Narrative Review and The Cleveland Clinic Practical Recommendations. Surgery for Obesity and Related Diseases 2022. [DOI: 10.1016/j.soard.2022.05.008] [Reference Citation Analysis]
436 Gobaru M, Sakai K, Sugiyama Y, Kohara C, Yoshimizu A, Matsui R, Sato Y, Tsukamoto T, Ashida K, Higashi H. Transient Antidiuretic Hormone Insufficiency Caused by Severe Hyperosmolar Hyperglycemic Syndrome Based on Nephrogenic Diabetes Insipidus. AACE Clin Case Rep 2021;7:372-5. [PMID: 34765734 DOI: 10.1016/j.aace.2021.06.009] [Reference Citation Analysis]
437 Akturk HK, Snell-Bergeon J, Pyle L, Fivekiller E, Garg S, Cobry E. Accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. J Diabetes Complications 2021;35:108030. [PMID: 34481712 DOI: 10.1016/j.jdiacomp.2021.108030] [Reference Citation Analysis]
438 Calimag APP, Chlebek S, Lerma EV, Chaiban JT. Diabetic ketoacidosis. Disease-a-Month 2022. [DOI: 10.1016/j.disamonth.2022.101418] [Reference Citation Analysis]
439 Inzucchi SE, Sherwin RS. Type 1 Diabetes Mellitus. Goldman's Cecil Medicine. Elsevier; 2012. pp. e78-94. [DOI: 10.1016/b978-1-4377-1604-7.00561-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
440 Haas NL, Gianchandani RY, Gunnerson KJ, Bassin BS, Ganti A, Hapner C, Boyd C, Cranford JA, Whitmore SP. The Two-Bag Method for Treatment of Diabetic Ketoacidosis in Adults. J Emerg Med 2018;54:593-9. [PMID: 29628184 DOI: 10.1016/j.jemermed.2018.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
441 Smiley D, Chandra P, Umpierrez GE. Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Manag (Lond). 2011;1:589-600. [PMID: 22611441 DOI: 10.2217/dmt.11.57] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
442 Ullal J, Aloi JA, Reyes-Umpierrez D, Pasquel FJ, McFarland R, Rabinovich M, Umpierrez GE. Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. J Diabetes Sci Technol 2018;12:39-46. [PMID: 29291648 DOI: 10.1177/1932296817750899] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
443 Takeuchi M, Kawamura T, Sato I, Kawakami K. Population-based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan. Pharmacoepidemiol Drug Saf 2018;27:123-6. [PMID: 28752620 DOI: 10.1002/pds.4271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
444 Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA. Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126. Diabetes Care 2022;45:e17-8. [PMID: 34986256 DOI: 10.2337/dci21-0048] [Reference Citation Analysis]
445 Sarkar P, Basak P, Ghosh S, Kundu M, Sil PC. Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. Food Chem Toxicol 2017;110:109-21. [PMID: 29050977 DOI: 10.1016/j.fct.2017.10.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
446 Levy N, Hall GM. National guidance contributes to the high incidence of inpatient hypoglycaemia. Diabet Med 2019;36:120-1. [PMID: 30092604 DOI: 10.1111/dme.13795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
447 Capitao R, Bello C, Fonseca R, Saraiva C. New onset diabetes after nivolumab treatment. BMJ Case Rep 2018;2018:bcr-2017-220999. [PMID: 29378735 DOI: 10.1136/bcr-2017-220999] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
448 Zhou VL, Shofer FS, Desai NG, Lorincz IS, Mull NK, Adler DH, Greenwood JC. Predictors of Short Intensive Care Unit Stay for Patients with Diabetic Ketoacidosis Using a Novel Emergency Department-Based Resuscitation and Critical Care Unit. J Emerg Med 2019;56:127-34. [PMID: 30401511 DOI: 10.1016/j.jemermed.2018.09.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
449 Kitabchi AE, Umpierrez G, Miles J, Fisher J. Hyperglycemic Crises in Adult Patients With Diabetes. Diabetes Care 2009;32:e158-e158. [DOI: 10.2337/dc09-1563] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
450 . The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised). Journal of Endocrinology, Metabolism and Diabetes of South Africa 2014;17:S1-S95. [DOI: 10.1080/22201009.2012.10872287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
451 Brown HD, Tran RH, Patka JH. Effect of Bolus Insulin Administration Followed by a Continuous Insulin Infusion on Diabetic Ketoacidosis Management. Pharmacy (Basel) 2018;6:E129. [PMID: 30544554 DOI: 10.3390/pharmacy6040129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
452 Hunt L, Vinayagam R, Gopalan P, Bains A, Scott A. Asymptomatic prostatic abscess: a cause of staphylococcal bacteraemia in uncontrolled diabetes: Case report. Practical Diabetes 2013;30:318-20. [DOI: 10.1002/pdi.1803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
453 Asarani NAM, Paddison J, Walker R, Downie M, Wheeler BJ. New-onset type 1 diabetes complicated by diabetic ketoacidosis and severe sepsis requiring extracorporeal membrane oxygenation and kidney replacement therapy. J Diabetes Metab Disord 2021;20:1075-9. [PMID: 34178873 DOI: 10.1007/s40200-021-00736-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
454 Huang C, Kuo S, Chien T, Lin H, Guo H, Chen W, Chen J, Chang S, Su S. Predicting the hyperglycemic crisis death (PHD) score: a new decision rule for emergency and critical care. The American Journal of Emergency Medicine 2013;31:830-4. [DOI: 10.1016/j.ajem.2013.02.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
455 Sagy I, Zimhony-Nissim N, Brandstaetter E, Lipnitzki I, Musa H, Rosen Y, Barski L. Outcomes of diabetic ketoacidosis in a tertiary centre with restricted intensive care unit bed capacity. Intern Med J 2021;51:948-54. [PMID: 32253805 DOI: 10.1111/imj.14842] [Reference Citation Analysis]
456 Godman B, Basu D, Pillay Y, Almeida PHRF, Mwita JC, Rwegerera GM, Anand Paramadhas BD, Tiroyakgosi C, Patrick O, Niba LL, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia AC, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hospital Practice 2020;48:51-67. [DOI: 10.1080/21548331.2020.1745509] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
457 Rosenbloom AL. The management of diabetic ketoacidosis in children. Diabetes Ther. 2010;1:103-120. [PMID: 22127748 DOI: 10.1007/s13300-010-008-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
458 Menéndez Torre E, Lafita Tejedor FJ, Artola Menéndez S, Millán Núñez-Cortés J, Alonso García Á, Puig Domingo M, García Solans JR, Alvarez Guisasola F, García Alegría J, Mediavilla Bravo J, Miranda Fernández-Santos C, Romero González R; Working Group for Consensus and Clinical Guidelines of the Spanish Diabetes Society. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]. Endocrinol Nutr 2011;58:112-20. [PMID: 21354873 DOI: 10.1016/j.endonu.2010.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
459 Singh H, Saroch A, Pannu AK, Sachin HJ, Sharma N, Dutta P. Clinical and biochemical profile, precipitants and prognostic factors of diabetic ketoacidosis: A retrospective study from a tertiary care center of north India. Diabetes Metab Syndr 2019;13:2357-60. [PMID: 31405643 DOI: 10.1016/j.dsx.2019.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
460 Remy KE, Verhoef PA, Malone JR, Ruppe MD, Kaselitz TB, Lodeserto F, Hirshberg EL, Slonim A, Dezfulian C. Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists. Pediatr Crit Care Med 2020;21:607-19. [PMID: 32420720 DOI: 10.1097/PCC.0000000000002429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
461 Liu M, Tang L, Hu C, Huang Z, Sun B, Lam JCW, Lam PKS, Chen L. Antagonistic interaction between perfluorobutanesulfonate and probiotic on lipid and glucose metabolisms in the liver of zebrafish. Aquat Toxicol 2021;237:105897. [PMID: 34153904 DOI: 10.1016/j.aquatox.2021.105897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
462 Gordon A, LaCapra G, Roberti R. DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM. Case Rep Crit Care 2017;2017:4287125. [PMID: 28473928 DOI: 10.1155/2017/4287125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
463 Sampani E, Sarafidis P, Papagianni A. Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment. Expert Opin Drug Saf 2020;19:673-82. [PMID: 32521174 DOI: 10.1080/14740338.2020.1764532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
464 Nambu T, Mori K, Shinoto Y, Izumi R, Matsuo K, Kanai Y, Kanamoto N, Miura M, Yonemitsu S, Yasoda A, Muro S, Arai H, Oki S, Nakao K. Diabetic ketoacidosis accompanied by hypothermia: A case report. Diabetes Research and Clinical Practice 2012;96:326-30. [DOI: 10.1016/j.diabres.2012.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
465 Barski L, Kezerle L, Zeller L, Zektser M, Jotkowitz A. New approaches to the use of insulin in patients with diabetic ketoacidosis. Eur J Intern Med 2013;24:213-6. [PMID: 23395363 DOI: 10.1016/j.ejim.2013.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
466 Al-Hayek AA, Robert AA, Braham RB, Turki AS, Al-Sabaan FS. Frequency and associated risk factors of recurrent diabetic ketoacidosis among Saudi adolescents with type 1 diabetes mellitus. Saudi Med J. 2015;36:216-220. [PMID: 25719588 DOI: 10.15537/smj.2015.2.10560] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
467 Garg SK, Garg P. Differential Diagnosis of Ketoacidosis in Hyperglycemic Alcoholic Diabetic Patient: Role of Insulin. Indian J Crit Care Med 2021;25:1203-4. [PMID: 34916758 DOI: 10.5005/jp-journals-10071-23988] [Reference Citation Analysis]
468 Desse TA, Eshetie TC, Gudina EK. Predictors and treatment outcome of hyperglycemic emergencies at Jimma University Specialized Hospital, southwest Ethiopia. BMC Res Notes. 2015;8:553. [PMID: 26455633 DOI: 10.1186/s13104-015-1495-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
469 Fluegge K. Community water fluoridation predicts increase in age-adjusted incidence and prevalence of diabetes in 22 states from 2005 and 2010. J Water Health 2016;14:864-77. [PMID: 27740551 DOI: 10.2166/wh.2016.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
470 Li Q, Lv L, Chen Y, Zhou Y. Early prediction models for prognosis of diabetic ketoacidosis in the emergency department: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e26113. [PMID: 34032754 DOI: 10.1097/MD.0000000000026113] [Reference Citation Analysis]
471 Berndt M, Lehnert H. Diabetische Ketoazidose. Diabetologe 2014;10:638-44. [DOI: 10.1007/s11428-014-1266-9] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
472 Palmiere C. Postmortem diagnosis of diabetes mellitus and its complications. Croat Med J 2015;56:181-93. [PMID: 26088843 DOI: 10.3325/cmj.2015.56.181] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
473 Rosival V. [Letter to the editor concerning the article "Hyperglycemic crisis in patients with diabetes mellitus"]. Med Klin Intensivmed Notfmed 2013;108:519-20. [PMID: 23812016 DOI: 10.1007/s00063-013-0239-x] [Reference Citation Analysis]
474 Monroy-Mérida G, Guzmán-Beltrán S, Hernández F, Santos-Mendoza T, Bobadilla K. High Glucose Concentrations Impair the Processing and Presentation of Mycobacterium tuberculosis Antigens In Vitro. Biomolecules 2021;11:1763. [PMID: 34944407 DOI: 10.3390/biom11121763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Musso G, Sircana A, Saba F, Cassader M, Gambino R. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression. PLoS Med. 2020;17:e1003461. [PMID: 33373368 DOI: 10.1371/journal.pmed.1003461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
476 Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019;365:l1114. [PMID: 31142480 DOI: 10.1136/bmj.l1114] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 11.7] [Reference Citation Analysis]
477 Sun Y, Roumelioti ME, Ganta K, Glew RH, Gibb J, Vigil D, Do C, Servilla KS, Wagner B, Owen J, Rohrscheib M, Dorin RI, Murata GH, Tzamaloukas AH. Dialysis-associated hyperglycemia: manifestations and treatment. Int Urol Nephrol 2020;52:505-17. [PMID: 31955362 DOI: 10.1007/s11255-019-02373-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
478 Bassham B, Estrada C, Abramo T. Hyperglycemic hyperosmolar syndrome in the pediatric patient: a case report and review of the literature. Pediatr Emerg Care 2012;28:699-702. [PMID: 22766588 DOI: 10.1097/PEC.0b013e31825d23c9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
479 Jacobi J. Management of Endocrine Emergencies in the ICU. J Pharm Pract 2019;32:314-26. [PMID: 30852927 DOI: 10.1177/0897190019834771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
480 Chiu HY, Hsu HY, Kuo LC, Su FC, Yu HI, Hua SC, Lu CH. How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives. PLoS One 2014;9:e94452. [PMID: 24722361 DOI: 10.1371/journal.pone.0094452] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
481 Wang Y, Zhou H, Palyha O, Mu J. Restoration of insulin receptor improves diabetic phenotype in T2DM mice. JCI Insight 2019;4:124945. [PMID: 31391336 DOI: 10.1172/jci.insight.124945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
482 Yan JW, Liu S, Van Aarsen K, Columbus MP, Spaic T. Do Adult Patients With Type 1 or 2 Diabetes Who Present to the Emergency Department With Hyperglycemia Have Improved Outcomes if They Have Access to Specialized Diabetes Care? Can J Diabetes 2021;45:59-63. [PMID: 32847767 DOI: 10.1016/j.jcjd.2020.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
483 Opie LH. Cardiac Metabolism in Health and Disease. Cellular and Molecular Pathobiology of Cardiovascular Disease. Elsevier; 2014. pp. 23-36. [DOI: 10.1016/b978-0-12-405206-2.00002-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
484 Galm BP, Bagshaw SM, Senior PA. Acute Management of Diabetic Ketoacidosis in Adults at 3 Teaching Hospitals in Canada: A Multicentre, Retrospective Cohort Study. Can J Diabetes 2019;43:309-315.e2. [PMID: 30579737 DOI: 10.1016/j.jcjd.2018.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
485 Ohara N, Kaneko M, Sato K, Maruyama R, Furukawa T, Tanaka J, Kaneko K, Kamoi K. Vildagliptin-induced acute lung injury: a case report. J Med Case Rep. 2016;10:225. [PMID: 27520566 DOI: 10.1186/s13256-016-1006-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
486 McCoy RG, Galindo RJ, Swarna KS, Van Houten HK, O'Connor PJ, Umpierrez GE, Shah ND. Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020. JAMA Netw Open 2021;4:e2123471. [PMID: 34468753 DOI: 10.1001/jamanetworkopen.2021.23471] [Reference Citation Analysis]
487 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapy of Type 1 Diabetes. Exp Clin Endocrinol Diabetes 2022. [PMID: 35373309 DOI: 10.1055/a-1624-3340] [Reference Citation Analysis]
488 Dhatariya KK. Why the definitions used to diagnose diabetic ketoacidosis should be standardised. Diabetes Res Clin Pract 2018;135:227-8. [PMID: 28941708 DOI: 10.1016/j.diabres.2017.08.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
489 Doostkam A, Fathalipour M, Anbardar MH, Purkhosrow A, Mirkhani H, Caspa Gokulan R. Therapeutic Effects of Milk Thistle (Silybum marianum L.) and Artichoke (Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/2868904] [Reference Citation Analysis]
490 Lee C, Szwak JA, Bastow S, McCarthy S. Impact of a Nurse-Driven Diabetic Ketoacidosis Insulin Infusion Calculator on the Rate of Hypoglycemia. J Patient Saf 2020;16:e255-9. [PMID: 33215892 DOI: 10.1097/PTS.0000000000000647] [Reference Citation Analysis]
491 Himuro H, Sugiyama T, Nishigori H, Saito M, Nagase S, Sugawara J, Yaegashi N. A case of a woman with late-pregnancy-onset DKA who had normal glucose tolerance in the first trimester. Endocrinol Diabetes Metab Case Rep 2014;2014:130085. [PMID: 24711923 DOI: 10.1530/EDM-13-0085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
492 Du S, Zhang H, Wu H, Ye S, Li W, Su Q. Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: A Retrospective Study. Diabetes Metab Syndr Obes 2020;13:2719-27. [PMID: 32801818 DOI: 10.2147/DMSO.S252492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
493 Dandare SU, Ezeonwumelu IJ, Shinkafi TS, Magaji UF, Adio AA, Ahmad K. L-alanine supplementation improves blood glucose level and biochemical indices in alloxan-induced diabetic rats. J Food Biochem 2021;45:e13590. [PMID: 33346923 DOI: 10.1111/jfbc.13590] [Reference Citation Analysis]
494 Priyadarsini S, Whelchel A, Nicholas S, Sharif R, Riaz K, Karamichos D. Diabetic keratopathy: Insights and challenges. Surv Ophthalmol 2020;65:513-29. [PMID: 32092364 DOI: 10.1016/j.survophthal.2020.02.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
495 Chua HR, Venkatesh B, Stachowski E, Schneider AG, Perkins K, Ladanyi S, Kruger P, Bellomo R. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care. 2012;27:138-145. [PMID: 22440386 DOI: 10.1016/j.jcrc.2012.01.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
496 Zhao X, Zhan X, Zhang H, Wan Y, Yang H, Wang Y, Chen Y, Xie W. Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors. Bioorg Med Chem Lett 2021;54:128447. [PMID: 34767915 DOI: 10.1016/j.bmcl.2021.128447] [Reference Citation Analysis]
497 Rasheed JI, Razak MKA, Hussein AAA. The value of venous blood gas analysis in the diagnosis of diabetic ketoacidosis. Diabetes Metab Syndr 2017;11 Suppl 2:S737-43. [PMID: 28807726 DOI: 10.1016/j.dsx.2017.05.008] [Reference Citation Analysis]
498 Mathieu C, Rudofsky G, Phillip M, Araki E, Lind M, Arya N, Thorén F, Scheerer MF, Iqbal N, Dandona P. Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial. Diabetes Obes Metab 2020;22:1516-26. [PMID: 32311204 DOI: 10.1111/dom.14060] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
499 Lu H, Chen Y, Li L. Metabolic Pathway Genes Associated with Susceptibility Genes to Coronary Artery Disease. Int J Genomics 2018;2018:9025841. [PMID: 29607312 DOI: 10.1155/2018/9025841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
500 Braithwaite SS, Umpierrez GE, Chase JG. Multiplicative surrogate standard deviation: a group metric for the glycemic variability of individual hospitalized patients. J Diabetes Sci Technol 2013;7:1319-27. [PMID: 24124960 DOI: 10.1177/193229681300700523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
501 Aung NM, Kaung M, Kyi TT, Kyaw MP, Min M, Htet ZW, Anstey NM, Kyi MM, Hanson J. The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria. PLoS One 2015;10:e0143062. [PMID: 26581060 DOI: 10.1371/journal.pone.0143062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
502 Atkilt HS, Turago MG, Tegegne BS. Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study. PLoS One 2017;12:e0169666. [PMID: 28135278 DOI: 10.1371/journal.pone.0169666] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
503 Carrizales-Sepúlveda EF, Del Cueto-Aguilera ÁN, Jiménez-Castillo RA, de la Cruz-Mata ON, Fikir-Ordoñez M, Vera-Pineda R, Hernández-Guajardo DA, Ordaz-Farías A, Flores-Ramírez R. Pseudomyocardial Infarction in a Patient with Severe Diabetic Ketoacidosis and Mild Hyperkalemia. Case Rep Cardiol 2019;2019:4063670. [PMID: 31049229 DOI: 10.1155/2019/4063670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
504 Ray GM, Rodriguez C, Schulman SM, Sarangarm P, Bardack M, Bouchonville MF. Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis. Clin Pract Cases Emerg Med 2019;3:140-3. [PMID: 31061971 DOI: 10.5811/cpcem.2019.2.41795] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
505 Hernández-Ochoa EO, Robison P, Contreras M, Shen T, Zhao Z, Schneider MF. Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle. Exp Biol Med (Maywood) 2012;237:1068-83. [PMID: 22966145 DOI: 10.1258/ebm.2012.012052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
506 Xiong X, Wei L, Xiao Y, Han Y, Yang J, Zhao H, Yang M, Sun L. Effects of family history of diabetes on pancreatic β-cell function and diabetic ketoacidosis in newly diagnosed patients with type 2 diabetes: a cross-sectional study in China. BMJ Open 2021;11:e041072. [PMID: 33431489 DOI: 10.1136/bmjopen-2020-041072] [Reference Citation Analysis]
507 Garg SK. Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes. Diabetes Technology & Therapeutics 2017;19:549-51. [DOI: 10.1089/dia.2017.1807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
508 Karoli R, Fatima J, Salman T, Sandhu S, Shankar R. Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs. Indian J Pharmacol. 2011;43:398-401. [PMID: 21844993 DOI: 10.4103/0253-7613.83109] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
509 Sawalha K, Kunnumpurath A, Kamoga GR. The Efficacy of Intravenous Insulin Infusion in the Management of Hypertriglyceridemia-Induced Pancreatitis in a Rural Community Hospital. J Investig Med High Impact Case Rep. 2020;8:2324709620940492. [PMID: 32643965 DOI: 10.1177/2324709620940492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Venkatesh B, Pilcher D, Prins J, Bellomo R, Morgan TJ, Bailey M. Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand. Crit Care. 2015;19:451. [PMID: 26715333 DOI: 10.1186/s13054-015-1171-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
511 Hsieh HC, Wu SH, Chiu CC, Ko KC. Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report. Diabetes Ther. 2019;10:765-771. [PMID: 30843157 DOI: 10.1007/s13300-019-0592-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
512 Schaapveld-Davis CM, Negrete AL, Hudson JQ, Saikumar J, Finch CK, Kocak M, Hu P, Van Berkel MA. End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State. Clin Diabetes 2017;35:202-8. [PMID: 29109609 DOI: 10.2337/cd16-0060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
513 McPhee PG, Gorter JW, Cotie LM, Timmons BW, Bentley T, MacDonald MJ. Descriptive data on cardiovascular and metabolic risk factors in ambulatory and non-ambulatory adults with cerebral palsy. Data Brief 2015;5:967-70. [PMID: 26759816 DOI: 10.1016/j.dib.2015.10.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
514 Park JE, Han JS. A Portulaca oleracea L. extract promotes insulin secretion via a K+ATP channel dependent pathway in INS-1 pancreatic β-cells. Nutr Res Pract 2018;12:183-90. [PMID: 29854323 DOI: 10.4162/nrp.2018.12.3.183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
515 Kasbawala K, Stamatiades GA, Majumdar SK. Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications. Am J Case Rep 2020;21:e921536. [PMID: 32483108 DOI: 10.12659/AJCR.921536] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
516 Menéndez Torre E, Lafita Tejedor FJ, Artola Menéndez S, Millán Núñez-Cortés J, Alonso García A, Puig Domingo M, García Solans JR, Alvarez Guisasola F, García Alegría J, Mediavilla Bravo J, Miranda Fernández-Santos C, Romero González R; Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]. Aten Primaria 2011;43:202.e1-9. [PMID: 21382648 DOI: 10.1016/j.aprim.2010.07.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
517 Rodriguez-Gutierrez R, Mancillas-Adame LG, Rodríguez-Tamez G, Diaz Gonzalez-Colmenero A, Solis-Pacheco RC, Elizondo-Plazas AS, Santos-Santillana KM, Gonzalez-Sariñana L, Gonzalez-Nava V, Gonzalez-Gonzalez JG. Hypertriglyceridemia and Its Association with HbA1c Test: A Prospective In Vivo Controlled Study. Int J Endocrinol 2019;2019:4784313. [PMID: 30891069 DOI: 10.1155/2019/4784313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
518 Rodríguez-Velver KV, Soto-Garcia AJ, Zapata-Rivera MA, Montes-Villarreal J, Villarreal-Pérez JZ, Rodríguez-Gutiérrez R. Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state. Case Rep Neurol Med 2014;2014:652523. [PMID: 25431711 DOI: 10.1155/2014/652523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
519 Xu D, Lin W, Xu M, Gu D, Zheng F, Tu J. Implementation of Standardized Perioperative Care for Laparoscopic Roux-en-Y Gastric Bypass in a New Program at a Chinese Hospital. Bariatric Surgical Practice and Patient Care 2015;10:49-54. [DOI: 10.1089/bari.2014.0043] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
520 Zangeneh MM, Zangeneh A, Tahvilian R, Moradi R, Tehrani PR. Preclinical evaluation of hematoprotective and nephroprotective activities of Bellis perennis L aqueous extract on CCl4-induced renal injury in mice. Comp Clin Pathol 2018;27:1557-66. [DOI: 10.1007/s00580-018-2773-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
521 Abejew AA, Belay AZ, Kerie MW. Diabetic Complications among Adult Diabetic Patients of a Tertiary Hospital in Northeast Ethiopia. Advances in Public Health 2015;2015:1-7. [DOI: 10.1155/2015/290920] [Cited by in Crossref: 26] [Article Influence: 3.7] [Reference Citation Analysis]
522 Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr 2010;156:180-4. [PMID: 20105637 DOI: 10.1016/j.jpeds.2009.11.057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
523 Zangeneh MM, Zangeneh A, Tahvilian R, Moradi R. Evaluation of the nephroprotective effect of Glycyrrhiza glabra L aqueous extract on CCl4-induced nephrotoxicity in mice. Comp Clin Pathol 2018;27:1119-26. [DOI: 10.1007/s00580-018-2707-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
524 George JT, Mishra AK, Iyadurai R. Correlation between the outcomes and severity of diabetic ketoacidosis: A retrospective pilot study. J Family Med Prim Care 2018;7:787-90. [PMID: 30234054 DOI: 10.4103/jfmpc.jfmpc_116_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
525 Vellanki P, Stefanovski D, Anzola II, Smiley DD, Peng L, Umpierrez GE. Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises. BMJ Open Diabetes Res Care 2020;8:e001062. [PMID: 32475838 DOI: 10.1136/bmjdrc-2019-001062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
526 Thawabi M, Studyvin S. Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis. N Am J Med Sci. 2015;7:291-294. [PMID: 26199928 DOI: 10.4103/1947-2714.157490] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
527 Schwarzfuchs D, Rabaev E, Sagy I, Zimhony-Nissim N, Lipnitzki I, Musa H, Jotkowitz A, Brandstaetter E, Barski L. Clinical and Epidemiological Characteristics of Diabetic Ketoacidosis in Older Adults. J Am Geriatr Soc 2020;68:1256-61. [PMID: 32134118 DOI: 10.1111/jgs.16376] [Reference Citation Analysis]
528 Armor B, Harrison D, Lawler F. Assessment of the clinical outcome of a symptom-based outpatient hyperglycemia protocol. Diabetes Ther 2011;2:67-80. [PMID: 22127801 DOI: 10.1007/s13300-011-0001-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
529 Koscal LJ, Weeda ER, Matuskowitz AJ, Weant KA. Intravenous insulin for the management of non-emergent hyperglycemia in the emergency department. Am J Emerg Med 2021;45:335-9. [PMID: 33041132 DOI: 10.1016/j.ajem.2020.08.078] [Reference Citation Analysis]
530 Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Research and Clinical Practice 2011;94:340-51. [DOI: 10.1016/j.diabres.2011.09.012] [Cited by in Crossref: 72] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
531 Delaney SR, Kaleta EJ, Snozek CLH. Extreme Hyperglycemia in an Elderly Patient. Clin Chem 2021;67:724-8. [PMID: 33462604 DOI: 10.1093/clinchem/hvaa330] [Reference Citation Analysis]
532 Sonia TA, Sharma CP. Routes of administration of insulin. Oral Delivery of Insulin. Elsevier; 2014. pp. 59-112. [DOI: 10.1533/9781908818683.59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
533 Girlescu N, Stoica B, Hunea I, Diac M, Damian SI, David S, Iov T, Tabian D, Bulgaru Iliescu D. The Vital Role of Thanatochemistry in the Postmortem Diagnostic of Diabetic Ketoacidosis-Case Report. Diagnostics (Basel) 2021;11:988. [PMID: 34072541 DOI: 10.3390/diagnostics11060988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Amalnath DS, Dutta TK. Hypokalemic paralysis as the presenting manifestation of diabetes in two patients. Indian J Endocrinol Metab. 2013;17:1127-1128. [PMID: 24381899 DOI: 10.4103/2230-8210.122648] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
535 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S83-96. [PMID: 34964868 DOI: 10.2337/dc22-S006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 31.0] [Reference Citation Analysis]
536 Cohn BG, Keim SM, Watkins JW, Camargo CA. Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission? J Emerg Med. 2015;49:530-538. [PMID: 26238182 DOI: 10.1016/j.jemermed.2015.05.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
537 Bonora BM, Avogaro A, Fadini GP. Euglycemic Ketoacidosis. Curr Diab Rep. 2020;20:25. [PMID: 32424730 DOI: 10.1007/s11892-020-01307-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
538 Zhu B, Bu L, Zhang M, Gusdon AM, Zheng L, Rampersad S, Li J, Qu S. HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus. Sci Rep 2016;6:39687. [PMID: 28009017 DOI: 10.1038/srep39687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
539 Bozkurt B, Hershberger RE, Butler J, Grady KL, Heidenreich PA, Isler ML, Kirklin JK, Weintraub WS. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). J Am Coll Cardiol 2021;77:2053-150. [PMID: 33250265 DOI: 10.1016/j.jacc.2020.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
540 Anno T, Tsujimoto K, Shigemoto R, Kojima S, Kaneto H. Diabetic ketoacidosis and sinus arrest conditions in a patient with an inserted cardiac pacemaker. Acta Diabetol 2021;58:657-60. [PMID: 33392711 DOI: 10.1007/s00592-020-01615-4] [Reference Citation Analysis]
541 Priyambada L, Wolfsdorf JI, Brink SJ, Fritsch M, Codner E, Donaghue KC, Craig ME. ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes 2020;21:1394-402. [PMID: 32935435 DOI: 10.1111/pedi.13118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Dhatariya KK, Vellanki P. Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). Curr Diab Rep 2017;17:33. [PMID: 28364357 DOI: 10.1007/s11892-017-0857-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
543 Weatherbee A, Popov I, Vitkin A. Accurate viscosity measurements of flowing aqueous glucose solutions with suspended scatterers using a dynamic light scattering approach with optical coherence tomography. J Biomed Opt 2017;22:1-10. [PMID: 28861954 DOI: 10.1117/1.JBO.22.8.087003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
544 . The 2012 SEMDSA Guideline for the Management of type 2 Diabetes. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2014;17:S1-S94. [DOI: 10.1080/22201009.2012.10872277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
545 Keltanen T, Nenonen T, Ketola RA, Ojanperä I, Sajantila A, Lindroos K. Post-mortem analysis of lactate concentration in diabetics and metformin poisonings. Int J Legal Med 2015;129:1225-31. [DOI: 10.1007/s00414-015-1256-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
546 Marrie RA, Sellers EAC, Chen H, Fransoo R, Bernstein CN, Hitchon CA, Peschken CA, Garland A. Markedly increased incidence of critical illness in adults with Type 1 diabetes. Diabet Med 2017;34:1414-20. [PMID: 28626956 DOI: 10.1111/dme.13404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
547 Kar AK, Singh A, Singh D, Shraogi N, Verma R, Saji J, Jagdale P, Ghosh D, Patnaik S. Biopolymeric composite hydrogel loaded with silver NPs and epigallocatechin gallate (EGCG) effectively manages ROS for rapid wound healing in type II diabetic wounds. Int J Biol Macromol 2022;218:506-18. [PMID: 35817241 DOI: 10.1016/j.ijbiomac.2022.06.196] [Reference Citation Analysis]
548 Wagner DV, Stoeckel M, E Tudor M, Harris MA. Treating the most vulnerable and costly in diabetes. Curr Diab Rep 2015;15:606. [PMID: 25877049 DOI: 10.1007/s11892-015-0606-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
549 Abdel-moneim AH, Lutfi MF, Alsharidah AS, Shaker G, Faisal W, Abdellatif AAH, Rugaie OA, Mohany KM, Eid SY, El-readi MZ, Alsharidah M. Short-Term Treatment of Metformin and Glipizide on Oxidative Stress, Lipid Profile and Renal Function in a Rat Model with Diabetes Mellitus. Applied Sciences 2022;12:2019. [DOI: 10.3390/app12042019] [Reference Citation Analysis]
550 Kamel KS, Schreiber M, Carlotti AP, Halperin ML. Approach to the Treatment of Diabetic Ketoacidosis. Am J Kidney Dis 2016;68:967-72. [PMID: 27599629 DOI: 10.1053/j.ajkd.2016.05.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
551 Kim J, Khan M, Park S. Glucose Sensor using Liquid-Crystal Droplets Made by Microfluidics. ACS Appl Mater Interfaces 2013;5:13135-9. [DOI: 10.1021/am404174n] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
552 Fusco N, Gonzales J, Yeung SY. Evaluation of the treatment of diabetic ketoacidosis in the medical intensive care unit. Am J Health Syst Pharm 2015;72:S177-82. [PMID: 26582306 DOI: 10.2146/sp150028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
553 Jeon JY, Kim SK, Kim KS, Song SO, Yun JS, Kim BY, Kim CH, Park SO, Hong S, Seo DH, Seo JA, Noh JH, Kim DJ; DKA Study Group of Gyeonin Branch of the Korean Diabetes Association. Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors. Diabetes Metab 2019;45:453-7. [PMID: 30639566 DOI: 10.1016/j.diabet.2019.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
554 Firestone RL, Parker PL, Pandya KA, Wilson MD, Duby JJ. Moderate-Intensity Insulin Therapy Is Associated With Reduced Length of Stay in Critically Ill Patients With Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State. Crit Care Med 2019;47:700-5. [PMID: 30855284 DOI: 10.1097/CCM.0000000000003709] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
555 van der Vaart A, Yeung SMH, van Dijk PR, Bakker SJL, de Borst MH. Phosphate and fibroblast growth factor 23 in diabetes. Clin Sci (Lond) 2021;135:1669-87. [PMID: 34283205 DOI: 10.1042/CS20201290] [Reference Citation Analysis]
556 Vidyasagar K, Chandrasekar B, Chhabra M, Bhansali A, Bansal D. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison. Clin Ther 2020;42:e115-39. [PMID: 32798057 DOI: 10.1016/j.clinthera.2020.06.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
557 de Wit HM, Engwerda EE, Tack CJ, de Galan BE. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes. Diabetes Obes Metab 2015;17:1093-9. [PMID: 26259978 DOI: 10.1111/dom.12550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
558 Stephen AO, Rotimi OA, Adegoke AT, Samson OO. Reprotoxic activities of vildagliptin administration in male Wistar rats. Braz J Pharm Sci 2021;57:e19144. [DOI: 10.1590/s2175-97902020000119144] [Reference Citation Analysis]
559 Andrews TJ, Cox RD, Parker C, Kolb J. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. The Journal of Emergency Medicine 2017;52:223-6. [DOI: 10.1016/j.jemermed.2016.07.082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
560 Elkituni A, Elshwekh H, Bendala NM, Atwear WS, Aldaba FA, Fellah AM. Profile of diabetic ketoacidosis at the National Diabetes and Endocrine Center in Tripoli, Libya, 2015. Diabetes Metab Syndr 2021;15:771-5. [PMID: 33831773 DOI: 10.1016/j.dsx.2021.03.014] [Reference Citation Analysis]
561 Dhatariya K. Diabetic ketoacidosis and hyperosmolar crisis in adults. Medicine 2019;47:46-51. [DOI: 10.1016/j.mpmed.2018.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
562 Isaacs M, Tonks KT, Greenfield JR. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors. Intern Med J 2017;47:701-4. [PMID: 28580740 DOI: 10.1111/imj.13442] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
563 Fields JM, Dean AJ. Systemic causes of abdominal pain. Emerg Med Clin North Am 2011;29:195-210, vii. [PMID: 21515176 DOI: 10.1016/j.emc.2011.01.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
564 Modzelewski KL, Rybin DV, Weinberg JM, Alexanian SM, McDonnell ME, Steenkamp DW. Active cocaine use does not increase the likelihood of hyperglycemic crisis. J Clin Transl Endocrinol 2017;9:1-7. [PMID: 29067261 DOI: 10.1016/j.jcte.2017.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
565 Yusuff OT, Kolawole BA, Ikem RT, Soyoye DO, Amjo OO. Cardiovascular Risk Indices and Their Impact on Outcome in Patients with Hyperglycaemic Emergencies in a Nigerian Hospital. J Natl Med Assoc 2020;112:28-35. [PMID: 31973880 DOI: 10.1016/j.jnma.2019.12.004] [Reference Citation Analysis]
566 Dragic S, Momcicevic D, Zlojutro B, Jandric M, Kovacevic T, Djajic V, Gajic O, Kovacevic P. Successful Outcomes of Critically Ill Patients with Extreme Metabolic Acidosis Treated with Structured Approach: Case Series. Clin Med Insights Case Rep 2021;14:11795476211025138. [PMID: 34248359 DOI: 10.1177/11795476211025138] [Reference Citation Analysis]
567 Maghrabi AH, Hamoudeh E, Hassan T, Gress T, Yaqub A, Saleem TF. Safety And Efficacy of An Algorithm-Based Protocol In the Management of Diabetic Ketoacidosis. Endocrine Practice 2012;18:842-6. [DOI: 10.4158/ep12023.or] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
568 Dhatariya K. Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. Rev Diabet Stud 2016;13:217-25. [PMID: 28278308 DOI: 10.1900/RDS.2016.13.217] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 10.2] [Reference Citation Analysis]
569 Thuzar M, Malabu UH, Tisdell B, Sangla KS. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res Clin Pract. 2014;104:e8-e11. [PMID: 24507867 DOI: 10.1016/j.diabres.2014.01.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
570 Recio A, Linares C, Banegas JR, Díaz J. The short-term association of road traffic noise with cardiovascular, respiratory, and diabetes-related mortality. Environmental Research 2016;150:383-90. [DOI: 10.1016/j.envres.2016.06.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
571 Ikeoka T, Otsuka H, Fujita N, Masuda Y, Maeda S, Horie I, Ando T, Abiru N, Kawakami A. Thyroid Storm Precipitated by Diabetic Ketoacidosis and Influenza A: A Case Report and Literature Review. Intern Med 2017;56:181-5. [PMID: 28090049 DOI: 10.2169/internalmedicine.56.7593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
572 Clark A, Kraut E, Yen HH, Moore S, Hopman W, Houlden RL. Evaluation of a Diabetic Ketoacidosis Order Set in Adults With Type 1 and Type 2 Diabetes at a Tertiary Academic Medical Centre: A Retrospective Chart Audit. Can J Diabetes 2019;43:304-308.e3. [PMID: 30713091 DOI: 10.1016/j.jcjd.2018.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
573 Garg SK, Peters AL, Buse JB, Danne T. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol. Diabetes Technology & Therapeutics 2018;20:571-5. [DOI: 10.1089/dia.2018.0246] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
574 Donahey E, Folse S. Management of diabetic ketoacidosis. Adv Emerg Nurs J 2012;34:209-15. [PMID: 22842963 DOI: 10.1097/TME.0b013e31826176f7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
575 Hara JS, Rahbar AJ, Jeffres MN, Izuora KE. Impact of a hyperglycemic crises protocol. Endocr Pract. 2013;19:953-962. [PMID: 23807521 DOI: 10.4158/ep13077.or] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
576 Diallo AM, Novella JL, Lukas C, Souchon PF, Dramé M, François M, Decoudier B, Barraud S, Salmon AS, Ancelle D, Arndt C, Delemer B. Early predictors of diabetic retinopathy in type 1 diabetes: The Retinopathy Champagne Ardenne Diabète (ReCAD) study. J Diabetes Complications 2018;32:753-8. [PMID: 29980433 DOI: 10.1016/j.jdiacomp.2018.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
577 Cheng PC, Hsu SR, Cheng YC. Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus. J Diabetes Res 2016;2016:1269706. [PMID: 27504458 DOI: 10.1155/2016/1269706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
578 Kifle ZD, Abdelwuhab M, Melak AD, Genet G, Meseret T, Adugna M. Pharmacological evaluation of medicinal plants with antidiabetic activities in Ethiopia: A review. Metabolism Open 2022;13:100174. [DOI: 10.1016/j.metop.2022.100174] [Reference Citation Analysis]
579 Farzadfar D, Gordon CA, Falsetta KP, Calder T, Tsegaye A, Kohn N, Schulman-Rosenbaum R. Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients with Diabetic Ketoacidosis. Endocr Pract 2022:S1530-891X(22)00516-X. [PMID: 35623591 DOI: 10.1016/j.eprac.2022.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
580 John Wiley & Sons, Ltd. Current literature in diabetes. Diabetes Metab Res Rev 2010;26:i-ix. [DOI: 10.1002/dmrr.1015] [Reference Citation Analysis]
581 Yoshida N, Goto H, Suzuki H, Nagasawa K, Takeshita A, Okubo M, Miyakawa M, Mori Y, Fukuhara N, Nishioka H, Yamada S, Takeuchi Y. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur J Endocrinol 2013;169:127-32. [PMID: 23828957 DOI: 10.1530/eje-13-0060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
582 Mita T, Katakami N, Shiraiwa T, Yoshii H, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Gosho M, Shimomura I, Watada H. Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus. Sci Rep 2017;7:39965. [PMID: 28067320 DOI: 10.1038/srep39965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
583 Choi YM, Seo JW, Lee WJ, Park HJ, Shin JH, Kang SB, Lee J, Kim JH, Kim SY, Bae HY. Diabetic Ketoacidosis Associated with Emphysematous Gastritis: A Case Report. Endocrinol Metab 2011;26:355. [DOI: 10.3803/enm.2011.26.4.355] [Reference Citation Analysis]
584 McCabe DE, Strollo BP, Fuhrman GM. Euglycemic Diabetic Ketoacidosis in the Surgical Patient. Am Surg 2020;:3134820956352. [PMID: 33316172 DOI: 10.1177/0003134820956352] [Reference Citation Analysis]
585 Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016;CD011281. [PMID: 26798030 DOI: 10.1002/14651858.cd011281.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
586 Nyenwe EA, Razavi LN, Kitabchi AE, Khan AN, Wan JY. Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care. 2010;33:1837-1839. [PMID: 20484127 DOI: 10.2337/dc10-0102] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
587 Li Y, Staley B, Henriksen C, Xu D, Lipori G, Winterstein AG. Development and validation of a dynamic inpatient risk prediction model for clinically significant hypokalemia using electronic health record data. Am J Health Syst Pharm 2019;76:301-11. [PMID: 30698650 DOI: 10.1093/ajhp/zxy051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
588 Sampani E, Sarafidis P, Dimitriadis C, Kasimatis E, Daikidou D, Bantis K, Papanikolaou A, Papagianni A. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review. BMC Nephrol 2020;21:276. [PMID: 32669085 DOI: 10.1186/s12882-020-01930-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
589 Dhatariya KK; Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med 2022;:e14788. [PMID: 35224769 DOI: 10.1111/dme.14788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Patel MP, Ahmed A, Gunapalan T, Hesselbacher SE. Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review. World J Diabetes 2018; 9(11): 199-205 [PMID: 30479686 DOI: 10.4239/wjd.v9.i11.199] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
591 Rondon-Berrios H, Argyropoulos C, Ing TS, Raj DS, Malhotra D, Agaba EI, Rohrscheib M, Khitan ZJ, Murata GH, Shapiro JI, Tzamaloukas AH. Hypertonicity: Clinical entities, manifestations and treatment. World J Nephrol 2017; 6(1): 1-13 [PMID: 28101446 DOI: 10.5527/wjn.v6.i1.1] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
592 Gershkovich B, English SW, Doyle MA, Menon K, McIntyre L. Choice of crystalloid fluid in the treatment of hyperglycemic emergencies: a systematic review protocol. Syst Rev 2019;8:228. [PMID: 31481108 DOI: 10.1186/s13643-019-1130-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
593 Van de Vyver C, Damen J, Haentjens C, Ballaux D, Bouts B. An Exceptional Case of Diabetic Ketoacidosis. Case Reports in Emergency Medicine 2017;2017:1-4. [DOI: 10.1155/2017/4351620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
594 Ge V, Subramaniam A, Banakh I, Wang WC, Tiruvoipati R. Management of sodium-glucose cotransporter 2 inhibitors during the perioperative period: A retrospective comparative study. J Perioper Pract 2021;31:391-8. [PMID: 32894998 DOI: 10.1177/1750458920948693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
595 Rakariyatham K, Zhou D, Rakariyatham N, Shahidi F. Sapindaceae (Dimocarpus longan and Nephelium lappaceum) seed and peel by-products: Potential sources for phenolic compounds and use as functional ingredients in food and health applications. Journal of Functional Foods 2020;67:103846. [DOI: 10.1016/j.jff.2020.103846] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
596 Issa M, Alqahtani F, Ziada KM, Stanazai Q, Aljohani S, Berzingi C, Giordano J, Alkhouli M. Incidence and Outcomes of Non-ST Elevation Myocardial Infarction in Patients Hospitalized with Decompensated Diabetes. Am J Cardiol 2018;122:1297-302. [PMID: 30131108 DOI: 10.1016/j.amjcard.2018.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
597 Mohan M, Baagar KAM, Lindow S. Management of diabetic ketoacidosis in pregnancy. Obstet Gynecol 2017;19:55-62. [DOI: 10.1111/tog.12344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
598 Anno T, Minakawa F, Shigemoto R, Kawasaki F, Ishii K, Kawamoto H, Tomoda K, Kaku K, Kaneto H. Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report. Diabetol Int 2022;13:320-4. [DOI: 10.1007/s13340-021-00540-3] [Reference Citation Analysis]
599 Scott AR; Joint British Diabetes Societies (JBDS) for Inpatient Care., JBDS hyperosmolar hyperglycaemic guidelines group. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 2015;32:714-24. [PMID: 25980647 DOI: 10.1111/dme.12757] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
600 Ye S, Ran H, Zhang H, Wu H, Li W, Du S, Su Q. Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals. Diabetes Metab Syndr Obes 2021;14:497-504. [PMID: 33568926 DOI: 10.2147/DMSO.S296085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
601 Hendrickson AL, Ye XQ, Kalra SS, Franck AJ, Urbine D. Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes. Clin Diabetes 2021;39:121-3. [PMID: 33551563 DOI: 10.2337/cd20-0019] [Reference Citation Analysis]
602 Takai T, Okada Y, Takebe R, Nakamura T. Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types. Diabetol Int 2022;13:272-9. [DOI: 10.1007/s13340-021-00539-w] [Reference Citation Analysis]
603 Carr JR, Hawkins WA, Newsome AS, Smith SE, Amber B C, Bland CM, Branan TN; University of Georgia College of Pharmacy Critical Care Collaborative (UGAC3). Fluid Stewardship of Maintenance Intravenous Fluids. J Pharm Pract 2021;:8971900211008261. [PMID: 33827313 DOI: 10.1177/08971900211008261] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
604 Boeder S, Edelman SV. Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials. Diabetes Obes Metab 2019;21 Suppl 2:62-77. [PMID: 31081593 DOI: 10.1111/dom.13749] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
605 Priyadarsini S, Sarker-Nag A, Allegood J, Chalfant C, Karamichos D. Description of the sphingolipid content and subspecies in the diabetic cornea. Curr Eye Res 2015;40:1204-10. [PMID: 25426847 DOI: 10.3109/02713683.2014.990984] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
606 Baldrighi M, Sainaghi PP, Bellan M, Bartoli E, Castello LM. Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements. Curr Diabetes Rev 2018;14:534-41. [PMID: 29557753 DOI: 10.2174/1573399814666180320091451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
607 Xu Y, Bai J, Wang G, Zhong S, Su X, Huang Z, Chen G, Zhang J, Hou X, Yu X, Lu B, Wang Y, Li X, Hu H, Zhang C, Liang Y, Shaw J, Wu X. Clinical profile of diabetic ketoacidosis in tertiary hospitals in China: a multicentre, clinic-based study. Diabet Med 2016;33:261-8. [DOI: 10.1111/dme.12820] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
608 Bonora BM, Cappellari R, Grasso M, Mazzucato M, D'Anna M, Avogaro A, Fadini GP. Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study. Diabetes Ther 2022;13:1327-37. [PMID: 35676613 DOI: 10.1007/s13300-022-01273-5] [Reference Citation Analysis]
609 Dhatariya K. Diabetic ketoacidosis and hyperosmolar crisis in adults. Medicine 2014;42:723-6. [DOI: 10.1016/j.mpmed.2014.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Wang G, Li Z, Zhang Y, Pan Y, Chen L. Comparison of Combined Hemodialysis and Hemoperfusion with Hemoperfusion Alone in 106 Patients with Diabetic Ketoacidosis and Acute Renal Failure: A Retrospective Study from a Single Center in China. Med Sci Monit 2021;27:e922753. [PMID: 33640896 DOI: 10.12659/MSM.922753] [Reference Citation Analysis]
611 Osborne AD. Care of Metabolic and Endocrine Conditions in the Observation Unit. Emergency Medicine Clinics of North America 2017;35:589-601. [DOI: 10.1016/j.emc.2017.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
612 Vishnu VY, Kattadimmal A, Rao SA, Kadhiravan T. Sporadic hypokalemic paralysis caused by osmotic diuresis in diabetes mellitus. J Clin Neurosci. 2014;21:1267-1268. [PMID: 24472241 DOI: 10.1016/j.jocn.2013.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
613 Corwell B, Knight B, Olivieri L, Willis GC. Current Diagnosis and Treatment of Hyperglycemic Emergencies. Emergency Medicine Clinics of North America 2014;32:437-52. [DOI: 10.1016/j.emc.2014.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
614 Chuang M, Lin Y, Tung T, Chang L, Zan H, Meng H, Lu C, Tao Y. Room-temperature-operated organic-based acetone gas sensor for breath analysis. Sensors and Actuators B: Chemical 2018;260:593-600. [DOI: 10.1016/j.snb.2017.12.168] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 9.8] [Reference Citation Analysis]
615 Gupta RD, Ramachandran R, Gangadhara P, Anoop S, Singh SH, Satyaraddi A, Sathyakumar S, Asha HS, Thomas N. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians. J Diabetes Complications 2017;31:1401-7. [PMID: 28668376 DOI: 10.1016/j.jdiacomp.2017.06.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
616 Lee SH. New Onset Diabetic Ketoacidosis Associated with Quetiapine. Endocrinol Metab 2010;25:231. [DOI: 10.3803/enm.2010.25.3.231] [Reference Citation Analysis]
617 Chow L, Valesky W. Subcutaneous Rapid-acting Insulin Analogs for Diabetic Ketoacidosis. Acad Emerg Med 2021;28:700-2. [PMID: 33145848 DOI: 10.1111/acem.14170] [Reference Citation Analysis]
618 Arora S, Henderson SO, Long T, Menchine M. Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: {beta}-hydroxybutyrate versus the urine dipstick. Diabetes Care 2011;34:852-4. [PMID: 21307381 DOI: 10.2337/dc10-1844] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
619 Gupta D, Kirn M, Jamkhana ZA, Lee R, Albert SG, Rollins KM. A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units. Diabetes Metab Syndr 2017;11:265-71. [PMID: 27658894 DOI: 10.1016/j.dsx.2016.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
620 Vigil D, Ganta K, Sun Y, Dorin RI, Tzamaloukas AH, Servilla KS. Prolonged hypernatremia triggered by hyperglycemic hyperosmolar state with coma: A case report. World J Nephrol 2015; 4(2): 319-323 [PMID: 25949947 DOI: 10.5527/wjn.v4.i2.319] [Reference Citation Analysis]
621 Hörber S, Hudak S, Kächele M, Overkamp D, Fritsche A, Häring HU, Peter A, Heni M. Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus. Endocrinol Diabetes Metab Case Rep 2018;2018. [PMID: 30306778 DOI: 10.1530/EDM-18-0094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
622 Yasunari E, Mita T, Osonoi Y, Azuma K, Goto H, Ohmura C, Kanazawa A, Kawamori R, Fujitani Y, Watada H. Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery. Endocrinology 2014;155:2244-53. [PMID: 24684300 DOI: 10.1210/en.2013-1628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
623 Anderson JD, Rondeau DA, Hess RS. Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats. J Vet Intern Med 2019;33:1593-601. [PMID: 31134702 DOI: 10.1111/jvim.15518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
624 Chen Y, Weng S, Yang C, Wang J, Tien K. Long-term risk of stroke in type 2 diabetes patients with diabetic ketoacidosis: A population-based, propensity score-matched, longitudinal follow-up study. Diabetes & Metabolism 2017;43:223-8. [DOI: 10.1016/j.diabet.2016.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
625 Ng KY, Ma MT, Leung KK, Leung PS. Vitamin D and Vitamin A Receptor Expression and the Proliferative Effects of Ligand Activation of These Receptors on the Development of Pancreatic Progenitor Cells Derived from Human Fetal Pancreas. Stem Cell Rev and Rep 2011;7:53-63. [DOI: 10.1007/s12015-010-9146-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
626 Takeishi S, Mori A, Fushimi N, Hachiya H, Yumura T, Ito S, Shibuya T, Ohashi N, Kawai H. Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring. J Diabetes Investig 2016;7:374-80. [PMID: 27330724 DOI: 10.1111/jdi.12409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
627 De Pretto LR, Yoshimura TM, Ribeiro MS, Zanardi de Freitas A. Optical coherence tomography for blood glucose monitoring in vitro through spatial and temporal approaches. J Biomed Opt 2016;21:86007. [PMID: 27533444 DOI: 10.1117/1.JBO.21.8.086007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
628 Edholm K, Lappé K, Kukhareva P, Hopkins C, Hatton ND, Gebhart B, Nyman H, Signor E, Davis M, Kawamoto K, Johnson SA. Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway. J Healthc Qual 2020;42:e66-74. [DOI: 10.1097/jhq.0000000000000247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Allcock B, Stewart R, Jackson M. Psychosocial factors associated with repeat diabetic ketoacidosis in people living with type 1 diabetes: A systematic review. Diabet Med 2021;:e14663. [PMID: 34324739 DOI: 10.1111/dme.14663] [Reference Citation Analysis]
630 Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise? The Lancet Diabetes & Endocrinology 2017;5:321-3. [DOI: 10.1016/s2213-8587(17)30093-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
631 Maduemem KE, Adesanya O, Anuruegbe OO, Rafiq A. Hyperglycaemic hyperosmolar state: first presentation of type 1 diabetes mellitus in an adolescent with complex medical needs. BMJ Case Rep 2021;14:e237793. [PMID: 33542015 DOI: 10.1136/bcr-2020-237793] [Reference Citation Analysis]
632 Singh K, Lou B, Her J, Pan T. Influence of Annealing Temperature on Structural Compositions and pH Sensing Properties of Sol-Gel Derived YTi x O y Electroceramic Sensing Membranes. J Electrochem Soc 2019;166:B187-92. [DOI: 10.1149/2.0141904jes] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Hati S, Madurkar SM, Bathula C, Thulluri C, Agarwal R, Siddiqui FA, Dangi P, Adepally U, Singh A, Singh S, Sen S. Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors. European Journal of Medicinal Chemistry 2015;100:188-96. [DOI: 10.1016/j.ejmech.2015.04.059] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
634 Devi R, Zohra T, Howard BS, Braithwaite SS. Target attainment through algorithm design during intravenous insulin infusion. Diabetes Technol Ther 2014;16:208-18. [PMID: 24354344 DOI: 10.1089/dia.2013.0287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
635 Helmersson-Karlqvist J, Höög Hammarström K, Palmberg K, Backman-Johansson C. Evaluation of Nova StatStrip and FreeStyle Precision Pro blood ketone tests using 3-hydroxybutyrate doped samples. J Clin Lab Anal 2019;33:e22851. [PMID: 30811634 DOI: 10.1002/jcla.22851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
636 Ishii M. Endocrine Emergencies With Neurologic Manifestations. Continuum (Minneap Minn) 2017;23:778-801. [PMID: 28570329 DOI: 10.1212/CON.0000000000000467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
637 Goyal A, Mathew UE, Golla KK, Mannar V, Kubihal S, Gupta Y, Tandon N. A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia: Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia. Diabetes Metab Syndr 2021;15:102244. [PMID: 34425556 DOI: 10.1016/j.dsx.2021.102244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
638 Nemecek BD, Hermayer KL, Arnold PC, Bohm NM. Evaluation of Ward Management of Diabetic Ketoacidosis. Clin Diabetes 2014;32:100-4. [PMID: 26246680 DOI: 10.2337/diaclin.32.3.100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
639 Orozco-Beltrán D, Guillen-Mollá A, Cebrián-Cuenca AM, Navarro-Pérez J, Gil-Guillén VF, Quesada JA, Pomares-Gómez FJ, Lopez-Pineda A, Carratalá-Munuera C. Hospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015. Diabetes Res Clin Pract 2021;171:108565. [PMID: 33242511 DOI: 10.1016/j.diabres.2020.108565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
640 Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism. 2016;65:507-521. [PMID: 26975543 DOI: 10.1016/j.metabol.2015.12.007] [Cited by in Crossref: 129] [Cited by in F6Publishing: 84] [Article Influence: 18.4] [Reference Citation Analysis]
641 Reddy A, Finley L, Horrall S. Hyperosmolar hyperglycemic syndrome in a young boy. Proc (Bayl Univ Med Cent) 2019;32:627-8. [PMID: 31656445 DOI: 10.1080/08998280.2019.1646598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
642 Bunn S, Halm M. Long-Acting Insulin on the Road to Recovery With Diabetic Ketoacidosis. Am J Crit Care 2016;25:277-80. [PMID: 27134235 DOI: 10.4037/ajcc2016681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
643 Cusumano MC. "High-Intensity" May Not Be the Intent of "Low-Dose" Insulin: Request for Full Protocol. Crit Care Med 2019;47:e793-5. [PMID: 31415329 DOI: 10.1097/CCM.0000000000003845] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
644 Zhai X, Wang Y, Mu Q, Chen X, Huang Q, Wang Q, Li M. Methodological Reporting Quality of Randomized Controlled Trials in 3 Leading Diabetes Journals From 2011 to 2013 Following CONSORT Statement: A System Review. Medicine (Baltimore) 2015;94:e1083. [PMID: 26166088 DOI: 10.1097/MD.0000000000001083] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
645 Shahwan MJ, Khattab MH, Jairoun AA. Association of Serum Calcium Level with Waist Circumference and Other Biochemical Health-care Predictors among Patients with Type 2 Diabetes. J Pharm Bioallied Sci 2019;11:292-8. [PMID: 31555037 DOI: 10.4103/jpbs.JPBS_137_19] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
646 Ing TS, Ganta K, Bhave G, Lew SQ, Agaba EI, Argyropoulos C, Tzamaloukas AH. The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications. Front Med (Lausanne) 2020;7:477. [PMID: 32984372 DOI: 10.3389/fmed.2020.00477] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
647 Robles Arévalo A, Maley JH, Baker L, da Silva Vieira SM, da Costa Sousa JM, Finkelstein S, Mateo-Collado R, Raffa JD, Celi LA, DeMichele F 3rd. Data-driven curation process for describing the blood glucose management in the intensive care unit. Sci Data 2021;8:80. [PMID: 33692359 DOI: 10.1038/s41597-021-00864-4] [Reference Citation Analysis]
648 Stasishin D, Schaffer P, Khan Z, Murphy C. Severe metabolic derangement: a case of concomitant diabetic ketoacidosis and beer potomania. BMJ Case Rep 2021;14:e243486. [PMID: 34373242 DOI: 10.1136/bcr-2021-243486] [Reference Citation Analysis]
649 Blanchard F, Charbit J, Van der Meersch G, Popoff B, Picod A, Cohen R, Chemouni F, Gaudry S, Bihan H, Cohen Y. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care 2020;10:58. [PMID: 32430795 DOI: 10.1186/s13613-020-00676-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
650 Hurtado CR, Lemor A, Vallejo F, Lopez K, Garcia R, Mathew J, Galindo RJ. Causes and Predictors for 30-DAY Re-Admissions in Adult Patients with Diabetic Ketoacidosis in the United States: a Nationwide Analysis, 2010–2014. Endocrine Practice 2019;25:242-53. [DOI: 10.4158/ep-2018-0457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
651 Gomez-peralta F, Escalada San Martín FJ, Menéndez Torre E, Mata Cases M, Ferrer García JC, Ezkurra Loiola P, Ávila Lachica L, Fornos Pérez JA, Artola Menéndez S, Álvarez-guisasola F, Rica Echevarría I, Girbés Borrás J. Recomendaciones de la Sociedad Española de Diabetes (SED) para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: Actualización 2018. Endocrinología, Diabetes y Nutrición 2018;65:611-24. [DOI: 10.1016/j.endinu.2018.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
652 Gao S, Wolanyk N, Chen Y, Jia S, Hessner MJ, Wang X. Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes. BMC Med Genomics 2017;10:7. [PMID: 28143555 DOI: 10.1186/s12920-017-0243-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
653 Reidy C, Bracher M, Foster C, Vassilev I, Rogers A. The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis. Health Expect 2018;21:714-29. [PMID: 29418050 DOI: 10.1111/hex.12666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
654 Lovrenčić MV, Biljak VR, Blaslov K, Božičević S, Duvnjak LS. Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes 2017; 8(5): 222-229 [PMID: 28572883 DOI: 10.4239/wjd.v8.i5.222] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
655 Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers 2020;6:40. [PMID: 32409703 DOI: 10.1038/s41572-020-0165-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
656 Rahmadi A, Decroli E, Kam A. Sepsis in Latent Autoimmune Diabetes in Adults with Diabetic Ketoacidosis: A Case Report. Open Access Maced J Med Sci 2019;7:3501-4. [PMID: 32002083 DOI: 10.3889/oamjms.2019.687] [Reference Citation Analysis]
657 Sriperumbuduri S, Clark E, Biyani M, Ruzicka M. High Anion Gap Metabolic Acidosis on Continuous Renal Replacement Therapy. Kidney Int Rep 2020;5:1833-5. [PMID: 33102978 DOI: 10.1016/j.ekir.2020.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
658 Bone RN, Evans-Molina C. Combination Immunotherapy for Type 1 Diabetes. Curr Diab Rep 2017;17:50. [PMID: 28534310 DOI: 10.1007/s11892-017-0878-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
659 Huang CC, Chou W, Lin HJ, Chen SC, Kuo SC, Chen WL, Chen JH, Wang HY, Guo HR. Cancer history, bandemia, and serum creatinine are independent mortality predictors in patients with infection-precipitated hyperglycemic crises. BMC Endocr Disord 2013;13:23. [PMID: 23866067 DOI: 10.1186/1472-6823-13-23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
660 Defayette AA, Voigt LM, Zammit KT, Nadler JN, Kersten BP. Evaluation of a Computerized Insulin Dosing Tool for the Treatment of Diabetic Ketoacidosis. J Pharm Pract 2020;33:768-73. [PMID: 30852934 DOI: 10.1177/0897190019834367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
661 Long B, Lentz S, Gottlieb M. Alcoholic Ketoacidosis: Etiologies, Evaluation, and Management. J Emerg Med 2021:S0736-4679(21)00717-4. [PMID: 34711442 DOI: 10.1016/j.jemermed.2021.09.007] [Reference Citation Analysis]
662 Piro S, Purrello F. Acute diabetes complications. JGG 2021;69:269-75. [DOI: 10.36150/2499-6564-n457] [Reference Citation Analysis]
663 Yii ESS, Azli AW, Sitaram PN. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report. J Med Case Rep 2022;16:17. [PMID: 34983625 DOI: 10.1186/s13256-021-03232-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
664 Houshyar J, Bahrami A, Aliasgarzadeh A. Effectiveness of Insulin Glargine on Recovery of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial. J Clin Diagn Res 2015;9:OC01-5. [PMID: 26155506 DOI: 10.7860/JCDR/2015/12005.5883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
665 Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int 2018;9:1-45. [PMID: 30603347 DOI: 10.1007/s13340-018-0345-3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 24.8] [Reference Citation Analysis]
666 Chee YJ, Ng SJH, Yeoh E. Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract 2020;166:108305. [PMID: 32623039 DOI: 10.1016/j.diabres.2020.108305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
667 Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases 2014; 2(10): 488-496 [PMID: 25325058 DOI: 10.12998/wjcc.v2.i10.488] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 126] [Article Influence: 18.1] [Reference Citation Analysis]
668 Fukuda M, Nabeta M, Muta T, Fukami K, Takasu O. Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report. Int J Emerg Med 2020;13:2. [PMID: 31969112 DOI: 10.1186/s12245-020-0261-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
669 Cardoso L, Vicente N, Rodrigues D, Gomes L, Carrilho F. Controversies in the management of hyperglycaemic emergencies in adults with diabetes. Metabolism 2017;68:43-54. [DOI: 10.1016/j.metabol.2016.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
670 Ndebele NFM, Naidoo M. The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal. Afr J Prim Health Care Fam Med 2018;10:e1-6. [PMID: 29781681 DOI: 10.4102/phcfm.v10i1.1612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
671 Zangeneh MM, Zangeneh A, Amiri H, Amiri N, Tahvilian R, Moradi R, Zhaleh H, Tehrani PR. Nephroprotective activity of Alyssum meniocoides Boiss aqueous extract on streptozotocin-induced diabetic nephrotoxicity in male mice. Comp Clin Pathol 2018;27:1147-54. [DOI: 10.1007/s00580-018-2712-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
672 Seibold J, Ramshorn-zimmer A, Ebert T, Tönjes A. Diabetologische Notfälle im Krankenhaus. Diabetologe. [DOI: 10.1007/s11428-022-00875-8] [Reference Citation Analysis]
673 Chen YC, Tsai SJ. Bilateral cerebral infarction in diabetic ketoacidosis and bilateral internal carotid artery occlusion: A case report and review of literature. World J Clin Cases 2021; 9(15): 3787-3795 [PMID: 34046484 DOI: 10.12998/wjcc.v9.i15.3787] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
674 Alsofiani WA, Alessa BH, Alsabaan F, Althemery AU, Ghith AM, Alfaifi AA. Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients. Diabetes Metab Syndr Obes 2022;15:733-9. [PMID: 35280501 DOI: 10.2147/DMSO.S351155] [Reference Citation Analysis]
675 Maletkovic J, Drexler A. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am. 2013;42:677-695. [PMID: 24286946 DOI: 10.1016/j.ecl.2013.07.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
676 Bahremand S, Ko HS, Balouchzadeh R, Felix Lee H, Park S, Kwon G. Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system. Med Biol Eng Comput 2019;57:177-91. [PMID: 30069675 DOI: 10.1007/s11517-018-1872-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
677 Gosmanov AR, Gosmanova EO, Dillard-Cannon E. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014;7:255-264. [PMID: 25061324 DOI: 10.2147/dmso.s50516] [Cited by in Crossref: 86] [Cited by in F6Publishing: 44] [Article Influence: 10.8] [Reference Citation Analysis]
678 Cavka L, Bencak Ferko U, Pitz N, Trpkovski Z, Lainscak M. Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2631-6. [PMID: 34102028 DOI: 10.1002/ehf2.13452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
679 Wang L, Voss EA, Weaver J, Hester L, Yuan Z, DeFalco F, Schuemie MJ, Ryan PB, Sun D, Freedman A, Alba M, Lind J, Meininger G, Berlin JA, Rosenthal N. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases. Pharmacoepidemiol Drug Saf 2019;28:1620-8. [PMID: 31456304 DOI: 10.1002/pds.4887] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
680 Umadat G, Moktan V, Shapiro B. 61-Year-Old Man With Nausea and Vomiting. Mayo Clin Proc 2021:S0025-6196(21)00716-3. [PMID: 34862073 DOI: 10.1016/j.mayocp.2021.04.031] [Reference Citation Analysis]
681 Worndl E, Fung K, Fischer HD, Austin PC, Krzyzanowska MK, Lipscombe LL. Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study. JNCI Cancer Spectr 2018;2:pky008. [PMID: 29795802 DOI: 10.1093/jncics/pky008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
682 Gershengorn HB, Iwashyna TJ, Cooke CR, Scales DC, Kahn JM, Wunsch H. Variation in use of intensive care for adults with diabetic ketoacidosis*. Crit Care Med. 2012;40:2009-2015. [PMID: 22564962 DOI: 10.1097/ccm.0b013e31824e9eae] [Cited by in Crossref: 79] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
683 Roumelioti ME, Tzamaloukas AH. Management of plasma hypertonicity resulting from osmotic diuresis. Int Urol Nephrol 2019;51:1079-80. [PMID: 31098817 DOI: 10.1007/s11255-019-02137-x] [Reference Citation Analysis]
684 Gupta RD, Atri A, Mondal S, Bhattacharjee A, Garai R, Hazra AK, Choudhury B, Dutta DS, Lodh M, Ganguly A. Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India. J Diabetes Complications 2021;:108100. [PMID: 34916147 DOI: 10.1016/j.jdiacomp.2021.108100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
685 Surya S, Salam AD, Tomy DV, Carla B, Kumar RA, Sunil C. Diabetes mellitus and medicinal plants-a review. Asian Pacific Journal of Tropical Disease 2014;4:337-47. [DOI: 10.1016/s2222-1808(14)60585-5] [Cited by in Crossref: 37] [Article Influence: 4.6] [Reference Citation Analysis]
686 Vidyarthi M, Chowdhury TA. Diagnosis and early management of hyperglycaemic emergencies in the emergency department. QJM 2012;105:296-7. [PMID: 22179102 DOI: 10.1093/qjmed/hcr252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
687 Kreider KE, Gabrielski AA, Hammonds FB. Hyperglycemia Syndromes. Nursing Clinics of North America 2018;53:303-17. [DOI: 10.1016/j.cnur.2018.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
688 Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Endocr Rev. 2019;40:17-65. [PMID: 30184160 DOI: 10.1210/er.2018-00006] [Cited by in Crossref: 134] [Cited by in F6Publishing: 115] [Article Influence: 44.7] [Reference Citation Analysis]
689 Joyner Blair AM, Hamilton BK, Spurlock A. Evaluating an Order Set for Improvement of Quality Outcomes in Diabetic Ketoacidosis. Adv Emerg Nurs J 2018;40:59-72. [PMID: 29384776 DOI: 10.1097/TME.0000000000000178] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
690 Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med. 2019;63:9-14. [PMID: 30910328 DOI: 10.1016/j.ejim.2019.03.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
691 Li X, Si H, Chen Y, Li S, Yin N, Wang Z. Effects of fitness qigong and tai chi on middle-aged and elderly patients with type 2 diabetes mellitus. PLoS One 2020;15:e0243989. [PMID: 33332396 DOI: 10.1371/journal.pone.0243989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
692 Inokuchi R, Matsumoto A, Odajima H, Shinohara K. Fulminant type 1 diabetes mellitus. BMJ Case Rep. 2012;2012:pii: bcr2012006560. [PMID: 22854241 DOI: 10.1136/bcr-2012-006560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
693 Perilli G, Saraceni C, Daniels MN, Ahmad A. Diabetic Ketoacidosis: A Review and Update. Curr Emerg Hosp Med Rep 2013;1:10-7. [DOI: 10.1007/s40138-012-0001-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
694 Zurek AM, Yendapally R, Urteaga EM. A Review of the Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors: A Focus on Diabetic Ketoacidosis. Diabetes Spectr 2017;30:137-42. [PMID: 28588380 DOI: 10.2337/ds16-0030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
695 Huiying Z, Guangying C, Shiyang Z. Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers. J Enzyme Inhib Med Chem 2019;34:981-9. [PMID: 31072232 DOI: 10.1080/14756366.2019.1608197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
696 Li J, Shen X. Leptin concentration and oxidative stress in diabetic ketoacidosis. Eur J Clin Invest 2018;48:e13006. [PMID: 30053313 DOI: 10.1111/eci.13006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
697 Segebrecht R, Moncure M, Bennett A, Geehan D, Van Way CW, Weide L. Ketoacidosis in Euglycemic Patients With Type 2 Diabetes After Abdominal Surgery. Journal of Parenteral and Enteral Nutrition 2019;43:937-40. [DOI: 10.1002/jpen.1594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
698 Noll KM, Franck AJ, Hendrickson AL, Telford ED, Maltese Dietrich N. Integration of Around-the-Clock Clinical Pharmacy Specialists Into the Critical Care Team Can Increase Safety of Hyperglycemic Crisis Management. Clin Diabetes 2019;37:86-9. [PMID: 30705502 DOI: 10.2337/cd18-0017] [Reference Citation Analysis]
699 Lindsay PJ, Gibson LE, Bittner EA, Berg S, Chang MG. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report. Int J Surg Case Rep 2020;77:463-6. [PMID: 33395826 DOI: 10.1016/j.ijscr.2020.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
700 Sadeghi M, Moradi M, Madanchi H, Johari B. In silico study of garlic (Allium sativum L.)-derived compounds molecular interactions with α-glucosidase. In Silico Pharmacol 2021;9:11. [PMID: 33457179 DOI: 10.1007/s40203-020-00072-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
701 Menzen M. [21/m-Severe deterioration of general condition : Preparation for the medical specialist examination: part 22]. Internist (Berl) 2021;62:125-9. [PMID: 33635368 DOI: 10.1007/s00108-021-00960-y] [Reference Citation Analysis]
702 Caduff A, Heinemann L, Talary MS, Di Benedetto G, Lutz HU, Theander S. A 4-h hyperglycaemic excursion induces rapid and slow changes in major electrolytes in blood in healthy human subjects. Acta Diabetol 2012;49:333-9. [PMID: 21574002 DOI: 10.1007/s00592-011-0292-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
703 You JH, Song SO, Park SH, Park KH, Nam JY, Kim DW, Kim HM, Kim DJ, Lee YH, Lee BW. Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data. Endocrinol Metab (Seoul) 2019;34:275-81. [PMID: 31565880 DOI: 10.3803/EnM.2019.34.3.275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
704 Konstantinov NK, Rohrscheib M, Agaba EI, Dorin RI, Murata GH, Tzamaloukas AH. Respiratory failure in diabetic ketoacidosis. World J Diabetes 2015; 6(8): 1009-1023 [PMID: 26240698 DOI: 10.4239/wjd.v6.i8.1009] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
705 Hallett A, Modi A, Levy N. Developments in the management of diabetic ketoacidosis in adults: implications for anaesthetists. BJA Education 2016;16:8-14. [DOI: 10.1093/bjaceaccp/mkv006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
706 Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, Saeed A, Iqbal J, Khan I. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Bioorganic Chemistry 2018;77:190-202. [DOI: 10.1016/j.bioorg.2017.12.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
707 Xin Y, Zhang H, Jia Z, Ding X, Sun Y, Wang Q, Xu T. Resveratrol improves uric acid-induced pancreatic β-cells injury and dysfunction through regulation of miR-126. Biomedicine & Pharmacotherapy 2018;102:1120-6. [DOI: 10.1016/j.biopha.2018.03.172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
708 Long B, Willis GC, Lentz S, Koyfman A, Gottlieb M. Evaluation and Management of the Critically Ill Adult With Diabetic Ketoacidosis. The Journal of Emergency Medicine 2020;59:371-83. [DOI: 10.1016/j.jemermed.2020.06.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
709 Mohamed GA, Abd-elrahman MZ, Bahriz R, Albehairy A. Inflammatory cytokine and plasma C-reactive protein response to ketoacidosis in adults with type 1 diabetes: Egyptian multicenter study. Egypt J Intern Med 2020;32. [DOI: 10.1186/s43162-020-00011-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
710 Wang W. Research of Epidemic Big Data Based on Improved Deep Convolutional Neural Network. Comput Math Methods Med 2020;2020:3641745. [PMID: 32774444 DOI: 10.1155/2020/3641745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
711 Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes Metab Syndr. 2020;14:1563-1569. [PMID: 32853901 DOI: 10.1016/j.dsx.2020.08.015] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 26.5] [Reference Citation Analysis]
712 Rizo IM, Apovian CM. Diabetic Ketoacidosis Post Bariatric Surgery. Front Endocrinol (Lausanne) 2018;9:812. [PMID: 30697192 DOI: 10.3389/fendo.2018.00812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
713 Lorenson JL, Cusumano MC, Stewart AM, Buhnerkempe MG, Sanghavi D. Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: a retrospective cohort study. Int J Pharm Pract 2019;27:380-5. [PMID: 30847977 DOI: 10.1111/ijpp.12525] [Reference Citation Analysis]
714 Qiu C, Enquobahrie DA, Frederick IO, Sorensen TK, Fernandez MA, David RM, Bralley JA, Williams MA. Early pregnancy urinary biomarkers of fatty acid and carbohydrate metabolism in pregnancies complicated by gestational diabetes. Diabetes Res Clin Pract. 2014;104:393-400. [PMID: 24703806 DOI: 10.1016/j.diabres.2014.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
715 Nishikawa T, Kinoshita H, Ono K, Kodama-Hashimoto S, Kobayashi Y, Nakamura T, Yoshinaga T, Ohkubo Y, Harada M, Toyonaga T, Takahashi T, Araki E. Clinical profiles of hyperglycemic crises: A single-center retrospective study from Japan. J Diabetes Investig 2021;12:1359-66. [PMID: 33277786 DOI: 10.1111/jdi.13475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
716 Clark JL, Rudloff E, Rick M. Percent recovery of insulin from two different concentrations (3 U/250 mL and 45 U/250 mL) of regular insulin solutions prepared for continuous rate infusion. J Vet Emerg Crit Care (San Antonio) 2021;31:117-20. [PMID: 33135244 DOI: 10.1111/vec.13023] [Reference Citation Analysis]
717 Tanda N, Hinokio Y, Washio J, Takahashi N, Koseki T. Analysis of ketone bodies in exhaled breath and blood of ten healthy Japanese at OGTT using a portable gas chromatograph. J Breath Res 2014;8:046008. [DOI: 10.1088/1752-7155/8/4/046008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
718 Alakkas Z, Alzaedi OA, Somannavar SS, Alfaifi A. Steroid-Induced Diabetes Ketoacidosis in an Immune Thrombocytopenia Patient: A Case Report and Literature Review. Am J Case Rep 2020;21:e923372. [PMID: 32418984 DOI: 10.12659/AJCR.923372] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
719 Huang J, Yeung AM, Nguyen KT, Xu NY, Preiser JC, Rushakoff RJ, Seley JJ, Umpierrez GE, Wallia A, Drincic AT, Gianchandani R, Lansang MC, Masharani U, Mathioudakis N, Pasquel FJ, Schmidt S, Shah VN, Spanakis EK, Stuhr A, Treiber GM, Klonoff DC. Hospital Diabetes Meeting 2022. J Diabetes Sci Technol 2022;:19322968221110878. [PMID: 35904143 DOI: 10.1177/19322968221110878] [Reference Citation Analysis]
720 Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N. Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes. Lancet Diabetes Endocrinol 2020;8:436-46. [PMID: 32333879 DOI: 10.1016/S2213-8587(20)30042-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
721 Firestone RL, Duby JJ. The authors reply. Crit Care Med 2019;47:e793-4. [PMID: 31415330 DOI: 10.1097/CCM.0000000000003885] [Reference Citation Analysis]
722 Alghamdi NA, Major P, Chaudhuri D, Tsui J, Brown B, Self WH, Semler MW, Ramanan M, Rochwerg B. Saline Compared to Balanced Crystalloid in Patients With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Explor 2022;4:e0613. [PMID: 35018349 DOI: 10.1097/CCE.0000000000000613] [Reference Citation Analysis]
723 Lertdetkajorn K, Sriphrapradang C. Management of Diabetic Ketoacidosis with Dengue Hemorrhagic Fever. Cureus 2018;10:e3336. [PMID: 30473969 DOI: 10.7759/cureus.3336] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
724 Mendez Y, Surani S, Varon J. Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward? World J Diabetes 2017; 8(2): 40-44 [PMID: 28265341 DOI: 10.4239/wjd.v8.i2.40] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
725 Inzucchi SE, Sherwin RS. Type 1 Diabetes Mellitus. Goldman's Cecil Medicine. Elsevier; 2012. pp. 1475-89. [DOI: 10.1016/b978-1-4377-1604-7.00236-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
726 Hare MJL, Deitch JM, Kang MJY, Bach LA. Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes. Intern Med J 2021;51:1292-7. [PMID: 32358796 DOI: 10.1111/imj.14877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
727 Abu-Abed Abdin A, Hamza M, Khan MS, Ahmed A. Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication. Case Rep Crit Care. 2016;2016:4275651. [PMID: 27579186 DOI: 10.1155/2016/4275651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
728 Talebi S, Ghobadi F, Cacacho A, Olatunde O, Derobertis A, Pekler G, Visco F, Mushiyev S, Hassen GW. Looking at diabetic ketoacidosis through electrocardiogram window! The American Journal of Emergency Medicine 2016;34:263-5. [DOI: 10.1016/j.ajem.2015.10.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
729 Cheng Q, Yang S, Zhao C, Wang Z, Feng Z, Li R, Ye P, Zhang S, Deng H, Zhou B, Long J, Gong L, Qing H, Luo C, Li Q. Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy. J Diabetes 2015;7:182-91. [PMID: 24823280 DOI: 10.1111/1753-0407.12167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
730 Yang S, Mi J, Liu Z, Wang B, Xia X, Wang R, Liu Y, Li Y. Pharmacokinetics, Tissue Distribution, and Elimination of Three Active Alkaloids in Rats after Oral Administration of the Effective Fraction of Alkaloids from Ramulus Mori, an Innovative Hypoglycemic Agent. Molecules 2017;22:E1616. [PMID: 28954438 DOI: 10.3390/molecules22101616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
731 Ramesh J, Rajesh M, Varghese J, Reddy SLS. Calculated plasma osmolality at hospital admission correlates well with eGFR and D-Dimer, a simple outcome predictor and guiding tool for management of severe COVID-19 patients. Diabetes Metab Syndr 2021;15:102240. [PMID: 34403950 DOI: 10.1016/j.dsx.2021.102240] [Reference Citation Analysis]
732 Charoenpiriya A, Chailurkit L, Ongphiphadhanakul B. Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes. BMC Endocr Disord 2022;22:7. [PMID: 34986830 DOI: 10.1186/s12902-021-00922-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
733 Chen YL, Weng SF, Yang CY, Wang JJ, Tien KJ. Diabetic ketoacidosis further increases risk of Alzheimer's disease in patients with type 2 diabetes. Diabetes Res Clin Pract 2019;147:55-61. [PMID: 30481578 DOI: 10.1016/j.diabres.2018.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
734 Andreano A, Bosio M, Russo AG. Emergency attendance for acute hyper- and hypoglycaemia in the adult diabetic population of the metropolitan area of Milan: quantifying the phenomenon and studying its predictors. BMC Endocr Disord 2020;20:72. [PMID: 32429960 DOI: 10.1186/s12902-020-0546-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
735 Jiménez-castillo RA, Carrizales-sepúlveda EF, Román-montalvo MA, Benavides-salgado DE, Vera-pineda R, Violante-cumpa JR, Herrera-elizondo JL, Rivas-wong G, Corpus-ruiz DG, Náñez-terreros H. Clinical outcomes and biochemical characteristics of a Hispanic cohort of patients with diabetic ketoacidosis: 10-Year experience in an emergency department. Endocrinología, Diabetes y Nutrición 2020;67:216-8. [DOI: 10.1016/j.endinu.2019.09.007]